Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review</title><author><name sortKey="Sever, Sakine" sort="Sever, Sakine" uniqKey="Sever S" first="Sakine" last="Sever">Sakine Sever</name><affiliation><nlm:aff id="aff1"><institution>Division of Endocrinology</institution><addr-line>Diabetes, and Metabolism, Baylor College of Medicine, Alkek Building for Biomedical Research, Houston, Texas, USA</addr-line></nlm:aff></affiliation></author><author><name sortKey="White, Donna L" sort="White, Donna L" uniqKey="White D" first="Donna L" last="White">Donna L. White</name><affiliation><nlm:aff id="aff2"><institution>Section of Gastroenterology and Hepatology</institution><addr-line>Baylor College of Medicine Medical Center, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff3"><institution>Clinical Epidemiology and Comparative Effectiveness Program</institution><addr-line>Section of Health Services Research (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, HSR&D Center of Innovation (152), Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff4"><institution>Texas Medical Center Digestive Disease Center</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff5"><institution>Dan L. Duncan Comprehensive Cancer Center</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff6"><institution>Center for Translational Research on Inflammatory Diseases (CTRID)</institution><addr-line>Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Garcia, Jose M" sort="Garcia, Jose M" uniqKey="Garcia J" first="José M" last="Garcia">José M. Garcia</name><affiliation><nlm:aff id="aff1"><institution>Division of Endocrinology</institution><addr-line>Diabetes, and Metabolism, Baylor College of Medicine, Alkek Building for Biomedical Research, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff6"><institution>Center for Translational Research on Inflammatory Diseases (CTRID)</institution><addr-line>Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff7"><institution>Department of Molecular and Cellular Biology</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff8"><institution>Huffington Center on Aging</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff9"><institution>Geriatrics Research Education and Clinical Center</institution><addr-line>Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA</addr-line></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">27552970</idno><idno type="pmc">5064755</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064755</idno><idno type="RBID">PMC:5064755</idno><idno type="doi">10.1530/ERC-16-0130</idno><date when="2016">2016</date><idno type="wicri:Area/Pmc/Corpus">000460</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review</title><author><name sortKey="Sever, Sakine" sort="Sever, Sakine" uniqKey="Sever S" first="Sakine" last="Sever">Sakine Sever</name><affiliation><nlm:aff id="aff1"><institution>Division of Endocrinology</institution><addr-line>Diabetes, and Metabolism, Baylor College of Medicine, Alkek Building for Biomedical Research, Houston, Texas, USA</addr-line></nlm:aff></affiliation></author><author><name sortKey="White, Donna L" sort="White, Donna L" uniqKey="White D" first="Donna L" last="White">Donna L. White</name><affiliation><nlm:aff id="aff2"><institution>Section of Gastroenterology and Hepatology</institution><addr-line>Baylor College of Medicine Medical Center, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff3"><institution>Clinical Epidemiology and Comparative Effectiveness Program</institution><addr-line>Section of Health Services Research (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, HSR&D Center of Innovation (152), Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff4"><institution>Texas Medical Center Digestive Disease Center</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff5"><institution>Dan L. Duncan Comprehensive Cancer Center</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff6"><institution>Center for Translational Research on Inflammatory Diseases (CTRID)</institution><addr-line>Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Garcia, Jose M" sort="Garcia, Jose M" uniqKey="Garcia J" first="José M" last="Garcia">José M. Garcia</name><affiliation><nlm:aff id="aff1"><institution>Division of Endocrinology</institution><addr-line>Diabetes, and Metabolism, Baylor College of Medicine, Alkek Building for Biomedical Research, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff6"><institution>Center for Translational Research on Inflammatory Diseases (CTRID)</institution><addr-line>Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff7"><institution>Department of Molecular and Cellular Biology</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff8"><institution>Huffington Center on Aging</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff9"><institution>Geriatrics Research Education and Clinical Center</institution><addr-line>Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA</addr-line></nlm:aff></affiliation></author></analytic><series><title level="j">Endocrine-Related Cancer</title><idno type="ISSN">1351-0088</idno><idno type="eISSN">1479-6821</idno><imprint><date when="2016">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Ghrelin is a hormone with multiple physiologic functions, including promotion of growth hormone release, stimulation of appetite and regulation of energy homeostasis. Treatment with ghrelin/ghrelin-receptor agonists is a prospective therapy for disease-related cachexia and malnutrition. <italic>In vitro</italic> studies have shown high expression of ghrelin in cancer tissue, although its role including its impact in cancer risk and progression has not been established. We performed a systematic literature review to identify peer-reviewed human or animal <italic>in vivo</italic> original research studies of ghrelin, ghrelin-receptor agonists, or ghrelin genetic variants and the risk, presence, or growth of cancer using structured searches in PubMed database as well as secondary searches of article reference lists, additional reviews and meta-analyses. Overall, 45 (73.8%) of the 61 studies reviewed, including all 11 involving exogenous ghrelin/ghrelin-receptor agonist treatment, reported either a null (no statistically significant difference) or inverse association of ghrelin/ghrelin-receptor agonists or ghrelin genetic variants with cancer risk, presence or growth; 10 (16.7%) studies reported positive associations; and 6 (10.0%) reported both negative or null and positive associations. Differences in serum ghrelin levels in cancer cases vs controls (typically lower) were reported for some but not all cancers. The majority of <italic>in vivo</italic> studies showed a null or inverse association of ghrelin with risk and progression of most cancers, suggesting that ghrelin/ghrelin-receptor agonist treatment may have a favorable safety profile to use for cancer cachexia. Additional large-scale prospective clinical trials as well as basic bioscientific research are warranted to further evaluate the safety and benefits of ghrelin treatment in patients with cancer.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Akamizu, T" uniqKey="Akamizu T">T Akamizu</name></author><author><name sortKey="Shinomiya, T" uniqKey="Shinomiya T">T Shinomiya</name></author><author><name sortKey="Irako, T" uniqKey="Irako T">T Irako</name></author><author><name sortKey="Fukunaga, M" uniqKey="Fukunaga M">M Fukunaga</name></author><author><name sortKey="Nakai, Y" uniqKey="Nakai Y">Y Nakai</name></author><author><name sortKey="Nakai, Y" uniqKey="Nakai Y">Y Nakai</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ali, S" uniqKey="Ali S">S Ali</name></author><author><name sortKey="Chen, Ja" uniqKey="Chen J">JA Chen</name></author><author><name sortKey="Garcia, Jm" uniqKey="Garcia J">JM Garcia</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Allen, Db" uniqKey="Allen D">DB Allen</name></author><author><name sortKey="Rundle, Ac" uniqKey="Rundle A">AC Rundle</name></author><author><name sortKey="Graves, Da" uniqKey="Graves D">DA Graves</name></author><author><name sortKey="Blethen, Sl" uniqKey="Blethen S">SL Blethen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ataseven, H" uniqKey="Ataseven H">H Ataseven</name></author><author><name sortKey="Bahcecioglu, Ih" uniqKey="Bahcecioglu I">IH Bahcecioglu</name></author><author><name sortKey="Kuzu, N" uniqKey="Kuzu N">N Kuzu</name></author><author><name sortKey="Yalniz, M" uniqKey="Yalniz M">M Yalniz</name></author><author><name sortKey="Celebi, S" uniqKey="Celebi S">S Celebi</name></author><author><name sortKey="Erensoy, A" uniqKey="Erensoy A">A Erensoy</name></author><author><name sortKey="Ustundag, B" uniqKey="Ustundag B">B Ustundag</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Aydin, S" uniqKey="Aydin S">S Aydin</name></author><author><name sortKey="Karatas, F" uniqKey="Karatas F">F Karatas</name></author><author><name sortKey="Geckil, H" uniqKey="Geckil H">H Geckil</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bataar, D" uniqKey="Bataar D">D Bataar</name></author><author><name sortKey="Patel, K" uniqKey="Patel K">K Patel</name></author><author><name sortKey="Taub, Dd" uniqKey="Taub D">DD Taub</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bednarek, Ma" uniqKey="Bednarek M">MA Bednarek</name></author><author><name sortKey="Feighner, Sd" uniqKey="Feighner S">SD Feighner</name></author><author><name sortKey="Pong, Ss" uniqKey="Pong S">SS Pong</name></author><author><name sortKey="Mckee, Kk" uniqKey="Mckee K">KK McKee</name></author><author><name sortKey="Hreniuk, Dl" uniqKey="Hreniuk D">DL Hreniuk</name></author><author><name sortKey="Silva, Mv" uniqKey="Silva M">MV Silva</name></author><author><name sortKey="Warren, Va" uniqKey="Warren V">VA Warren</name></author><author><name sortKey="Howard, Ad" uniqKey="Howard A">AD Howard</name></author><author><name sortKey="Van Der Ploeg, Lh" uniqKey="Van Der Ploeg L">LH Van Der Ploeg</name></author><author><name sortKey="Heck, Jv" uniqKey="Heck J">JV Heck</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Benedix, F" uniqKey="Benedix F">F Benedix</name></author><author><name sortKey="Westphal, S" uniqKey="Westphal S">S Westphal</name></author><author><name sortKey="Patschke, R" uniqKey="Patschke R">R Patschke</name></author><author><name sortKey="Luley, C" uniqKey="Luley C">C Luley</name></author><author><name sortKey="Lippert, H" uniqKey="Lippert H">H Lippert</name></author><author><name sortKey="Wolff, S" uniqKey="Wolff S">S Wolff</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Brignardello, E" uniqKey="Brignardello E">E Brignardello</name></author><author><name sortKey="Felicetti, F" uniqKey="Felicetti F">F Felicetti</name></author><author><name sortKey="Castiglione, A" uniqKey="Castiglione A">A Castiglione</name></author><author><name sortKey="Fortunati, N" uniqKey="Fortunati N">N Fortunati</name></author><author><name sortKey="Matarazzo, P" uniqKey="Matarazzo P">P Matarazzo</name></author><author><name sortKey="Biasin, E" uniqKey="Biasin E">E Biasin</name></author><author><name sortKey="Sacerdote, C" uniqKey="Sacerdote C">C Sacerdote</name></author><author><name sortKey="Ricardi, U" uniqKey="Ricardi U">U Ricardi</name></author><author><name sortKey="Fagioli, F" uniqKey="Fagioli F">F Fagioli</name></author><author><name sortKey="Corrias, A" uniqKey="Corrias A">A Corrias</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Callaghan, B" uniqKey="Callaghan B">B Callaghan</name></author><author><name sortKey="Furness, Jb" uniqKey="Furness J">JB Furness</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Campa, D" uniqKey="Campa D">D Campa</name></author><author><name sortKey="Pardini, B" uniqKey="Pardini B">B Pardini</name></author><author><name sortKey="Naccarati, A" uniqKey="Naccarati A">A Naccarati</name></author><author><name sortKey="Vodickova, L" uniqKey="Vodickova L">L Vodickova</name></author><author><name sortKey="Novotny, J" uniqKey="Novotny J">J Novotny</name></author><author><name sortKey="Steinke, V" uniqKey="Steinke V">V Steinke</name></author><author><name sortKey="Rahner, N" uniqKey="Rahner N">N Rahner</name></author><author><name sortKey="Holinski Feder, E" uniqKey="Holinski Feder E">E Holinski-Feder</name></author><author><name sortKey="Morak, M" uniqKey="Morak M">M Morak</name></author><author><name sortKey="Schackert, Hk" uniqKey="Schackert H">HK Schackert</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cao, H" uniqKey="Cao H">H Cao</name></author><author><name sortKey="Wang, G" uniqKey="Wang G">G Wang</name></author><author><name sortKey="Meng, L" uniqKey="Meng L">L Meng</name></author><author><name sortKey="Shen, H" uniqKey="Shen H">H Shen</name></author><author><name sortKey="Feng, Z" uniqKey="Feng Z">Z Feng</name></author><author><name sortKey="Liu, Q" uniqKey="Liu Q">Q Liu</name></author><author><name sortKey="Du, J" uniqKey="Du J">J Du</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, W" uniqKey="Chen W">W Chen</name></author><author><name sortKey="Enriori, Pj" uniqKey="Enriori P">PJ Enriori</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, Ja" uniqKey="Chen J">JA Chen</name></author><author><name sortKey="Splenser, A" uniqKey="Splenser A">A Splenser</name></author><author><name sortKey="Guillory, B" uniqKey="Guillory B">B Guillory</name></author><author><name sortKey="Luo, J" uniqKey="Luo J">J Luo</name></author><author><name sortKey="Mendiratta, M" uniqKey="Mendiratta M">M Mendiratta</name></author><author><name sortKey="Belinova, B" uniqKey="Belinova B">B Belinova</name></author><author><name sortKey="Halder, T" uniqKey="Halder T">T Halder</name></author><author><name sortKey="Zhang, G" uniqKey="Zhang G">G Zhang</name></author><author><name sortKey="Li, Yp" uniqKey="Li Y">YP Li</name></author><author><name sortKey="Garcia, Jm" uniqKey="Garcia J">JM Garcia</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Child, Cj" uniqKey="Child C">CJ Child</name></author><author><name sortKey="Conroy, D" uniqKey="Conroy D">D Conroy</name></author><author><name sortKey="Zimmerman, Ag" uniqKey="Zimmerman A">AG Zimmerman</name></author><author><name sortKey="Woodmansee, Ww" uniqKey="Woodmansee W">WW Woodmansee</name></author><author><name sortKey="Erfurth, Em" uniqKey="Erfurth E">EM Erfurth</name></author><author><name sortKey="Robison, Ll" uniqKey="Robison L">LL Robison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chopin, Lk" uniqKey="Chopin L">LK Chopin</name></author><author><name sortKey="Seim, I" uniqKey="Seim I">I Seim</name></author><author><name sortKey="Walpole, Cm" uniqKey="Walpole C">CM Walpole</name></author><author><name sortKey="Herington, Ac" uniqKey="Herington A">AC Herington</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Clemmons, Dr" uniqKey="Clemmons D">DR Clemmons</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Corbetta, S" uniqKey="Corbetta S">S Corbetta</name></author><author><name sortKey="Peracchi, M" uniqKey="Peracchi M">M Peracchi</name></author><author><name sortKey="Cappiello, V" uniqKey="Cappiello V">V Cappiello</name></author><author><name sortKey="Lania, A" uniqKey="Lania A">A Lania</name></author><author><name sortKey="Lauri, E" uniqKey="Lauri E">E Lauri</name></author><author><name sortKey="Vago, L" uniqKey="Vago L">L Vago</name></author><author><name sortKey="Beck Peccoz, P" uniqKey="Beck Peccoz P">P Beck-Peccoz</name></author><author><name sortKey="Spada, A" uniqKey="Spada A">A Spada</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Crawley, Dj" uniqKey="Crawley D">DJ Crawley</name></author><author><name sortKey="Holmberg, L" uniqKey="Holmberg L">L Holmberg</name></author><author><name sortKey="Melvin, Jc" uniqKey="Melvin J">JC Melvin</name></author><author><name sortKey="Loda, M" uniqKey="Loda M">M Loda</name></author><author><name sortKey="Chowdhury, S" uniqKey="Chowdhury S">S Chowdhury</name></author><author><name sortKey="Rudman, Sm" uniqKey="Rudman S">SM Rudman</name></author><author><name sortKey="Van Hemelrijck, M" uniqKey="Van Hemelrijck M">M Van Hemelrijck</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Currow, Dc" uniqKey="Currow D">DC Currow</name></author><author><name sortKey="Temel, Js" uniqKey="Temel J">JS Temel</name></author><author><name sortKey="Fearon, K" uniqKey="Fearon K">K Fearon</name></author><author><name sortKey="Yan, Y" uniqKey="Yan Y">Y Yan</name></author><author><name sortKey="Friend, J" uniqKey="Friend J">J Friend</name></author><author><name sortKey="Abernethy, Ap" uniqKey="Abernethy A">AP Abernethy</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Deboer, Md" uniqKey="Deboer M">MD DeBoer</name></author><author><name sortKey="Zhu, Xx" uniqKey="Zhu X">XX Zhu</name></author><author><name sortKey="Levasseur, P" uniqKey="Levasseur P">P Levasseur</name></author><author><name sortKey="Meguid, Mm" uniqKey="Meguid M">MM Meguid</name></author><author><name sortKey="Suzuki, S" uniqKey="Suzuki S">S Suzuki</name></author><author><name sortKey="Inui, A" uniqKey="Inui A">A Inui</name></author><author><name sortKey="Taylor, Je" uniqKey="Taylor J">JE Taylor</name></author><author><name sortKey="Halem, Ha" uniqKey="Halem H">HA Halem</name></author><author><name sortKey="Dong, Jz" uniqKey="Dong J">JZ Dong</name></author><author><name sortKey="Datta, R" uniqKey="Datta R">R Datta</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Delhanty, Pj" uniqKey="Delhanty P">PJ Delhanty</name></author><author><name sortKey="Sun, Y" uniqKey="Sun Y">Y Sun</name></author><author><name sortKey="Visser, Ja" uniqKey="Visser J">JA Visser</name></author><author><name sortKey="Van Kerkwijk, A" uniqKey="Van Kerkwijk A">A van Kerkwijk</name></author><author><name sortKey="Huisman, M" uniqKey="Huisman M">M Huisman</name></author><author><name sortKey="Van Ijcken, Wf" uniqKey="Van Ijcken W">WF van Ijcken</name></author><author><name sortKey="Swagemakers, S" uniqKey="Swagemakers S">S Swagemakers</name></author><author><name sortKey="Smith, Rg" uniqKey="Smith R">RG Smith</name></author><author><name sortKey="Themmen, Ap" uniqKey="Themmen A">AP Themmen</name></author><author><name sortKey="Van Der Lely, Aj" uniqKey="Van Der Lely A">AJ van der Lely</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Delhanty, Pj" uniqKey="Delhanty P">PJ Delhanty</name></author><author><name sortKey="Huisman, M" uniqKey="Huisman M">M Huisman</name></author><author><name sortKey="Julien, M" uniqKey="Julien M">M Julien</name></author><author><name sortKey="Mouchain, K" uniqKey="Mouchain K">K Mouchain</name></author><author><name sortKey="Brune, P" uniqKey="Brune P">P Brune</name></author><author><name sortKey="Themmen, Ap" uniqKey="Themmen A">AP Themmen</name></author><author><name sortKey="Abribat, T" uniqKey="Abribat T">T Abribat</name></author><author><name sortKey="Van Der Lely, Aj" uniqKey="Van Der Lely A">AJ van der Lely</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Delporte, C" uniqKey="Delporte C">C Delporte</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Martel, C" uniqKey="De Martel C">C de Martel</name></author><author><name sortKey="Haggerty, Td" uniqKey="Haggerty T">TD Haggerty</name></author><author><name sortKey="Corley, Da" uniqKey="Corley D">DA Corley</name></author><author><name sortKey="Vogelman, Jh" uniqKey="Vogelman J">JH Vogelman</name></author><author><name sortKey="Orentreich, N" uniqKey="Orentreich N">N Orentreich</name></author><author><name sortKey="Parsonnet, J" uniqKey="Parsonnet J">J Parsonnet</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dixit, Vd" uniqKey="Dixit V">VD Dixit</name></author><author><name sortKey="Schaffer, Em" uniqKey="Schaffer E">EM Schaffer</name></author><author><name sortKey="Pyle, Rs" uniqKey="Pyle R">RS Pyle</name></author><author><name sortKey="Collins, Gd" uniqKey="Collins G">GD Collins</name></author><author><name sortKey="Sakthivel, Sk" uniqKey="Sakthivel S">SK Sakthivel</name></author><author><name sortKey="Palaniappan, R" uniqKey="Palaniappan R">R Palaniappan</name></author><author><name sortKey="Lillard, Jw" uniqKey="Lillard J">JW Lillard</name></author><author><name sortKey="Taub, Dd" uniqKey="Taub D">DD Taub</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="D Nghia, V" uniqKey="D Nghia V">V D’Onghia</name></author><author><name sortKey="Leoncini, R" uniqKey="Leoncini R">R Leoncini</name></author><author><name sortKey="Carli, R" uniqKey="Carli R">R Carli</name></author><author><name sortKey="Santoro, A" uniqKey="Santoro A">A Santoro</name></author><author><name sortKey="Giglioni, S" uniqKey="Giglioni S">S Giglioni</name></author><author><name sortKey="Sorbellini, F" uniqKey="Sorbellini F">F Sorbellini</name></author><author><name sortKey="Marzocca, G" uniqKey="Marzocca G">G Marzocca</name></author><author><name sortKey="Bernini, A" uniqKey="Bernini A">A Bernini</name></author><author><name sortKey="Campagna, S" uniqKey="Campagna S">S Campagna</name></author><author><name sortKey="Marinello, E" uniqKey="Marinello E">E Marinello</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Doecke, Jd" uniqKey="Doecke J">JD Doecke</name></author><author><name sortKey="Zhao, Zz" uniqKey="Zhao Z">ZZ Zhao</name></author><author><name sortKey="Stark, Ms" uniqKey="Stark M">MS Stark</name></author><author><name sortKey="Green, Ac" uniqKey="Green A">AC Green</name></author><author><name sortKey="Hayward, Nk" uniqKey="Hayward N">NK Hayward</name></author><author><name sortKey="Montgomery, Gw" uniqKey="Montgomery G">GW Montgomery</name></author><author><name sortKey="Webb, Pm" uniqKey="Webb P">PM Webb</name></author><author><name sortKey="Whiteman, Dc" uniqKey="Whiteman D">DC Whiteman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dossus, L" uniqKey="Dossus L">L Dossus</name></author><author><name sortKey="Mckay, Jd" uniqKey="Mckay J">JD McKay</name></author><author><name sortKey="Canzian, F" uniqKey="Canzian F">F Canzian</name></author><author><name sortKey="Wilkening, S" uniqKey="Wilkening S">S Wilkening</name></author><author><name sortKey="Rinaldi, S" uniqKey="Rinaldi S">S Rinaldi</name></author><author><name sortKey="Biessy, C" uniqKey="Biessy C">C Biessy</name></author><author><name sortKey="Olsen, A" uniqKey="Olsen A">A Olsen</name></author><author><name sortKey="Tj Nneland, A" uniqKey="Tj Nneland A">A Tjønneland</name></author><author><name sortKey="Jakobsen, Mu" uniqKey="Jakobsen M">MU Jakobsen</name></author><author><name sortKey="Overvad, K" uniqKey="Overvad K">K Overvad</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ekeblad, S" uniqKey="Ekeblad S">S Ekeblad</name></author><author><name sortKey="Lejonklou, Mh" uniqKey="Lejonklou M">MH Lejonklou</name></author><author><name sortKey="Grimfj Rd, P" uniqKey="Grimfj Rd P">P Grimfjärd</name></author><author><name sortKey="Johansson, T" uniqKey="Johansson T">T Johansson</name></author><author><name sortKey="Eriksson, B" uniqKey="Eriksson B">B Eriksson</name></author><author><name sortKey="Grimelius, L" uniqKey="Grimelius L">L Grimelius</name></author><author><name sortKey="Stridsberg, M" uniqKey="Stridsberg M">M Stridsberg</name></author><author><name sortKey="St Lberg, P" uniqKey="St Lberg P">P Stålberg</name></author><author><name sortKey="Skogseid, B" uniqKey="Skogseid B">B Skogseid</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ergun Longmire, B" uniqKey="Ergun Longmire B">B Ergun-Longmire</name></author><author><name sortKey="Mertens, Ac" uniqKey="Mertens A">AC Mertens</name></author><author><name sortKey="Mitby, P" uniqKey="Mitby P">P Mitby</name></author><author><name sortKey="Qin, J" uniqKey="Qin J">J Qin</name></author><author><name sortKey="Heller, G" uniqKey="Heller G">G Heller</name></author><author><name sortKey="Shi, W" uniqKey="Shi W">W Shi</name></author><author><name sortKey="Yasui, Y" uniqKey="Yasui Y">Y Yasui</name></author><author><name sortKey="Robison, Ll" uniqKey="Robison L">LL Robison</name></author><author><name sortKey="Sklar, Ca" uniqKey="Sklar C">CA Sklar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Feigelson, Hs" uniqKey="Feigelson H">HS Feigelson</name></author><author><name sortKey="Teras, Lr" uniqKey="Teras L">LR Teras</name></author><author><name sortKey="Diver, Wr" uniqKey="Diver W">WR Diver</name></author><author><name sortKey="Tang, W" uniqKey="Tang W">W Tang</name></author><author><name sortKey="Patel, Av" uniqKey="Patel A">AV Patel</name></author><author><name sortKey="Stevens, Vl" uniqKey="Stevens V">VL Stevens</name></author><author><name sortKey="Calle, Ee" uniqKey="Calle E">EE Calle</name></author><author><name sortKey="Thun, Mj" uniqKey="Thun M">MJ Thun</name></author><author><name sortKey="Bouzyk, M" uniqKey="Bouzyk M">M Bouzyk</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Feigerlova, E" uniqKey="Feigerlova E">E Feigerlová</name></author><author><name sortKey="Diene, G" uniqKey="Diene G">G Diene</name></author><author><name sortKey="Conte Auriol, F" uniqKey="Conte Auriol F">F Conte-Auriol</name></author><author><name sortKey="Molinas, C" uniqKey="Molinas C">C Molinas</name></author><author><name sortKey="Gennero, I" uniqKey="Gennero I">I Gennero</name></author><author><name sortKey="Salles, Jp" uniqKey="Salles J">JP Salles</name></author><author><name sortKey="Arnaud, C" uniqKey="Arnaud C">C Arnaud</name></author><author><name sortKey="Tauber, M" uniqKey="Tauber M">M Tauber</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fung, Jn" uniqKey="Fung J">JN Fung</name></author><author><name sortKey="Jeffrey, Pl" uniqKey="Jeffrey P">PL Jeffrey</name></author><author><name sortKey="Lee, Jd" uniqKey="Lee J">JD Lee</name></author><author><name sortKey="Seim, I" uniqKey="Seim I">I Seim</name></author><author><name sortKey="Roche, D" uniqKey="Roche D">D Roche</name></author><author><name sortKey="Obermair, A" uniqKey="Obermair A">A Obermair</name></author><author><name sortKey="Chopin, Lk" uniqKey="Chopin L">LK Chopin</name></author><author><name sortKey="Chen, C" uniqKey="Chen C">C Chen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Garcia, Jm" uniqKey="Garcia J">JM Garcia</name></author><author><name sortKey="Polvino, Wj" uniqKey="Polvino W">WJ Polvino</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Garcia, Jm" uniqKey="Garcia J">JM Garcia</name></author><author><name sortKey="Li, H" uniqKey="Li H">H Li</name></author><author><name sortKey="Mann, D" uniqKey="Mann D">D Mann</name></author><author><name sortKey="Epner, D" uniqKey="Epner D">D Epner</name></author><author><name sortKey="Hayes, Tg" uniqKey="Hayes T">TG Hayes</name></author><author><name sortKey="Marcelli, M" uniqKey="Marcelli M">M Marcelli</name></author><author><name sortKey="Cunningham, Gr" uniqKey="Cunningham G">GR Cunningham</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Garcia, Jm" uniqKey="Garcia J">JM Garcia</name></author><author><name sortKey="Swerdloff, R" uniqKey="Swerdloff R">R Swerdloff</name></author><author><name sortKey="Wang, C" uniqKey="Wang C">C Wang</name></author><author><name sortKey="Kyle, M" uniqKey="Kyle M">M Kyle</name></author><author><name sortKey="Kipnes, M" uniqKey="Kipnes M">M Kipnes</name></author><author><name sortKey="Biller, Bm" uniqKey="Biller B">BM Biller</name></author><author><name sortKey="Cook, D" uniqKey="Cook D">D Cook</name></author><author><name sortKey="Yuen, Kc" uniqKey="Yuen K">KC Yuen</name></author><author><name sortKey="Bonert, V" uniqKey="Bonert V">V Bonert</name></author><author><name sortKey="Dobs, A" uniqKey="Dobs A">A Dobs</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Garcia, Jm" uniqKey="Garcia J">JM Garcia</name></author><author><name sortKey="Boccia, Rv" uniqKey="Boccia R">RV Boccia</name></author><author><name sortKey="Graham, Cd" uniqKey="Graham C">CD Graham</name></author><author><name sortKey="Yan, Y" uniqKey="Yan Y">Y Yan</name></author><author><name sortKey="Duus, Em" uniqKey="Duus E">EM Duus</name></author><author><name sortKey="Allen, S" uniqKey="Allen S">S Allen</name></author><author><name sortKey="Friend, J" uniqKey="Friend J">J Friend</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gauna, C" uniqKey="Gauna C">C Gauna</name></author><author><name sortKey="Van De Zande, B" uniqKey="Van De Zande B">B van de Zande</name></author><author><name sortKey="Van Kerkwijk, A" uniqKey="Van Kerkwijk A">A van Kerkwijk</name></author><author><name sortKey="Themmen, Ap" uniqKey="Themmen A">AP Themmen</name></author><author><name sortKey="Van Der Lely, Aj" uniqKey="Van Der Lely A">AJ van der Lely</name></author><author><name sortKey="Delhanty, Pj" uniqKey="Delhanty P">PJ Delhanty</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gonzalez Rey, E" uniqKey="Gonzalez Rey E">E Gonzalez-Rey</name></author><author><name sortKey="Chorny, A" uniqKey="Chorny A">A Chorny</name></author><author><name sortKey="Delgado, M" uniqKey="Delgado M">M Delgado</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Guney, Y" uniqKey="Guney Y">Y Guney</name></author><author><name sortKey="Ozel Turkcu, U" uniqKey="Ozel Turkcu U">U Ozel Turkcu</name></author><author><name sortKey="Hicsonmez, A" uniqKey="Hicsonmez A">A Hicsonmez</name></author><author><name sortKey="Nalca Andrieu, M" uniqKey="Nalca Andrieu M">M Nalca Andrieu</name></author><author><name sortKey="Kurtman, C" uniqKey="Kurtman C">C Kurtman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hanada, T" uniqKey="Hanada T">T Hanada</name></author><author><name sortKey="Toshinai, K" uniqKey="Toshinai K">K Toshinai</name></author><author><name sortKey="Kajimura, N" uniqKey="Kajimura N">N Kajimura</name></author><author><name sortKey="Nara Ashizawa, N" uniqKey="Nara Ashizawa N">N Nara-Ashizawa</name></author><author><name sortKey="Tsukada, T" uniqKey="Tsukada T">T Tsukada</name></author><author><name sortKey="Hayashi, Y" uniqKey="Hayashi Y">Y Hayashi</name></author><author><name sortKey="Osuye, K" uniqKey="Osuye K">K Osuye</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author><author><name sortKey="Matsukura, S" uniqKey="Matsukura S">S Matsukura</name></author><author><name sortKey="Nakazato, M" uniqKey="Nakazato M">M Nakazato</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hartman, Ml" uniqKey="Hartman M">ML Hartman</name></author><author><name sortKey="Xu, R" uniqKey="Xu R">R Xu</name></author><author><name sortKey="Crowe, Bj" uniqKey="Crowe B">BJ Crowe</name></author><author><name sortKey="Robison, Ll" uniqKey="Robison L">LL Robison</name></author><author><name sortKey="Erfurth, Em" uniqKey="Erfurth E">EM Erfurth</name></author><author><name sortKey="Kleinberg, Dl" uniqKey="Kleinberg D">DL Kleinberg</name></author><author><name sortKey="Zimmermann, Ag" uniqKey="Zimmermann A">AG Zimmermann</name></author><author><name sortKey="Woodmansee, Ww" uniqKey="Woodmansee W">WW Woodmansee</name></author><author><name sortKey="Cutler, Gb" uniqKey="Cutler G">GB Cutler</name></author><author><name sortKey="Chipman, Jj" uniqKey="Chipman J">JJ Chipman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hiura, Y" uniqKey="Hiura Y">Y Hiura</name></author><author><name sortKey="Takiguchi, S" uniqKey="Takiguchi S">S Takiguchi</name></author><author><name sortKey="Yamamoto, K" uniqKey="Yamamoto K">K Yamamoto</name></author><author><name sortKey="Takahashi, T" uniqKey="Takahashi T">T Takahashi</name></author><author><name sortKey="Kurokawa, Y" uniqKey="Kurokawa Y">Y Kurokawa</name></author><author><name sortKey="Yamasaki, M" uniqKey="Yamasaki M">M Yamasaki</name></author><author><name sortKey="Nakajima, K" uniqKey="Nakajima K">K Nakajima</name></author><author><name sortKey="Miyata, H" uniqKey="Miyata H">H Miyata</name></author><author><name sortKey="Fujiwara, Y" uniqKey="Fujiwara Y">Y Fujiwara</name></author><author><name sortKey="Mori, M" uniqKey="Mori M">M Mori</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Holmer, H" uniqKey="Holmer H">H Holmer</name></author><author><name sortKey="Pozarek, G" uniqKey="Pozarek G">G Pozarek</name></author><author><name sortKey="Wirf Lt, E" uniqKey="Wirf Lt E">E Wirfält</name></author><author><name sortKey="Popovic, V" uniqKey="Popovic V">V Popovic</name></author><author><name sortKey="Ekman, B" uniqKey="Ekman B">B Ekman</name></author><author><name sortKey="Bjork, J" uniqKey="Bjork J">J Björk</name></author><author><name sortKey="Erfurth, Em" uniqKey="Erfurth E">EM Erfurth</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hotta, M" uniqKey="Hotta M">M Hotta</name></author><author><name sortKey="Ohwada, R" uniqKey="Ohwada R">R Ohwada</name></author><author><name sortKey="Katakami, H" uniqKey="Katakami H">H Katakami</name></author><author><name sortKey="Shibasaki, T" uniqKey="Shibasaki T">T Shibasaki</name></author><author><name sortKey="Hizuka, N" uniqKey="Hizuka N">N Hizuka</name></author><author><name sortKey="Takano, K" uniqKey="Takano K">K Takano</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Huang, Q" uniqKey="Huang Q">Q Huang</name></author><author><name sortKey="Fan, Yz" uniqKey="Fan Y">YZ Fan</name></author><author><name sortKey="Ge, Bj" uniqKey="Ge B">BJ Ge</name></author><author><name sortKey="Zhu, Q" uniqKey="Zhu Q">Q Zhu</name></author><author><name sortKey="Tu, Zy" uniqKey="Tu Z">ZY Tu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ingelsson, E" uniqKey="Ingelsson E">E Ingelsson</name></author><author><name sortKey="Larson, Mg" uniqKey="Larson M">MG Larson</name></author><author><name sortKey="Yin, X" uniqKey="Yin X">X Yin</name></author><author><name sortKey="Wang, Tj" uniqKey="Wang T">TJ Wang</name></author><author><name sortKey="Meigs, Jb" uniqKey="Meigs J">JB Meigs</name></author><author><name sortKey="Lipinska, I" uniqKey="Lipinska I">I Lipinska</name></author><author><name sortKey="Benjamin, Ej" uniqKey="Benjamin E">EJ Benjamin</name></author><author><name sortKey="Keaney, Jf" uniqKey="Keaney J">JF Keaney</name></author><author><name sortKey="Vasan, Rs" uniqKey="Vasan R">RS Vasan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Isomoto, J" uniqKey="Isomoto J">J Isomoto</name></author><author><name sortKey="Ueno, H" uniqKey="Ueno H">H Ueno</name></author><author><name sortKey="Nishi, Y" uniqKey="Nishi Y">Y Nishi</name></author><author><name sortKey="Yasutake, T" uniqKey="Yasutake T">T Yasutake</name></author><author><name sortKey="Tanaka, K" uniqKey="Tanaka K">K Tanaka</name></author><author><name sortKey="Kawano, N" uniqKey="Kawano N">N Kawano</name></author><author><name sortKey="Ohnita, K" uniqKey="Ohnita K">K Ohnita</name></author><author><name sortKey="Mizuta, Y" uniqKey="Mizuta Y">Y Mizuta</name></author><author><name sortKey="Inoue, K" uniqKey="Inoue K">K Inoue</name></author><author><name sortKey="Nakazato, M" uniqKey="Nakazato M">M Nakazato</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jeffery, Pl" uniqKey="Jeffery P">PL Jeffery</name></author><author><name sortKey="Herington, Ac" uniqKey="Herington A">AC Herington</name></author><author><name sortKey="Chopin, Lk" uniqKey="Chopin L">LK Chopin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jeon, Ty" uniqKey="Jeon T">TY Jeon</name></author><author><name sortKey="Lee, S" uniqKey="Lee S">S Lee</name></author><author><name sortKey="Kim, Hh" uniqKey="Kim H">HH Kim</name></author><author><name sortKey="Kim, Yj" uniqKey="Kim Y">YJ Kim</name></author><author><name sortKey="Son, Hc" uniqKey="Son H">HC Son</name></author><author><name sortKey="Kim, Dh" uniqKey="Kim D">DH Kim</name></author><author><name sortKey="Sim, Ms" uniqKey="Sim M">MS Sim</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Karapanagiotou, Em" uniqKey="Karapanagiotou E">EM Karapanagiotou</name></author><author><name sortKey="Polyzos, A" uniqKey="Polyzos A">A Polyzos</name></author><author><name sortKey="Dilana, Kd" uniqKey="Dilana K">KD Dilana</name></author><author><name sortKey="Gratsias, I" uniqKey="Gratsias I">I Gratsias</name></author><author><name sortKey="Boura, P" uniqKey="Boura P">P Boura</name></author><author><name sortKey="Gkiozos, I" uniqKey="Gkiozos I">I Gkiozos</name></author><author><name sortKey="Syrigos, Kn" uniqKey="Syrigos K">KN Syrigos</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kawaguchi, M" uniqKey="Kawaguchi M">M Kawaguchi</name></author><author><name sortKey="Kanemaru, A" uniqKey="Kanemaru A">A Kanemaru</name></author><author><name sortKey="Fukushima, T" uniqKey="Fukushima T">T Fukushima</name></author><author><name sortKey="Yamamoto, K" uniqKey="Yamamoto K">K Yamamoto</name></author><author><name sortKey="Tanaka, H" uniqKey="Tanaka H">H Tanaka</name></author><author><name sortKey="Haruyama, Y" uniqKey="Haruyama Y">Y Haruyama</name></author><author><name sortKey="Itoh, H" uniqKey="Itoh H">H Itoh</name></author><author><name sortKey="Matsumoto, N" uniqKey="Matsumoto N">N Matsumoto</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author><author><name sortKey="Nakazato, M" uniqKey="Nakazato M">M Nakazato</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Khandwala, Hm" uniqKey="Khandwala H">HM Khandwala</name></author><author><name sortKey="Mccutcheon, Ie" uniqKey="Mccutcheon I">IE McCutcheon</name></author><author><name sortKey="Flyvbjerg, A" uniqKey="Flyvbjerg A">A Flyvbjerg</name></author><author><name sortKey="Friend, Ke" uniqKey="Friend K">KE Friend</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kemik, O" uniqKey="Kemik O">O Kemik</name></author><author><name sortKey="Sumer, A" uniqKey="Sumer A">A Sumer</name></author><author><name sortKey="Kemik, As" uniqKey="Kemik A">AS Kemik</name></author><author><name sortKey="Hasirci, I" uniqKey="Hasirci I">I Hasirci</name></author><author><name sortKey="Purisa, S" uniqKey="Purisa S">S Purisa</name></author><author><name sortKey="Dulger, Ac" uniqKey="Dulger A">AC Dulger</name></author><author><name sortKey="Demiriz, B" uniqKey="Demiriz B">B Demiriz</name></author><author><name sortKey="Tuzun, S" uniqKey="Tuzun S">S Tuzun</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kemik, O" uniqKey="Kemik O">O Kemik</name></author><author><name sortKey="Kemik, As" uniqKey="Kemik A">AS Kemik</name></author><author><name sortKey="Begenik, H" uniqKey="Begenik H">H Begenik</name></author><author><name sortKey="Erdur, Fm" uniqKey="Erdur F">FM Erdur</name></author><author><name sortKey="Emre, H" uniqKey="Emre H">H Emre</name></author><author><name sortKey="Sumer, A" uniqKey="Sumer A">A Sumer</name></author><author><name sortKey="Purisa, S" uniqKey="Purisa S">S Purisa</name></author><author><name sortKey="Tuzun, S" uniqKey="Tuzun S">S Tuzun</name></author><author><name sortKey="Kotan, C" uniqKey="Kotan C">C Kotan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kerenidi, T" uniqKey="Kerenidi T">T Kerenidi</name></author><author><name sortKey="Lada, M" uniqKey="Lada M">M Lada</name></author><author><name sortKey="Tsaroucha, A" uniqKey="Tsaroucha A">A Tsaroucha</name></author><author><name sortKey="Georgoulias, P" uniqKey="Georgoulias P">P Georgoulias</name></author><author><name sortKey="Mystridou, P" uniqKey="Mystridou P">P Mystridou</name></author><author><name sortKey="Gourgoulianis, Ki" uniqKey="Gourgoulianis K">KI Gourgoulianis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kojima, M" uniqKey="Kojima M">M Kojima</name></author><author><name sortKey="Hosoda, H" uniqKey="Hosoda H">H Hosoda</name></author><author><name sortKey="Date, Y" uniqKey="Date Y">Y Date</name></author><author><name sortKey="Nakazato, M" uniqKey="Nakazato M">M Nakazato</name></author><author><name sortKey="Matsuo, H" uniqKey="Matsuo H">H Matsuo</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Korbonits, M" uniqKey="Korbonits M">M Korbonits</name></author><author><name sortKey="Goldstone, Ap" uniqKey="Goldstone A">AP Goldstone</name></author><author><name sortKey="Gueorguiev, M" uniqKey="Gueorguiev M">M Gueorguiev</name></author><author><name sortKey="Grossman, Ab" uniqKey="Grossman A">AB Grossman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kuppens, Rj" uniqKey="Kuppens R">RJ Kuppens</name></author><author><name sortKey="Diene, G" uniqKey="Diene G">G Diène</name></author><author><name sortKey="Bakker, Ne" uniqKey="Bakker N">NE Bakker</name></author><author><name sortKey="Molinas, C" uniqKey="Molinas C">C Molinas</name></author><author><name sortKey="Faye, S" uniqKey="Faye S">S Faye</name></author><author><name sortKey="Nicolino, M" uniqKey="Nicolino M">M Nicolino</name></author><author><name sortKey="Bernoux, D" uniqKey="Bernoux D">D Bernoux</name></author><author><name sortKey="Delhanty, Pj" uniqKey="Delhanty P">PJ Delhanty</name></author><author><name sortKey="Van Der Lely, Aj" uniqKey="Van Der Lely A">AJ van der Lely</name></author><author><name sortKey="Allas, S" uniqKey="Allas S">S Allas</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Laurila, M" uniqKey="Laurila M">M Laurila</name></author><author><name sortKey="Santaniemi, M" uniqKey="Santaniemi M">M Santaniemi</name></author><author><name sortKey="Kes Niemi, Ya" uniqKey="Kes Niemi Y">YA Kesäniemi</name></author><author><name sortKey="Ukkola, O" uniqKey="Ukkola O">O Ukkola</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Legakis, I" uniqKey="Legakis I">I Legakis</name></author><author><name sortKey="Stathopoulos, J" uniqKey="Stathopoulos J">J Stathopoulos</name></author><author><name sortKey="Matzouridis, T" uniqKey="Matzouridis T">T Matzouridis</name></author><author><name sortKey="Stathopoulos, Gp" uniqKey="Stathopoulos G">GP Stathopoulos</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, A" uniqKey="Li A">A Li</name></author><author><name sortKey="Cheng, G" uniqKey="Cheng G">G Cheng</name></author><author><name sortKey="Zhu, Gh" uniqKey="Zhu G">GH Zhu</name></author><author><name sortKey="Tarnawski, As" uniqKey="Tarnawski A">AS Tarnawski</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, Wg" uniqKey="Li W">WG Li</name></author><author><name sortKey="Gavrila, D" uniqKey="Gavrila D">D Gavrila</name></author><author><name sortKey="Liu, X" uniqKey="Liu X">X Liu</name></author><author><name sortKey="Wang, L" uniqKey="Wang L">L Wang</name></author><author><name sortKey="Gunnlaugsson, S" uniqKey="Gunnlaugsson S">S Gunnlaugsson</name></author><author><name sortKey="Stoll, Ll" uniqKey="Stoll L">LL Stoll</name></author><author><name sortKey="Mccormick, Ml" uniqKey="Mccormick M">ML McCormick</name></author><author><name sortKey="Sigmund, Cd" uniqKey="Sigmund C">CD Sigmund</name></author><author><name sortKey="Tang, C" uniqKey="Tang C">C Tang</name></author><author><name sortKey="Weintraub, Nl" uniqKey="Weintraub N">NL Weintraub</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lin, Cc" uniqKey="Lin C">CC Lin</name></author><author><name sortKey="Yin, Mc" uniqKey="Yin M">MC Yin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lundholm, K" uniqKey="Lundholm K">K Lundholm</name></author><author><name sortKey="Gunnebo, L" uniqKey="Gunnebo L">L Gunnebo</name></author><author><name sortKey="Korner, U" uniqKey="Korner U">U Körner</name></author><author><name sortKey="Iresjo, Bm" uniqKey="Iresjo B">BM Iresjö</name></author><author><name sortKey="Engstrom, C" uniqKey="Engstrom C">C Engström</name></author><author><name sortKey="Hyltander, A" uniqKey="Hyltander A">A Hyltander</name></author><author><name sortKey="Smedh, U" uniqKey="Smedh U">U Smedh</name></author><author><name sortKey="Bosaeus, I" uniqKey="Bosaeus I">I Bosaeus</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mahmoudi, T" uniqKey="Mahmoudi T">T Mahmoudi</name></author><author><name sortKey="Karimi, K" uniqKey="Karimi K">K Karimi</name></author><author><name sortKey="Arkani, M" uniqKey="Arkani M">M Arkani</name></author><author><name sortKey="Farahani, H" uniqKey="Farahani H">H Farahani</name></author><author><name sortKey="Vahedi, M" uniqKey="Vahedi M">M Vahedi</name></author><author><name sortKey="Dabiri, R" uniqKey="Dabiri R">R Dabiri</name></author><author><name sortKey="Nobakht, H" uniqKey="Nobakht H">H Nobakht</name></author><author><name sortKey="Asadi, A" uniqKey="Asadi A">A Asadi</name></author><author><name sortKey="Mirakhorli, M" uniqKey="Mirakhorli M">M Mirakhorli</name></author><author><name sortKey="Arshi, B" uniqKey="Arshi B">B Arshi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Malendowicz, W" uniqKey="Malendowicz W">W Malendowicz</name></author><author><name sortKey="Ziolkowska, A" uniqKey="Ziolkowska A">A Ziolkowska</name></author><author><name sortKey="Szyszka, M" uniqKey="Szyszka M">M Szyszka</name></author><author><name sortKey="Kwias, Z" uniqKey="Kwias Z">Z Kwias</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Malik, Nm" uniqKey="Malik N">NM Malik</name></author><author><name sortKey="Moore, Gb" uniqKey="Moore G">GB Moore</name></author><author><name sortKey="Kaur, R" uniqKey="Kaur R">R Kaur</name></author><author><name sortKey="Liu, Yl" uniqKey="Liu Y">YL Liu</name></author><author><name sortKey="Wood, Sl" uniqKey="Wood S">SL Wood</name></author><author><name sortKey="Morrow, Rw" uniqKey="Morrow R">RW Morrow</name></author><author><name sortKey="Sanger, Gj" uniqKey="Sanger G">GJ Sanger</name></author><author><name sortKey="Andrews, Pl" uniqKey="Andrews P">PL Andrews</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Markowska, A" uniqKey="Markowska A">A Markowska</name></author><author><name sortKey="Zi Kowska, A" uniqKey="Zi Kowska A">A Ziółkowska</name></author><author><name sortKey="Jaszczy Ska Nowinka, K" uniqKey="Jaszczy Ska Nowinka K">K Jaszczyńska-Nowinka</name></author><author><name sortKey="Madry, R" uniqKey="Madry R">R Madry</name></author><author><name sortKey="Malendowicz, Lk" uniqKey="Malendowicz L">LK Malendowicz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Maruna, P" uniqKey="Maruna P">P Maruna</name></author><author><name sortKey="Gurlich, R" uniqKey="Gurlich R">R Gürlich</name></author><author><name sortKey="Rosicka, M" uniqKey="Rosicka M">M Rosická</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Matsumoto, M" uniqKey="Matsumoto M">M Matsumoto</name></author><author><name sortKey="Hosoda, H" uniqKey="Hosoda H">H Hosoda</name></author><author><name sortKey="Kitajima, Y" uniqKey="Kitajima Y">Y Kitajima</name></author><author><name sortKey="Morozumi, N" uniqKey="Morozumi N">N Morozumi</name></author><author><name sortKey="Minamitake, Y" uniqKey="Minamitake Y">Y Minamitake</name></author><author><name sortKey="Tanaka, S" uniqKey="Tanaka S">S Tanaka</name></author><author><name sortKey="Matsuo, H" uniqKey="Matsuo H">H Matsuo</name></author><author><name sortKey="Kojima, M" uniqKey="Kojima M">M Kojima</name></author><author><name sortKey="Hayashi, Y" uniqKey="Hayashi Y">Y Hayashi</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mikami, K" uniqKey="Mikami K">K Mikami</name></author><author><name sortKey="Ozasa, K" uniqKey="Ozasa K">K Ozasa</name></author><author><name sortKey="Nakao, M" uniqKey="Nakao M">M Nakao</name></author><author><name sortKey="Miki, T" uniqKey="Miki T">T Miki</name></author><author><name sortKey="Hayashi, K" uniqKey="Hayashi K">K Hayashi</name></author><author><name sortKey="Watanabe, Y" uniqKey="Watanabe Y">Y Watanabe</name></author><author><name sortKey="Mori, M" uniqKey="Mori M">M Mori</name></author><author><name sortKey="Sakauchi, F" uniqKey="Sakauchi F">F Sakauchi</name></author><author><name sortKey="Washio, M" uniqKey="Washio M">M Washio</name></author><author><name sortKey="Kubo, T" uniqKey="Kubo T">T Kubo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Miyazaki, T" uniqKey="Miyazaki T">T Miyazaki</name></author><author><name sortKey="Tanaka, N" uniqKey="Tanaka N">N Tanaka</name></author><author><name sortKey="Hirai, H" uniqKey="Hirai H">H Hirai</name></author><author><name sortKey="Yokobori, T" uniqKey="Yokobori T">T Yokobori</name></author><author><name sortKey="Sano, A" uniqKey="Sano A">A Sano</name></author><author><name sortKey="Sakai, M" uniqKey="Sakai M">M Sakai</name></author><author><name sortKey="Inose, T" uniqKey="Inose T">T Inose</name></author><author><name sortKey="Sohda, M" uniqKey="Sohda M">M Sohda</name></author><author><name sortKey="Nakajima, M" uniqKey="Nakajima M">M Nakajima</name></author><author><name sortKey="Fukuchi, M" uniqKey="Fukuchi M">M Fukuchi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moher, D" uniqKey="Moher D">D Moher</name></author><author><name sortKey="Shamseer, L" uniqKey="Shamseer L">L Shamseer</name></author><author><name sortKey="Clarke, M" uniqKey="Clarke M">M Clarke</name></author><author><name sortKey="Ghersi, D" uniqKey="Ghersi D">D Ghersi</name></author><author><name sortKey="Liberati, A" uniqKey="Liberati A">A Liberati</name></author><author><name sortKey="Petticrew, M" uniqKey="Petticrew M">M Petticrew</name></author><author><name sortKey="Shekelle, P" uniqKey="Shekelle P">P Shekelle</name></author><author><name sortKey="Stewart, La" uniqKey="Stewart L">LA Stewart</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mondello, P" uniqKey="Mondello P">P Mondello</name></author><author><name sortKey="Lacquaniti, A" uniqKey="Lacquaniti A">A Lacquaniti</name></author><author><name sortKey="Mondello, S" uniqKey="Mondello S">S Mondello</name></author><author><name sortKey="Bolignano, D" uniqKey="Bolignano D">D Bolignano</name></author><author><name sortKey="Pitini, V" uniqKey="Pitini V">V Pitini</name></author><author><name sortKey="Aloisi, C" uniqKey="Aloisi C">C Aloisi</name></author><author><name sortKey="Buemi, M" uniqKey="Buemi M">M Buemi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Morpurgo, Ps" uniqKey="Morpurgo P">PS Morpurgo</name></author><author><name sortKey="Cappiello, V" uniqKey="Cappiello V">V Cappiello</name></author><author><name sortKey="Verga, U" uniqKey="Verga U">U Verga</name></author><author><name sortKey="Vicentini, L" uniqKey="Vicentini L">L Vicentini</name></author><author><name sortKey="Vaghi, I" uniqKey="Vaghi I">I Vaghi</name></author><author><name sortKey="Lauri, E" uniqKey="Lauri E">E Lauri</name></author><author><name sortKey="Nebuloni, M" uniqKey="Nebuloni M">M Nebuloni</name></author><author><name sortKey="Beck Peccoz, P" uniqKey="Beck Peccoz P">P Beck-Peccoz</name></author><author><name sortKey="Spada, A" uniqKey="Spada A">A Spada</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moschovi, M" uniqKey="Moschovi M">M Moschovi</name></author><author><name sortKey="Trimis, G" uniqKey="Trimis G">G Trimis</name></author><author><name sortKey="Vounatsou, M" uniqKey="Vounatsou M">M Vounatsou</name></author><author><name sortKey="Katsibardi, K" uniqKey="Katsibardi K">K Katsibardi</name></author><author><name sortKey="Margeli, A" uniqKey="Margeli A">A Margeli</name></author><author><name sortKey="Dimitriadi, F" uniqKey="Dimitriadi F">F Dimitriadi</name></author><author><name sortKey="Papassotiriou, I" uniqKey="Papassotiriou I">I Papassotiriou</name></author><author><name sortKey="Chrousos, G" uniqKey="Chrousos G">G Chrousos</name></author><author><name sortKey="Tzortzatou Stathopoulou, F" uniqKey="Tzortzatou Stathopoulou F">F Tzortzatou-Stathopoulou</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Motawi, Tk" uniqKey="Motawi T">TK Motawi</name></author><author><name sortKey="Shaker, Og" uniqKey="Shaker O">OG Shaker</name></author><author><name sortKey="Ismail, Mf" uniqKey="Ismail M">MF Ismail</name></author><author><name sortKey="Sayed, Nh" uniqKey="Sayed N">NH Sayed</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Muller, Td" uniqKey="Muller T">TD Müller</name></author><author><name sortKey="Perez Tilve, D" uniqKey="Perez Tilve D">D Perez-Tilve</name></author><author><name sortKey="Tong, J" uniqKey="Tong J">J Tong</name></author><author><name sortKey="Pfluger, Pt" uniqKey="Pfluger P">PT Pfluger</name></author><author><name sortKey="Tschop, Mh" uniqKey="Tschop M">MH Tschöp</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mungan, Na" uniqKey="Mungan N">NA Mungan</name></author><author><name sortKey="Eminferzane, S" uniqKey="Eminferzane S">S Eminferzane</name></author><author><name sortKey="Mungan, Ag" uniqKey="Mungan A">AG Mungan</name></author><author><name sortKey="Yesilli, C" uniqKey="Yesilli C">C Yesilli</name></author><author><name sortKey="Seckiner, I" uniqKey="Seckiner I">I Seckiner</name></author><author><name sortKey="Can, M" uniqKey="Can M">M Can</name></author><author><name sortKey="Ayoglu, F" uniqKey="Ayoglu F">F Ayoglu</name></author><author><name sortKey="Akduman, B" uniqKey="Akduman B">B Akduman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Murdolo, G" uniqKey="Murdolo G">G Murdolo</name></author><author><name sortKey="Lucidi, P" uniqKey="Lucidi P">P Lucidi</name></author><author><name sortKey="Di Loreto, C" uniqKey="Di Loreto C">C Di Loreto</name></author><author><name sortKey="Parlanti, N" uniqKey="Parlanti N">N Parlanti</name></author><author><name sortKey="De Cicco, A" uniqKey="De Cicco A">A De Cicco</name></author><author><name sortKey="Fatone, C" uniqKey="Fatone C">C Fatone</name></author><author><name sortKey="Fanelli, Cg" uniqKey="Fanelli C">CG Fanelli</name></author><author><name sortKey="Bolli, Gb" uniqKey="Bolli G">GB Bolli</name></author><author><name sortKey="Santeusanio, F" uniqKey="Santeusanio F">F Santeusanio</name></author><author><name sortKey="De Feo, P" uniqKey="De Feo P">P De Feo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Murphy, G" uniqKey="Murphy G">G Murphy</name></author><author><name sortKey="Kamangar, F" uniqKey="Kamangar F">F Kamangar</name></author><author><name sortKey="Dawsey, Sm" uniqKey="Dawsey S">SM Dawsey</name></author><author><name sortKey="Stanczyk, Fz" uniqKey="Stanczyk F">FZ Stanczyk</name></author><author><name sortKey="Weinstein, Sj" uniqKey="Weinstein S">SJ Weinstein</name></author><author><name sortKey="Taylor, Pr" uniqKey="Taylor P">PR Taylor</name></author><author><name sortKey="Virtamo, J" uniqKey="Virtamo J">J Virtamo</name></author><author><name sortKey="Abnet, Cc" uniqKey="Abnet C">CC Abnet</name></author><author><name sortKey="Albanes, D" uniqKey="Albanes D">D Albanes</name></author><author><name sortKey="Freedman, Nd" uniqKey="Freedman N">ND Freedman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Murphy, G" uniqKey="Murphy G">G Murphy</name></author><author><name sortKey="Kamangar, F" uniqKey="Kamangar F">F Kamangar</name></author><author><name sortKey="Albanes, D" uniqKey="Albanes D">D Albanes</name></author><author><name sortKey="Stanczyk, Fz" uniqKey="Stanczyk F">FZ Stanczyk</name></author><author><name sortKey="Weinstein, Sj" uniqKey="Weinstein S">SJ Weinstein</name></author><author><name sortKey="Taylor, Pr" uniqKey="Taylor P">PR Taylor</name></author><author><name sortKey="Virtamo, J" uniqKey="Virtamo J">J Virtamo</name></author><author><name sortKey="Abnet, Cc" uniqKey="Abnet C">CC Abnet</name></author><author><name sortKey="Dawsey, Sm" uniqKey="Dawsey S">SM Dawsey</name></author><author><name sortKey="Freedman, Nd" uniqKey="Freedman N">ND Freedman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nagaya, N" uniqKey="Nagaya N">N Nagaya</name></author><author><name sortKey="Moriya, J" uniqKey="Moriya J">J Moriya</name></author><author><name sortKey="Yasumura, Y" uniqKey="Yasumura Y">Y Yasumura</name></author><author><name sortKey="Uematsu, M" uniqKey="Uematsu M">M Uematsu</name></author><author><name sortKey="Ono, F" uniqKey="Ono F">F Ono</name></author><author><name sortKey="Shimizu, W" uniqKey="Shimizu W">W Shimizu</name></author><author><name sortKey="Ueno, K" uniqKey="Ueno K">K Ueno</name></author><author><name sortKey="Kitakaze, M" uniqKey="Kitakaze M">M Kitakaze</name></author><author><name sortKey="Miyatake, K" uniqKey="Miyatake K">K Miyatake</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nagaya, N" uniqKey="Nagaya N">N Nagaya</name></author><author><name sortKey="Itoh, T" uniqKey="Itoh T">T Itoh</name></author><author><name sortKey="Murakami, S" uniqKey="Murakami S">S Murakami</name></author><author><name sortKey="Oya, H" uniqKey="Oya H">H Oya</name></author><author><name sortKey="Uematsu, M" uniqKey="Uematsu M">M Uematsu</name></author><author><name sortKey="Miyatake, K" uniqKey="Miyatake K">K Miyatake</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nakazato, M" uniqKey="Nakazato M">M Nakazato</name></author><author><name sortKey="Murakami, N" uniqKey="Murakami N">N Murakami</name></author><author><name sortKey="Date, Y" uniqKey="Date Y">Y Date</name></author><author><name sortKey="Kojima, M" uniqKey="Kojima M">M Kojima</name></author><author><name sortKey="Matsuo, H" uniqKey="Matsuo H">H Matsuo</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author><author><name sortKey="Matsukura, S" uniqKey="Matsukura S">S Matsukura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nass, Rm" uniqKey="Nass R">RM Nass</name></author><author><name sortKey="Gaylinn, Bd" uniqKey="Gaylinn B">BD Gaylinn</name></author><author><name sortKey="Rogol, Ad" uniqKey="Rogol A">AD Rogol</name></author><author><name sortKey="Thorner, Mo" uniqKey="Thorner M">MO Thorner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nikolopoulos, D" uniqKey="Nikolopoulos D">D Nikolopoulos</name></author><author><name sortKey="Theocharis, S" uniqKey="Theocharis S">S Theocharis</name></author><author><name sortKey="Kouraklis, G" uniqKey="Kouraklis G">G Kouraklis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nikolopoulos, D" uniqKey="Nikolopoulos D">D Nikolopoulos</name></author><author><name sortKey="Theocharis, S" uniqKey="Theocharis S">S Theocharis</name></author><author><name sortKey="Moutsios Rentzos, A" uniqKey="Moutsios Rentzos A">A Moutsios-Rentzos</name></author><author><name sortKey="Kouraklis, G" uniqKey="Kouraklis G">G Kouraklis</name></author><author><name sortKey="Kostakis, A" uniqKey="Kostakis A">A Kostakis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Northrup, R" uniqKey="Northrup R">R Northrup</name></author><author><name sortKey="Kuroda, K" uniqKey="Kuroda K">K Kuroda</name></author><author><name sortKey="Duus, Em" uniqKey="Duus E">EM Duus</name></author><author><name sortKey="Barnes, Sr" uniqKey="Barnes S">SR Barnes</name></author><author><name sortKey="Cheatham, L" uniqKey="Cheatham L">L Cheatham</name></author><author><name sortKey="Wiley, T" uniqKey="Wiley T">T Wiley</name></author><author><name sortKey="Pietra, C" uniqKey="Pietra C">C Pietra</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Olsson, Ds" uniqKey="Olsson D">DS Olsson</name></author><author><name sortKey="Buchfelder, M" uniqKey="Buchfelder M">M Buchfelder</name></author><author><name sortKey="Wiendieck, K" uniqKey="Wiendieck K">K Wiendieck</name></author><author><name sortKey="Kremenevskaja, N" uniqKey="Kremenevskaja N">N Kremenevskaja</name></author><author><name sortKey="Bengtsson, B" uniqKey="Bengtsson B">BÅ Bengtsson</name></author><author><name sortKey="Jakobsson, Ke" uniqKey="Jakobsson K">KE Jakobsson</name></author><author><name sortKey="Jarfelt, M" uniqKey="Jarfelt M">M Jarfelt</name></author><author><name sortKey="Johannsson, G" uniqKey="Johannsson G">G Johannsson</name></author><author><name sortKey="Nilsson, Ag" uniqKey="Nilsson A">AG Nilsson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ozsoy, S" uniqKey="Ozsoy S">S Ozsoy</name></author><author><name sortKey="Besirli, A" uniqKey="Besirli A">A Besirli</name></author><author><name sortKey="Unal, D" uniqKey="Unal D">D Unal</name></author><author><name sortKey="Abdulrezzak, U" uniqKey="Abdulrezzak U">U Abdulrezzak</name></author><author><name sortKey="Orhan, O" uniqKey="Orhan O">O Orhan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pabalan, Na" uniqKey="Pabalan N">NA Pabalan</name></author><author><name sortKey="Seim, I" uniqKey="Seim I">I Seim</name></author><author><name sortKey="Jarjanazi, H" uniqKey="Jarjanazi H">H Jarjanazi</name></author><author><name sortKey="Chopin, Lk" uniqKey="Chopin L">LK Chopin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Patterson, Bc" uniqKey="Patterson B">BC Patterson</name></author><author><name sortKey="Chen, Y" uniqKey="Chen Y">Y Chen</name></author><author><name sortKey="Sklar, Ca" uniqKey="Sklar C">CA Sklar</name></author><author><name sortKey="Neglia, J" uniqKey="Neglia J">J Neglia</name></author><author><name sortKey="Yasui, Y" uniqKey="Yasui Y">Y Yasui</name></author><author><name sortKey="Mertens, A" uniqKey="Mertens A">A Mertens</name></author><author><name sortKey="Armstrong, Gt" uniqKey="Armstrong G">GT Armstrong</name></author><author><name sortKey="Meadows, A" uniqKey="Meadows A">A Meadows</name></author><author><name sortKey="Stovall, M" uniqKey="Stovall M">M Stovall</name></author><author><name sortKey="Robison, Ll" uniqKey="Robison L">LL Robison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pekic, S" uniqKey="Pekic S">S Pekic</name></author><author><name sortKey="Popovic, V" uniqKey="Popovic V">V Popovic</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Porporato, Pe" uniqKey="Porporato P">PE Porporato</name></author><author><name sortKey="Filigheddu, N" uniqKey="Filigheddu N">N Filigheddu</name></author><author><name sortKey="Reano, S" uniqKey="Reano S">S Reano</name></author><author><name sortKey="Ferrara, M" uniqKey="Ferrara M">M Ferrara</name></author><author><name sortKey="Angelino, E" uniqKey="Angelino E">E Angelino</name></author><author><name sortKey="Gnocchi, Vf" uniqKey="Gnocchi V">VF Gnocchi</name></author><author><name sortKey="Prodam, F" uniqKey="Prodam F">F Prodam</name></author><author><name sortKey="Ronchi, G" uniqKey="Ronchi G">G Ronchi</name></author><author><name sortKey="Fagoonee, S" uniqKey="Fagoonee S">S Fagoonee</name></author><author><name sortKey="Fornaro, M" uniqKey="Fornaro M">M Fornaro</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pourtau, L" uniqKey="Pourtau L">L Pourtau</name></author><author><name sortKey="Leemburg, S" uniqKey="Leemburg S">S Leemburg</name></author><author><name sortKey="Roux, P" uniqKey="Roux P">P Roux</name></author><author><name sortKey="Leste Lasserre, T" uniqKey="Leste Lasserre T">T Leste-Lasserre</name></author><author><name sortKey="Costaglioli, P" uniqKey="Costaglioli P">P Costaglioli</name></author><author><name sortKey="Garbay, B" uniqKey="Garbay B">B Garbay</name></author><author><name sortKey="Drutel, G" uniqKey="Drutel G">G Drutel</name></author><author><name sortKey="Konsman, Jp" uniqKey="Konsman J">JP Konsman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Prudom, C" uniqKey="Prudom C">C Prudom</name></author><author><name sortKey="Liu, J" uniqKey="Liu J">J Liu</name></author><author><name sortKey="Patrie, J" uniqKey="Patrie J">J Patrie</name></author><author><name sortKey="Gaylinn, Bd" uniqKey="Gaylinn B">BD Gaylinn</name></author><author><name sortKey="Foster Schubert, Ke" uniqKey="Foster Schubert K">KE Foster-Schubert</name></author><author><name sortKey="Cummings, De" uniqKey="Cummings D">DE Cummings</name></author><author><name sortKey="Thorner, Mo" uniqKey="Thorner M">MO Thorner</name></author><author><name sortKey="Geysen, Hm" uniqKey="Geysen H">HM Geysen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Raman, S" uniqKey="Raman S">S Raman</name></author><author><name sortKey="Grimberg, A" uniqKey="Grimberg A">A Grimberg</name></author><author><name sortKey="Waquespack, Sg" uniqKey="Waquespack S">SG Waquespack</name></author><author><name sortKey="Miller, Bs" uniqKey="Miller B">BS Miller</name></author><author><name sortKey="Sklar, Ca" uniqKey="Sklar C">CA Sklar</name></author><author><name sortKey="Meacham, Lr" uniqKey="Meacham L">LR Meacham</name></author><author><name sortKey="Patterson, Bc" uniqKey="Patterson B">BC Patterson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rau, Tt" uniqKey="Rau T">TT Rau</name></author><author><name sortKey="Sonst, A" uniqKey="Sonst A">A Sonst</name></author><author><name sortKey="Rogler, A" uniqKey="Rogler A">A Rogler</name></author><author><name sortKey="Burnat, G" uniqKey="Burnat G">G Burnat</name></author><author><name sortKey="Neumann, H" uniqKey="Neumann H">H Neumann</name></author><author><name sortKey="Oeckl, K" uniqKey="Oeckl K">K Oeckl</name></author><author><name sortKey="Neuhuber, W" uniqKey="Neuhuber W">W Neuhuber</name></author><author><name sortKey="Dimmler, A" uniqKey="Dimmler A">A Dimmler</name></author><author><name sortKey="Faller, G" uniqKey="Faller G">G Faller</name></author><author><name sortKey="Brzozowski, T" uniqKey="Brzozowski T">T Brzozowski</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Renehan, Ag" uniqKey="Renehan A">AG Renehan</name></author><author><name sortKey="Zwahlen, M" uniqKey="Zwahlen M">M Zwahlen</name></author><author><name sortKey="Minder, C" uniqKey="Minder C">C Minder</name></author><author><name sortKey="O Wyer, St" uniqKey="O Wyer S">ST O’Dwyer</name></author><author><name sortKey="Shalet, Sm" uniqKey="Shalet S">SM Shalet</name></author><author><name sortKey="Egger, M" uniqKey="Egger M">M Egger</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Renehan, Ag" uniqKey="Renehan A">AG Renehan</name></author><author><name sortKey="Harvie, M" uniqKey="Harvie M">M Harvie</name></author><author><name sortKey="Howell, Ia" uniqKey="Howell I">IA Howell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Roemmler Zehrer, J" uniqKey="Roemmler Zehrer J">J Roemmler-Zehrer</name></author><author><name sortKey="Geigenberger, V" uniqKey="Geigenberger V">V Geigenberger</name></author><author><name sortKey="Stormann, S" uniqKey="Stormann S">S Störmann</name></author><author><name sortKey="Losa, M" uniqKey="Losa M">M Losa</name></author><author><name sortKey="Crippa, V" uniqKey="Crippa V">V Crippa</name></author><author><name sortKey="Otto, B" uniqKey="Otto B">B Otto</name></author><author><name sortKey="Bidlingmaier, M" uniqKey="Bidlingmaier M">M Bidlingmaier</name></author><author><name sortKey="Dimopoulou, C" uniqKey="Dimopoulou C">C Dimopoulou</name></author><author><name sortKey="Stalla, Gk" uniqKey="Stalla G">GK Stalla</name></author><author><name sortKey="Schopohl, J" uniqKey="Schopohl J">J Schopohl</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Roth, Cl" uniqKey="Roth C">CL Roth</name></author><author><name sortKey="Gebhardt, U" uniqKey="Gebhardt U">U Gebhardt</name></author><author><name sortKey="Muller, Hl" uniqKey="Muller H">HL Müller</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rowlands, Ma" uniqKey="Rowlands M">MA Rowlands</name></author><author><name sortKey="Holly, Jm" uniqKey="Holly J">JM Holly</name></author><author><name sortKey="Gunnell, D" uniqKey="Gunnell D">D Gunnell</name></author><author><name sortKey="Donovan, J" uniqKey="Donovan J">J Donovan</name></author><author><name sortKey="Lane, Ja" uniqKey="Lane J">JA Lane</name></author><author><name sortKey="Hamdy, F" uniqKey="Hamdy F">F Hamdy</name></author><author><name sortKey="Neal, De" uniqKey="Neal D">DE Neal</name></author><author><name sortKey="Oliver, S" uniqKey="Oliver S">S Oliver</name></author><author><name sortKey="Smith, Gd" uniqKey="Smith G">GD Smith</name></author><author><name sortKey="Martin, Rm" uniqKey="Martin R">RM Martin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sadjadi, A" uniqKey="Sadjadi A">A Sadjadi</name></author><author><name sortKey="Yazdanbod, A" uniqKey="Yazdanbod A">A Yazdanbod</name></author><author><name sortKey="Lee, Yy" uniqKey="Lee Y">YY Lee</name></author><author><name sortKey="Boreiri, M" uniqKey="Boreiri M">M Boreiri</name></author><author><name sortKey="Samadi, F" uniqKey="Samadi F">F Samadi</name></author><author><name sortKey="Alizadeh, Bz" uniqKey="Alizadeh B">BZ Alizadeh</name></author><author><name sortKey="Islami, F" uniqKey="Islami F">F Islami</name></author><author><name sortKey="Fyfe, V" uniqKey="Fyfe V">V Fyfe</name></author><author><name sortKey="Babaei, M" uniqKey="Babaei M">M Babaei</name></author><author><name sortKey="Namazi, Mj" uniqKey="Namazi M">MJ Namazi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="S Vendahl, L" uniqKey="S Vendahl L">L Sävendahl</name></author><author><name sortKey="Maes, M" uniqKey="Maes M">M Maes</name></author><author><name sortKey="Albertsson Wikland, K" uniqKey="Albertsson Wikland K">K Albertsson-Wikland</name></author><author><name sortKey="Borgstrom, B" uniqKey="Borgstrom B">B Borgström</name></author><author><name sortKey="Carel, Jc" uniqKey="Carel J">JC Carel</name></author><author><name sortKey="Henrard, S" uniqKey="Henrard S">S Henrard</name></author><author><name sortKey="Speybroeck, N" uniqKey="Speybroeck N">N Speybroeck</name></author><author><name sortKey="Thomas, M" uniqKey="Thomas M">M Thomas</name></author><author><name sortKey="Zandwijken, G" uniqKey="Zandwijken G">G Zandwijken</name></author><author><name sortKey="Hokken Koelega, A" uniqKey="Hokken Koelega A">A Hokken-Koelega</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schernhammer, Es" uniqKey="Schernhammer E">ES Schernhammer</name></author><author><name sortKey="Holly, Jm" uniqKey="Holly J">JM Holly</name></author><author><name sortKey="Hunter, Dj" uniqKey="Hunter D">DJ Hunter</name></author><author><name sortKey="Pollak, Mn" uniqKey="Pollak M">MN Pollak</name></author><author><name sortKey="Hankinson, Se" uniqKey="Hankinson S">SE Hankinson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schock, H" uniqKey="Schock H">H Schock</name></author><author><name sortKey="Fortner, Rt" uniqKey="Fortner R">RT Fortner</name></author><author><name sortKey="Surcel, Hm" uniqKey="Surcel H">HM Surcel</name></author><author><name sortKey="Grankvist, K" uniqKey="Grankvist K">K Grankvist</name></author><author><name sortKey="Pukkala, E" uniqKey="Pukkala E">E Pukkala</name></author><author><name sortKey="Lehtinen, M" uniqKey="Lehtinen M">M Lehtinen</name></author><author><name sortKey="Lundin, E" uniqKey="Lundin E">E Lundin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Severi, G" uniqKey="Severi G">G Severi</name></author><author><name sortKey="Morris, Ha" uniqKey="Morris H">HA Morris</name></author><author><name sortKey="Macinnis, Rj" uniqKey="Macinnis R">RJ MacInnis</name></author><author><name sortKey="English, Dr" uniqKey="English D">DR English</name></author><author><name sortKey="Tilley, Wd" uniqKey="Tilley W">WD Tilley</name></author><author><name sortKey="Hopper, Jl" uniqKey="Hopper J">JL Hopper</name></author><author><name sortKey="Boyle, P" uniqKey="Boyle P">P Boyle</name></author><author><name sortKey="Giles, Gg" uniqKey="Giles G">GG Giles</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shiiya, T" uniqKey="Shiiya T">T Shiiya</name></author><author><name sortKey="Nakazato, M" uniqKey="Nakazato M">M Nakazato</name></author><author><name sortKey="Mizuta, M" uniqKey="Mizuta M">M Mizuta</name></author><author><name sortKey="Date, Y" uniqKey="Date Y">Y Date</name></author><author><name sortKey="Mondal, Ms" uniqKey="Mondal M">MS Mondal</name></author><author><name sortKey="Tanaka, M" uniqKey="Tanaka M">M Tanaka</name></author><author><name sortKey="Nozoe, S" uniqKey="Nozoe S">S Nozoe</name></author><author><name sortKey="Hosoda, H" uniqKey="Hosoda H">H Hosoda</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author><author><name sortKey="Matsukura, S" uniqKey="Matsukura S">S Matsukura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shimizu, Y" uniqKey="Shimizu Y">Y Shimizu</name></author><author><name sortKey="Nagaya, N" uniqKey="Nagaya N">N Nagaya</name></author><author><name sortKey="Isobe, T" uniqKey="Isobe T">T Isobe</name></author><author><name sortKey="Imazu, M" uniqKey="Imazu M">M Imazu</name></author><author><name sortKey="Okumura, H" uniqKey="Okumura H">H Okumura</name></author><author><name sortKey="Hosoda, H" uniqKey="Hosoda H">H Hosoda</name></author><author><name sortKey="Kojima, M" uniqKey="Kojima M">M Kojima</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author><author><name sortKey="Kohno, N" uniqKey="Kohno N">N Kohno</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Skibola, Dr" uniqKey="Skibola D">DR Skibola</name></author><author><name sortKey="Smith, Mt" uniqKey="Smith M">MT Smith</name></author><author><name sortKey="Bracci, Pm" uniqKey="Bracci P">PM Bracci</name></author><author><name sortKey="Hubbard, Ae" uniqKey="Hubbard A">AE Hubbard</name></author><author><name sortKey="Agana, L" uniqKey="Agana L">L Agana</name></author><author><name sortKey="Chi, S" uniqKey="Chi S">S Chi</name></author><author><name sortKey="Holly, Ea" uniqKey="Holly E">EA Holly</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sklar, Ca" uniqKey="Sklar C">CA Sklar</name></author><author><name sortKey="Mertens, Ac" uniqKey="Mertens A">AC Mertens</name></author><author><name sortKey="Mitby, P" uniqKey="Mitby P">P Mitby</name></author><author><name sortKey="Occhiogrosso, G" uniqKey="Occhiogrosso G">G Occhiogrosso</name></author><author><name sortKey="Qin, J" uniqKey="Qin J">J Qin</name></author><author><name sortKey="Heller, G" uniqKey="Heller G">G Heller</name></author><author><name sortKey="Yasui, Y" uniqKey="Yasui Y">Y Yasui</name></author><author><name sortKey="Robison, Ll" uniqKey="Robison L">LL Robison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Soriano Guillen, L" uniqKey="Soriano Guillen L">L Soriano-Guillén</name></author><author><name sortKey="Barrios, V" uniqKey="Barrios V">V Barrios</name></author><author><name sortKey="Campos Barros, A" uniqKey="Campos Barros A">A Campos-Barros</name></author><author><name sortKey="Argente, J" uniqKey="Argente J">J Argente</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stochholm, K" uniqKey="Stochholm K">K Stochholm</name></author><author><name sortKey="Johannsson, G" uniqKey="Johannsson G">G Johannsson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Strasser, F" uniqKey="Strasser F">F Strasser</name></author><author><name sortKey="Lutz, Ta" uniqKey="Lutz T">TA Lutz</name></author><author><name sortKey="Maeder, Mt" uniqKey="Maeder M">MT Maeder</name></author><author><name sortKey="Thuerlimann, B" uniqKey="Thuerlimann B">B Thuerlimann</name></author><author><name sortKey="Bueche, D" uniqKey="Bueche D">D Bueche</name></author><author><name sortKey="Tschop, M" uniqKey="Tschop M">M Tschöp</name></author><author><name sortKey="Kaufmann, K" uniqKey="Kaufmann K">K Kaufmann</name></author><author><name sortKey="Holst, B" uniqKey="Holst B">B Holst</name></author><author><name sortKey="Br Ndle, M" uniqKey="Br Ndle M">M Brändle</name></author><author><name sortKey="Von Moos, R" uniqKey="Von Moos R">R von Moos</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takaya, K" uniqKey="Takaya K">K Takaya</name></author><author><name sortKey="Ariyasu, H" uniqKey="Ariyasu H">H Ariyasu</name></author><author><name sortKey="Kanamoto, N" uniqKey="Kanamoto N">N Kanamoto</name></author><author><name sortKey="Iwakura, H" uniqKey="Iwakura H">H Iwakura</name></author><author><name sortKey="Yoshimoto, A" uniqKey="Yoshimoto A">A Yoshimoto</name></author><author><name sortKey="Harada, M" uniqKey="Harada M">M Harada</name></author><author><name sortKey="Mori, K" uniqKey="Mori K">K Mori</name></author><author><name sortKey="Komatsu, Y" uniqKey="Komatsu Y">Y Komatsu</name></author><author><name sortKey="Usui, T" uniqKey="Usui T">T Usui</name></author><author><name sortKey="Shimatsu, A" uniqKey="Shimatsu A">A Shimatsu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Temel, Js" uniqKey="Temel J">JS Temel</name></author><author><name sortKey="Abernethy, Ap" uniqKey="Abernethy A">AP Abernethy</name></author><author><name sortKey="Currow, Dc" uniqKey="Currow D">DC Currow</name></author><author><name sortKey="Friend, J" uniqKey="Friend J">J Friend</name></author><author><name sortKey="Duus, Em" uniqKey="Duus E">EM Duus</name></author><author><name sortKey="Yan, Y" uniqKey="Yan Y">Y Yan</name></author><author><name sortKey="Fearon, Kc" uniqKey="Fearon K">KC Fearon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Till, H" uniqKey="Till H">H Till</name></author><author><name sortKey="Schlichting, N" uniqKey="Schlichting N">N Schlichting</name></author><author><name sortKey="Oberbach, A" uniqKey="Oberbach A">A Oberbach</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tong, J" uniqKey="Tong J">J Tong</name></author><author><name sortKey="Prigeon, Rl" uniqKey="Prigeon R">RL Prigeon</name></author><author><name sortKey="Davis, Hw" uniqKey="Davis H">HW Davis</name></author><author><name sortKey="Bidlingmaier, M" uniqKey="Bidlingmaier M">M Bidlingmaier</name></author><author><name sortKey="Tschop, Mh" uniqKey="Tschop M">MH Tschöp</name></author><author><name sortKey="D Lessio, D" uniqKey="D Lessio D">D D’Alessio</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Trivin, C" uniqKey="Trivin C">C Trivin</name></author><author><name sortKey="Busiah, K" uniqKey="Busiah K">K Busiah</name></author><author><name sortKey="Mahlaoui, N" uniqKey="Mahlaoui N">N Mahlaoui</name></author><author><name sortKey="Recasens, C" uniqKey="Recasens C">C Recasens</name></author><author><name sortKey="Souberbielle, Jc" uniqKey="Souberbielle J">JC Souberbielle</name></author><author><name sortKey="Zerah, M" uniqKey="Zerah M">M Zerah</name></author><author><name sortKey="Sainte Rose, C" uniqKey="Sainte Rose C">C Sainte-Rose</name></author><author><name sortKey="Brauner, R" uniqKey="Brauner R">R Brauner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tsao, Sm" uniqKey="Tsao S">SM Tsao</name></author><author><name sortKey="Yin, Mc" uniqKey="Yin M">MC Yin</name></author><author><name sortKey="Liu, Wh" uniqKey="Liu W">WH Liu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tschop, M" uniqKey="Tschop M">M Tschöp</name></author><author><name sortKey="Smiley, Dl" uniqKey="Smiley D">DL Smiley</name></author><author><name sortKey="Heiman, Ml" uniqKey="Heiman M">ML Heiman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tschop, M" uniqKey="Tschop M">M Tschöp</name></author><author><name sortKey="Weyer, C" uniqKey="Weyer C">C Weyer</name></author><author><name sortKey="Tataranni, Pa" uniqKey="Tataranni P">PA Tataranni</name></author><author><name sortKey="Devanaravan, V" uniqKey="Devanaravan V">V Devanaravan</name></author><author><name sortKey="Ravussin, E" uniqKey="Ravussin E">E Ravussin</name></author><author><name sortKey="Heiman, Ml" uniqKey="Heiman M">ML Heiman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tsolakis, Av" uniqKey="Tsolakis A">AV Tsolakis</name></author><author><name sortKey="Stridsberg, M" uniqKey="Stridsberg M">M Stridsberg</name></author><author><name sortKey="Grimelius, L" uniqKey="Grimelius L">L Grimelius</name></author><author><name sortKey="Portela Gomes, Gm" uniqKey="Portela Gomes G">GM Portela-Gomes</name></author><author><name sortKey="Falkmer, Se" uniqKey="Falkmer S">SE Falkmer</name></author><author><name sortKey="Waldum, Hl" uniqKey="Waldum H">HL Waldum</name></author><author><name sortKey="Janson, Et" uniqKey="Janson E">ET Janson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tsubouchi, H" uniqKey="Tsubouchi H">H Tsubouchi</name></author><author><name sortKey="Yanagi, S" uniqKey="Yanagi S">S Yanagi</name></author><author><name sortKey="Miura, A" uniqKey="Miura A">A Miura</name></author><author><name sortKey="Matsumoto, N" uniqKey="Matsumoto N">N Matsumoto</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author><author><name sortKey="Nakazato, M" uniqKey="Nakazato M">M Nakazato</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Varela, L" uniqKey="Varela L">L Varela</name></author><author><name sortKey="Vazquez, Mj" uniqKey="Vazquez M">MJ Vázquez</name></author><author><name sortKey="Cordido, F" uniqKey="Cordido F">F Cordido</name></author><author><name sortKey="Nogueiras, R" uniqKey="Nogueiras R">R Nogueiras</name></author><author><name sortKey="Vidal Puig, A" uniqKey="Vidal Puig A">A Vidal-Puig</name></author><author><name sortKey="Dieguez, C" uniqKey="Dieguez C">C Diéguez</name></author><author><name sortKey="L Pez, M" uniqKey="L Pez M">M López</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wagner, K" uniqKey="Wagner K">K Wagner</name></author><author><name sortKey="Hemminki, K" uniqKey="Hemminki K">K Hemminki</name></author><author><name sortKey="Grzybowska, E" uniqKey="Grzybowska E">E Grzybowska</name></author><author><name sortKey="Klaes, R" uniqKey="Klaes R">R Klaes</name></author><author><name sortKey="Burwinkel, B" uniqKey="Burwinkel B">B Burwinkel</name></author><author><name sortKey="Bugert, P" uniqKey="Bugert P">P Bugert</name></author><author><name sortKey="Schmutzler, Rk" uniqKey="Schmutzler R">RK Schmutzler</name></author><author><name sortKey="Wappenschmidt, B" uniqKey="Wappenschmidt B">B Wappenschmidt</name></author><author><name sortKey="Butkiewicz, D" uniqKey="Butkiewicz D">D Butkiewicz</name></author><author><name sortKey="Pamula, J" uniqKey="Pamula J">J Pamula</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, W" uniqKey="Wang W">W Wang</name></author><author><name sortKey="Andersson, M" uniqKey="Andersson M">M Andersson</name></author><author><name sortKey="Iresjo, Bm" uniqKey="Iresjo B">BM Iresjö</name></author><author><name sortKey="Lonnroth, C" uniqKey="Lonnroth C">C Lönnroth</name></author><author><name sortKey="Lundholm, K" uniqKey="Lundholm K">K Lundholm</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, Hs" uniqKey="Wang H">HS Wang</name></author><author><name sortKey="Oh, Ds" uniqKey="Oh D">DS Oh</name></author><author><name sortKey="Ohning, Gv" uniqKey="Ohning G">GV Ohning</name></author><author><name sortKey="Pisegna, Jr" uniqKey="Pisegna J">JR Pisegna</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Williams, Dl" uniqKey="Williams D">DL Williams</name></author><author><name sortKey="Cummings, De" uniqKey="Cummings D">DE Cummings</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wolfe, I" uniqKey="Wolfe I">I Wolfe</name></author><author><name sortKey="Sadetzki, S" uniqKey="Sadetzki S">S Sadetzki</name></author><author><name sortKey="Kanety, H" uniqKey="Kanety H">H Kanety</name></author><author><name sortKey="Kundel, Y" uniqKey="Kundel Y">Y Kundel</name></author><author><name sortKey="Pariente, C" uniqKey="Pariente C">C Pariente</name></author><author><name sortKey="Epstein, N" uniqKey="Epstein N">N Epstein</name></author><author><name sortKey="Oberman, B" uniqKey="Oberman B">B Oberman</name></author><author><name sortKey="Catane, R" uniqKey="Catane R">R Catane</name></author><author><name sortKey="Kaufman, B" uniqKey="Kaufman B">B Kaufman</name></author><author><name sortKey="Shimon, I" uniqKey="Shimon I">I Shimon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoon, Ys" uniqKey="Yoon Y">YS Yoon</name></author><author><name sortKey="Keum, N" uniqKey="Keum N">N Keum</name></author><author><name sortKey="Zhang, X" uniqKey="Zhang X">X Zhang</name></author><author><name sortKey="Cho, E" uniqKey="Cho E">E Cho</name></author><author><name sortKey="Giovannucci, El" uniqKey="Giovannucci E">EL Giovannucci</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoshimoto, A" uniqKey="Yoshimoto A">A Yoshimoto</name></author><author><name sortKey="Mori, K" uniqKey="Mori K">K Mori</name></author><author><name sortKey="Sugawara, A" uniqKey="Sugawara A">A Sugawara</name></author><author><name sortKey="Mukoyama, M" uniqKey="Mukoyama M">M Mukoyama</name></author><author><name sortKey="Yahata, K" uniqKey="Yahata K">K Yahata</name></author><author><name sortKey="Suganami, T" uniqKey="Suganami T">T Suganami</name></author><author><name sortKey="Takaya, K" uniqKey="Takaya K">K Takaya</name></author><author><name sortKey="Hosoda, H" uniqKey="Hosoda H">H Hosoda</name></author><author><name sortKey="Kojima, M" uniqKey="Kojima M">M Kojima</name></author><author><name sortKey="Kangawa, K" uniqKey="Kangawa K">K Kangawa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhang, J" uniqKey="Zhang J">J Zhang</name></author><author><name sortKey="Dhakal, Ib" uniqKey="Dhakal I">IB Dhakal</name></author><author><name sortKey="Zhang, X" uniqKey="Zhang X">X Zhang</name></author><author><name sortKey="Prizment, Ae" uniqKey="Prizment A">AE Prizment</name></author><author><name sortKey="Anderson, Ke" uniqKey="Anderson K">KE Anderson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhu, S" uniqKey="Zhu S">S Zhu</name></author><author><name sortKey="Shao, B" uniqKey="Shao B">B Shao</name></author><author><name sortKey="Hao, Y" uniqKey="Hao Y">Y Hao</name></author><author><name sortKey="Li, Z" uniqKey="Li Z">Z Li</name></author><author><name sortKey="Liu, H" uniqKey="Liu H">H Liu</name></author><author><name sortKey="Li, H" uniqKey="Li H">H Li</name></author><author><name sortKey="Wang, M" uniqKey="Wang M">M Wang</name></author><author><name sortKey="Wang, K" uniqKey="Wang K">K Wang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zub Pokrowiecka, A" uniqKey="Zub Pokrowiecka A">A Zub-Pokrowiecka</name></author><author><name sortKey="Rembiasz, K" uniqKey="Rembiasz K">K Rembiasz</name></author><author><name sortKey="Konturek, Sj" uniqKey="Konturek S">SJ Konturek</name></author><author><name sortKey="Budzynski, A" uniqKey="Budzynski A">A Budzynski</name></author><author><name sortKey="Konturek, Pc" uniqKey="Konturek P">PC Konturek</name></author><author><name sortKey="Budzynski, P" uniqKey="Budzynski P">P Budzynski</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zub Pokrowiecka, A" uniqKey="Zub Pokrowiecka A">A Zub-Pokrowiecka</name></author><author><name sortKey="Rembiasz, K" uniqKey="Rembiasz K">K Rembiasz</name></author><author><name sortKey="Konturek, Pc" uniqKey="Konturek P">PC Konturek</name></author><author><name sortKey="Budzy Ski, A" uniqKey="Budzy Ski A">A Budzyński</name></author><author><name sortKey="Konturek, Sj" uniqKey="Konturek S">SJ Konturek</name></author><author><name sortKey="Winiarski, M" uniqKey="Winiarski M">M Winiarski</name></author><author><name sortKey="Biela Ski, W" uniqKey="Biela Ski W">W Bielański</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Endocr Relat Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Endocr. Relat. Cancer</journal-id><journal-id journal-id-type="hwp">ERC</journal-id><journal-title-group><journal-title>Endocrine-Related Cancer</journal-title></journal-title-group><issn pub-type="ppub">1351-0088</issn><issn pub-type="epub">1479-6821</issn><publisher><publisher-name>Bioscientifica Ltd</publisher-name><publisher-loc>Bristol</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27552970</article-id><article-id pub-id-type="pmc">5064755</article-id><article-id pub-id-type="doi">10.1530/ERC-16-0130</article-id><article-id pub-id-type="publisher-id">ERC160130</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review</article-title><alt-title alt-title-type="lrh">S Sever et al.</alt-title><alt-title alt-title-type="short">Review of ghrelin/ghrelin analogs in cancer</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sever</surname><given-names>Sakine</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>White</surname><given-names>Donna L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Garcia</surname><given-names>José M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="corresp" rid="cor1"></xref></contrib><aff id="aff1"><label>1</label><institution>Division of Endocrinology</institution><addr-line>Diabetes, and Metabolism, Baylor College of Medicine, Alkek Building for Biomedical Research, Houston, Texas, USA</addr-line></aff><aff id="aff2"><label>2</label><institution>Section of Gastroenterology and Hepatology</institution><addr-line>Baylor College of Medicine Medical Center, Houston, Texas, USA</addr-line></aff><aff id="aff3"><label>3</label><institution>Clinical Epidemiology and Comparative Effectiveness Program</institution><addr-line>Section of Health Services Research (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, HSR&D Center of Innovation (152), Houston, Texas, USA</addr-line></aff><aff id="aff4"><label>4</label><institution>Texas Medical Center Digestive Disease Center</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></aff><aff id="aff5"><label>5</label><institution>Dan L. Duncan Comprehensive Cancer Center</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></aff><aff id="aff6"><label>6</label><institution>Center for Translational Research on Inflammatory Diseases (CTRID)</institution><addr-line>Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA</addr-line></aff><aff id="aff7"><label>7</label><institution>Department of Molecular and Cellular Biology</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></aff><aff id="aff8"><label>8</label><institution>Huffington Center on Aging</institution><addr-line>Baylor College of Medicine, Houston, Texas, USA</addr-line></aff><aff id="aff9"><label>9</label><institution>Geriatrics Research Education and Clinical Center</institution><addr-line>Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA</addr-line></aff></contrib-group><author-notes><corresp id="cor1">Correspondence should be addressed to J M Garcia; Email: <email>jose.garcia@va.gov</email></corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>01</day><month>9</month><year>2016</year></pub-date><volume>23</volume><issue>9</issue><fpage>R393</fpage><lpage>R409</lpage><history><date date-type="received"><day>11</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>14</day><month>7</month><year>2016</year></date></history><permissions><copyright-statement>© 2016 Society for Endocrinology</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Society for Endocrinology</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p><inline-graphic xlink:href="88x31.jpg"></inline-graphic> This work is licensed under a <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution 3.0 Unported License</ext-link></license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="erc-23-R393.pdf"></self-uri><abstract><p>Ghrelin is a hormone with multiple physiologic functions, including promotion of growth hormone release, stimulation of appetite and regulation of energy homeostasis. Treatment with ghrelin/ghrelin-receptor agonists is a prospective therapy for disease-related cachexia and malnutrition. <italic>In vitro</italic> studies have shown high expression of ghrelin in cancer tissue, although its role including its impact in cancer risk and progression has not been established. We performed a systematic literature review to identify peer-reviewed human or animal <italic>in vivo</italic> original research studies of ghrelin, ghrelin-receptor agonists, or ghrelin genetic variants and the risk, presence, or growth of cancer using structured searches in PubMed database as well as secondary searches of article reference lists, additional reviews and meta-analyses. Overall, 45 (73.8%) of the 61 studies reviewed, including all 11 involving exogenous ghrelin/ghrelin-receptor agonist treatment, reported either a null (no statistically significant difference) or inverse association of ghrelin/ghrelin-receptor agonists or ghrelin genetic variants with cancer risk, presence or growth; 10 (16.7%) studies reported positive associations; and 6 (10.0%) reported both negative or null and positive associations. Differences in serum ghrelin levels in cancer cases vs controls (typically lower) were reported for some but not all cancers. The majority of <italic>in vivo</italic> studies showed a null or inverse association of ghrelin with risk and progression of most cancers, suggesting that ghrelin/ghrelin-receptor agonist treatment may have a favorable safety profile to use for cancer cachexia. Additional large-scale prospective clinical trials as well as basic bioscientific research are warranted to further evaluate the safety and benefits of ghrelin treatment in patients with cancer.</p></abstract><kwd-group><title>Keywords</title><kwd>ghrelin</kwd><kwd>cancer</kwd><kwd>tumor growth</kwd><kwd>metastasis</kwd><kwd><italic>in vivo</italic></kwd><kwd>cachexia</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Ghrelin is a 28-amino acid peptide with an <italic>n</italic>-octanoyl ester at its third serine residue, which is the endogenous ligand for the ghrelin receptor (formerly known as the growth hormone (GH) secretagogue receptor) and a hormone with multiple biologic functions (<xref rid="bib58" ref-type="bibr">Kojima <italic>et al</italic>. 1999</xref>, <xref rid="bib59" ref-type="bibr">Korbonits <italic>et al</italic>. 2004</xref>, <xref rid="bib24" ref-type="bibr">Delporte 2013</xref>, <xref rid="bib13" ref-type="bibr">Chen & Enriori 2015</xref>). Circulating ghrelin in humans consists of acylated (acyl) ghrelin and unacylated (des-acyl) ghrelin, which vary in their proportions over time, due in part to the rapid conversion of acyl to des-acyl ghrelin that appears to occur through circulating esterases (<xref rid="bib122" ref-type="bibr">Tong <italic>et al</italic>. 2013</xref>, <xref rid="bib23" ref-type="bibr">Delhanty <italic>et al</italic>. 2015</xref>). When acyl ghrelin was stabilized by esterase inhibition, the acyl to des-acyl ghrelin ratio was shown to range from 1:2 to 1:8 (<xref rid="bib23" ref-type="bibr">Delhanty <italic>et al</italic>. 2015</xref>). Acyl ghrelin binds to the ghrelin receptor with 1000 times greater potency than des-acyl ghrelin, and is considered the only form capable of clinically relevant ghrelin-receptor activation; the term ghrelin (endogenous or exogenous) thus generally refers to the acyl or ‘active’ form (<xref rid="bib7" ref-type="bibr">Bednarek <italic>et al</italic>. 2000</xref>, <xref rid="bib72" ref-type="bibr">Matsumoto <italic>et al</italic>. 2001</xref>, <xref rid="bib39" ref-type="bibr">Gauna <italic>et al</italic>. 2007</xref>). Nonetheless, des-acyl ghrelin appears to have multiple physiologic actions, including modulation (agonism or antagonism) of several of ghrelin’s actions (<xref rid="bib22" ref-type="bibr">Delhanty <italic>et al</italic>. 2010</xref>, <xref rid="bib13" ref-type="bibr">Chen & Enriori 2015</xref>) that do not require the presence of the ghrelin receptor. The existence of receptors specific to des-acyl ghrelin, as well as additional ghrelin receptors, has been proposed, but not yet demonstrated (<xref rid="bib10" ref-type="bibr">Callaghan & Furness 2014</xref>).</p><p>Discovered in 1999, ghrelin was initially observed to stimulate pituitary release of GH in a dose-dependent manner (<xref rid="bib58" ref-type="bibr">Kojima <italic>et al</italic>. 1999</xref>, <xref rid="bib119" ref-type="bibr">Takaya <italic>et al</italic>. 2000</xref>), and later found to play an important role in the hypothalamic regulation of energy homeostasis by stimulating appetite and feeding through central and peripheral pathways, and via the vagus nerve (<xref rid="bib87" ref-type="bibr">Nakazato <italic>et al</italic>. 2001</xref>, <xref rid="bib133" ref-type="bibr">Williams & Cummings 2005</xref>, <xref rid="bib24" ref-type="bibr">Delporte 2013</xref>). While 70% of circulating ghrelin is produced in the stomach, it is also expressed in diverse tissues, including the lungs, heart, intestines, pancreas, kidneys, gonads, pituitary and hypothalamus (<xref rid="bib51" ref-type="bibr">Jeon <italic>et al</italic>. 2004</xref>, <xref rid="bib24" ref-type="bibr">Delporte 2013</xref>). Circulating ghrelin levels increase under conditions of fasting or low body mass index (BMI) such as disease-related cachexia, anorexia nervosa and other states of malnutrition. Conversely, ghrelin levels decrease in response to rising BMI and obesity, and increased levels of glucose, insulin, lipids, leptin, GH, somatostatin, peptide YY, urocortin-1 and gastrin (<xref rid="bib126" ref-type="bibr">Tschöp <italic>et al</italic>. 2001</xref>, <xref rid="bib112" ref-type="bibr">Shiiya <italic>et al</italic>. 2002</xref>, <xref rid="bib82" ref-type="bibr">Murdolo <italic>et al</italic>. 2003</xref>, <xref rid="bib59" ref-type="bibr">Korbonits <italic>et al</italic>. 2004</xref>, <xref rid="bib116" ref-type="bibr">Soriano-Guillén <italic>et al</italic>. 2004</xref>, <xref rid="bib36" ref-type="bibr">Garcia <italic>et al</italic>. 2006</xref>, <xref rid="bib48" ref-type="bibr">Ingelsson <italic>et al</italic>. 2008</xref>, <xref rid="bib101" ref-type="bibr">Rau <italic>et al</italic>. 2013</xref>). Ghrelin levels decline with age, and are higher in women than in men (<xref rid="bib59" ref-type="bibr">Korbonits <italic>et al</italic>. 2004</xref>, <xref rid="bib48" ref-type="bibr">Ingelsson <italic>et al</italic>. 2008</xref>).</p><p>Ghrelin also modulates blood glucose levels and glucose disposal in skeletal muscle and adipose tissue in conjunction with GH and insulin-like growth factor 1 (IGF1), and regulates peripheral lipid metabolism and anabolic processes such as lipid storage via mainly GH-independent mechanisms (<xref rid="bib88" ref-type="bibr">Nass <italic>et al</italic>. 2010</xref>, <xref rid="bib129" ref-type="bibr">Varela <italic>et al</italic>. 2011</xref>). Collectively, these actions and characteristics suggest a prominent physiologic role for ghrelin as a regulator of energy balance and homeostasis (<xref rid="bib59" ref-type="bibr">Korbonits <italic>et al</italic>. 2004</xref>, <xref rid="bib133" ref-type="bibr">Williams & Cummings 2005</xref>, <xref rid="bib129" ref-type="bibr">Varela <italic>et al</italic>. 2011</xref>, <xref rid="bib13" ref-type="bibr">Chen & Enriori 2015</xref>). In addition, ghrelin appears to contribute through both GH-dependent and GH-independent pathways to regulation of the cardiovascular and reproductive systems, gastrointestinal function, pancreatic function, adipogenesis, angiogenesis, bone formation, anti-inflammatory and immune functions, muscle function and cell proliferation (<xref rid="bib125" ref-type="bibr">Tschöp <italic>et al</italic>. 2000</xref>, <xref rid="bib126" ref-type="bibr">2001</xref>, <xref rid="bib59" ref-type="bibr">Korbonits <italic>et al</italic>. 2004</xref>, <xref rid="bib63" ref-type="bibr">Li <italic>et al</italic>. 2007</xref>, <xref rid="bib6" ref-type="bibr">Bataar <italic>et al</italic>. 2011</xref>, <xref rid="bib24" ref-type="bibr">Delporte 2013</xref>, <xref rid="bib97" ref-type="bibr">Porporato <italic>et al</italic>. 2013</xref>, <xref rid="bib13" ref-type="bibr">Chen & Enriori 2015</xref>) (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). Some consequences of ghrelin dysregulation may be demonstrated in Prader–Willi syndrome, a neurogenetic disorder that is characterized by poor feeding and weight gain in early infancy followed by hyperphagia, impaired satiety, severe obesity, and multiple dysmorphic and psychocognitive developmental problems in childhood and adulthood. This disorder is associated with hyperghrelinemia and increased acyl to des-acyl ghrelin ratio (<xref rid="bib33" ref-type="bibr">Feigerlová <italic>et al</italic>. 2008</xref>, <xref rid="bib60" ref-type="bibr">Kuppens <italic>et al</italic>. 2015</xref>). Based on its actions in maintaining energy homeostasis and promoting adipogenesis and muscle function, ghrelin/ghrelin-receptor agonist therapy is considered to have promising potential for restoring energy homeostasis in conditions such as eating/wasting disorders and cachexia related to cancer and other conditions, such as cardiovascular disease and chronic obstructive pulmonary disease (<xref rid="bib85" ref-type="bibr">Nagaya <italic>et al</italic>. 2004</xref>, <xref rid="bib86" ref-type="bibr">2005</xref>, <xref rid="bib118" ref-type="bibr">Strasser <italic>et al</italic>. 2008</xref>, <xref rid="bib80" ref-type="bibr">Müller <italic>et al</italic>. 2010</xref>, <xref rid="bib2" ref-type="bibr">Ali <italic>et al</italic>. 2013</xref>, <xref rid="bib38" ref-type="bibr">Garcia <italic>et al</italic>. 2015</xref>).
<fig fig-type="figure" id="fig1" position="float"><label>Figure 1</label><caption><p>Physiologic effects of ghrelin. ACTH, adrenocorticotropic hormone; GH, growth hormone; PRL, prolactin. Adapted, under the terms of the Creative Commons Attribution License, from Delporte <italic>et al</italic>. 2013; additional data from <xref rid="bib59" ref-type="bibr">Korbonits <italic>et al</italic>. 2004</xref>.</p></caption><graphic xlink:href="erc-23-R393-g001"></graphic></fig></p><p>Considerable <italic>in vitro</italic> research has investigated the potential role of ghrelin in carcinogenesis and cancer progression, possibly via an autocrine/paracrine pathway (<xref rid="bib50" ref-type="bibr">Jeffery <italic>et al</italic>. 2003</xref>, <xref rid="bib89" ref-type="bibr">Nikolopoulos <italic>et al</italic>. 2010</xref>, <xref rid="bib16" ref-type="bibr">Chopin <italic>et al</italic>. 2012</xref>). One rationale for this research is that endogenous ghrelin stimulates release of GH, which regulates IGF1 concentrations (<xref rid="bib50" ref-type="bibr">Jeffery <italic>et al</italic>. 2003</xref>, <xref rid="bib17" ref-type="bibr">Clemmons 2004</xref>). IGF1 has mitogenic and antiapoptotic properties (<xref rid="bib54" ref-type="bibr">Khandwala <italic>et al</italic>. 2000</xref>), and has been positively correlated in some preclinical, epidemiologic and case–control studies with modestly increased risk of several cancers, particularly hormone-dependent cancers of the breast and prostate (<xref rid="bib102" ref-type="bibr">Renehan <italic>et al</italic>. 2004</xref>, <xref rid="bib96" ref-type="bibr">Pekic & Popovic 2013</xref>, <xref rid="bib19" ref-type="bibr">Crawley & Holmberg 2014</xref>). However, other substantial clinical trial and meta-analysis data have shown no association of IGF1 or its binding proteins (e.g. IGF-binding protein 3 (IGFBP3)) with breast, prostate or colorectal cancers (<xref rid="bib103" ref-type="bibr">Renehan <italic>et al</italic>. 2006</xref>, <xref rid="bib109" ref-type="bibr">Schernhammer <italic>et al</italic>. 2006</xref>, <xref rid="bib111" ref-type="bibr">Severi <italic>et al</italic>. 2006</xref>, <xref rid="bib73" ref-type="bibr">Mikami <italic>et al</italic>. 2009</xref>, <xref rid="bib106" ref-type="bibr">Rowlands <italic>et al</italic>. 2012</xref>, <xref rid="bib135" ref-type="bibr">Yoon <italic>et al</italic>. 2015</xref>), although a positive correlation of insulin/hyperinsulinemia with advanced colorectal cancer has been noted (<xref rid="bib135" ref-type="bibr">Yoon <italic>et al</italic>. 2015</xref>). Inverse associations of IGFBP3 circulating level with lung cancer (<xref rid="bib12" ref-type="bibr">Cao <italic>et al</italic>. 2012</xref>), and of IGF1 and placental GH with epithelial ovarian cancer in women aged <55years at diagnosis (<xref rid="bib110" ref-type="bibr">Schock <italic>et al.</italic> 2015</xref>) have also been observed. Moreover, large, long-term clinical studies of GH therapy have demonstrated no increased risk of neoplasms or recurrent tumors in pediatric patients (<xref rid="bib3" ref-type="bibr">Allen <italic>et al.</italic> 1997</xref>, <xref rid="bib108" ref-type="bibr">Sävendahl <italic>et al.</italic> 2012</xref>, <xref rid="bib95" ref-type="bibr">Patterson <italic>et al.</italic> 2014</xref>, <xref rid="bib100" ref-type="bibr">Raman <italic>et al.</italic> 2015</xref>) or in adults (<xref rid="bib92" ref-type="bibr">Olsson <italic>et al.</italic> 2012</xref>, <xref rid="bib43" ref-type="bibr">Hartman <italic>et al.</italic> 2013</xref>, <xref rid="bib9" ref-type="bibr">Brignardello <italic>et al.</italic> 2015</xref>, <xref rid="bib15" ref-type="bibr">Child <italic>et al.</italic> 2015</xref>, <xref rid="bib117" ref-type="bibr">Stochholm & Johannsson 2015</xref>). Although it has been reported that GH therapy may increase the risk of a second neoplasm in pediatric cancer survivors (<xref rid="bib115" ref-type="bibr">Sklar <italic>et al.</italic> 2002</xref>), this risk appears to diminish over time (<xref rid="bib31" ref-type="bibr">Ergun-Longmire <italic>et al.</italic> 2006</xref>).</p><p>Regardless of the underlying rationale, numerous <italic>in vitro</italic> studies have investigated the association of ghrelin <italic>per se</italic> with various cancer types, either through or independent of its effect on GH/IGF1 (<xref rid="bib50" ref-type="bibr">Jeffery <italic>et al.</italic> 2003</xref>, <xref rid="bib89" ref-type="bibr">Nikolopoulos <italic>et al.</italic> 2010</xref>, <xref rid="bib16" ref-type="bibr">Chopin <italic>et al.</italic> 2012</xref>). These studies have provided mixed evidence, with most showing increased expression of ghrelin in neoplasms and potential indications of a carcinogenic role, while other studies demonstrated reduced ghrelin expression in tumors and/or a possible antineoplastic effect (<xref rid="bib16" ref-type="bibr">Chopin <italic>et al.</italic> 2012</xref>). Researchers have cited a need for more <italic>in vivo</italic> studies to clarify whether ghrelin plays a role in cancer (<xref rid="bib89" ref-type="bibr">Nikolopoulos <italic>et al.</italic> 2010</xref>, <xref rid="bib16" ref-type="bibr">Chopin <italic>et al.</italic> 2012</xref>). <italic>In vivo</italic> data are essential to illuminate this question since simplified <italic>in vitro</italic> models cannot account for the complex interactions – known and yet to be elucidated – that may lead to clinically important differences in outcomes.</p><p>It should be noted that research on plasma ghrelin levels and the effects of ghrelin agonist therapy is complicated by several methodologic factors. Although acyl and des-acyl ghrelin appear to have different actions, most published studies on endogenous ghrelin with regard to cancer have measured total ghrelin, which may be imprecise as to biologic implications (<xref rid="bib136" ref-type="bibr">Yoshimoto <italic>et al</italic>. 2002</xref>, <xref rid="bib1" ref-type="bibr">Akamizu <italic>et al</italic>. 2005</xref>, <xref rid="bib5" ref-type="bibr">Aydin <italic>et al</italic>. 2008</xref>). Indeed, 40–60% of total ghrelin measured using RIA may consist of deacylated C-terminal fragments, possibly as a consequence of the RIA procedure (<xref rid="bib1" ref-type="bibr">Akamizu <italic>et al</italic>. 2005</xref>). Newer assay methods, such as sandwich-type enzyme immunoassay and other novel adaptations of HPLC, ELISA and RIA can distinguish and separately measure acyl and des-acyl ghrelin (<xref rid="bib136" ref-type="bibr">Yoshimoto <italic>et al</italic>. 2002</xref>, <xref rid="bib46" ref-type="bibr">Hotta <italic>et al</italic>. 2004</xref>, <xref rid="bib1" ref-type="bibr">Akamizu <italic>et al</italic>. 2005</xref>, <xref rid="bib5" ref-type="bibr">Aydin <italic>et al</italic>. 2008</xref>, <xref rid="bib99" ref-type="bibr">Prudom <italic>et al</italic>. 2010</xref>). Yet, as noted above, due to the instability of acyl ghrelin, the levels of acyl ghrelin or proportions of acyl and des-acyl ghrelin constituting total ghrelin measures reported in studies may vary substantially. Moreover, ghrelin-receptor agonist therapies are typically designed to bind to the ghrelin receptor in similar manner as acyl ghrelin, thus representing a parallel to acyl but not to des-acyl ghrelin (<xref rid="bib35" ref-type="bibr">Garcia <italic>et al</italic>. 2009</xref>, <xref rid="bib37" ref-type="bibr">Garcia <italic>et al</italic>. 2013</xref>). This systematic literature review was conducted to evaluate the current status of the published <italic>in vivo</italic> studies on this topic and to assess the evidence and its implications.</p></sec><sec><title>Methods</title><p>A systematic literature review was conducted to gather and assess the <italic>in vivo</italic> (human and animal) research on the association between endogenous ghrelin levels or exogenously administered ghrelin (including receptor agonists and derivatives), and cancer risk, incidence, growth or metastasis (<xref ref-type="fig" rid="fig2">Fig. 2</xref>), following recommended methods for such reviews (<xref rid="bib75" ref-type="bibr">Moher <italic>et al.</italic> 2015</xref>). We searched National Library of Medicine/MEDLINE PubMed database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/">http://www.ncbi.nlm.nih.gov/pubmed/</ext-link>; last accessed 9 February 2016) for relevant studies using search terms such as ghrelin, GH, GH secretagogues, and cancer, published during the period of 1 January 1982, through 31 December 2015 (<xref ref-type="boxed-text" rid="box1">Box 1</xref>).
<fig fig-type="figure" id="fig2" position="float"><label>Figure 2</label><caption><p>Systematic review flow diagram: <italic>in vivo</italic> research evidence of associations of ghrelin with cancer.</p></caption><graphic xlink:href="erc-23-R393-g002"></graphic></fig><boxed-text id="box1" position="float"><label>Box 1</label><caption><title>MEDLINE search terms and strings.</title></caption><p>(‘ghrelin’(MeSH Terms) OR ‘ghrelin’(All Fields)) OR ((‘growth hormone’(MeSH Terms) OR (‘growth’(All Fields) AND ‘hormone’(All Fields)) OR ‘growth hormone’(All Fields)) AND (‘growth hormone’(MeSH Terms) OR (‘growth’(All Fields) AND ‘hormone’(All Fields)) OR ‘growth hormone’(All Fields)) AND secretagogues(All Fields)) AND ((‘tumour’(All Fields) OR ‘neoplasms’(MeSH Terms) OR ‘neoplasms’(All Fields) OR ‘tumor’(All Fields)) AND (‘neoplasms’(MeSH Terms) OR ‘neoplasms’(All Fields) OR ‘cancer’(All Fields)) AND (‘neoplasms’(MeSH Terms) OR ‘neoplasms’(All Fields) OR ‘neoplasia’(All Fields))) NOT (‘in vitro techniques’(MeSH Terms) OR (‘vitro’(All Fields) AND ‘techniques’(All Fields)) OR ‘in vitro techniques’(All Fields) OR ‘vitro’(All Fields) OR ‘in vitro’(All Fields)) NOT (‘review’(Publication Type) OR ‘review literature as topic’(MeSH Terms) OR ‘review’(All Fields)) AND ((‘1982/01/01’(PDAT) : ‘2015/12/31’(PDAT)) AND (‘humans’(MeSH Terms) OR ‘animals’(MeSH Terms:noexp)) AND English(lang))</p></boxed-text></p><p>Eligible items were published, original research, peer-reviewed, <italic>in vivo</italic> studies (including letters) that reported an association between endogenous ghrelin levels, the administration of ghrelin or ghrelin-receptor agonists, or ghrelin gene polymorphisms, with cancer incidence, presence, growth or metastasis, excluding noncancerous growths (e.g. polycystic ovary syndrome). Noncancer controls or a reference range of physiologic ghrelin levels were required for association with incidence or presence of cancer, but not for tumor growth or metastasis. Other eligibility requirements included an accessible abstract for review and publication in English. If repeat studies were performed in the same study population, only the later study was included. Case reports/series were excluded so as to maintain minimum standards of study design/size. Review articles and meta-analyses were also excluded so as to allow for direct evaluation of original study data.</p><p>In addition, reference lists of the articles selected for analysis were reviewed for additional original research citations (i.e. ancestry search). A secondary search was also conducted using the same search terms and limits as described above (<xref ref-type="boxed-text" rid="box1">Box 1</xref>) to identify reviews and meta-analyses only (excluded from the initial search), with review of the reference lists of articles thus obtained for original research citations not previously identified. Results were described narratively, without meta-analysis of the data.</p></sec><sec><title>Results</title><p>The initial search retrieved 291 records, of which 236 articles were excluded because they fell in the following categories: case reports (7); lack of data on ghrelin/ghrelin-receptor agonists and cancer (153); <italic>in vitro</italic> studies (70); reviews or meta-analyses (5); and duplicate articles (1) (<xref ref-type="fig" rid="fig2">Fig. 2</xref>). A total of 55 articles from the initial search were judged eligible for inclusion in addition to 6 articles identified from other sources (e.g. reference lists of original research articles, reviews and meta-analyses). Thus, a total of 61 original research articles were included in the analysis (<xref ref-type="fig" rid="fig2">Fig. 2</xref>).</p><p>Of these 61 studies, 50 examined endogenous levels and actions of ghrelin or polymorphisms of ghrelin genes and 11 reported the effects of exogenously administered ghrelin or ghrelin-receptor agonist therapy in association with cancer. A wide range of cancer types/locations were studied, including lung, prostate, breast, leukemic, head and neck, reproductive and neuroendocrine, although most commonly those of the gastrointestinal system (<xref ref-type="table" rid="tbl1">Tables 1</xref> and <xref ref-type="table" rid="tbl2">2</xref>). Ten studies investigated the association between ghrelin gene polymorphisms and cancer risk (<xref ref-type="table" rid="tbl1">Table 1</xref>).
<table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p><italic>In vivo</italic> studies of endogenous ghrelin in cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Cancer type</bold></th><th valign="bottom" align="center" colspan="3" rowspan="1"><bold>Species</bold></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th valign="bottom" align="left" colspan="2" rowspan="1"><bold>Human</bold> (<italic>n</italic>)</th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Citation</th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Animal</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Patients</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Controls</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Ghrelin measure</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Plasma/serum level (↑/↓) vs controls/effect on risk</bold> (inverse/positive)</th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Effect of genetic variant(s) on cancer risk</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Association of ↑ plasma ghrelin with tumor stage/growth/metastasis</bold></th></tr></thead><tbody><tr><th valign="bottom" align="left" colspan="8" rowspan="1"><bold>Acute lymphoblastic leukemia</bold></th></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib78" ref-type="bibr">Moschovi <italic>et al</italic>. (2008)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">9</td><td valign="bottom" align="left" rowspan="1" colspan="1">9</td><td valign="bottom" align="left" rowspan="1" colspan="1">Acyl</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Inverse*</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Breast</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib29" ref-type="bibr">Dossus <italic>et al</italic>. (2008)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">1359</td><td valign="bottom" align="left" rowspan="1" colspan="1">2389</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association/positive*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib32" ref-type="bibr">Feigelson <italic>et al</italic>. (2008)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">648</td><td valign="bottom" align="left" rowspan="1" colspan="1">659</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib130" ref-type="bibr">Wagner <italic>et al</italic>. (2006)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">798</td><td valign="bottom" align="left" rowspan="1" colspan="1">1011</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association/inverse*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Cancer (various)</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib36" ref-type="bibr">Garcia <italic>et al</italic>. (2006)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">31</td><td valign="bottom" align="left" rowspan="1" colspan="1">25</td><td valign="bottom" align="left" rowspan="1" colspan="1">Acyl</td><td valign="bottom" align="left" rowspan="1" colspan="1">Increased*<sup>b</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib61" ref-type="bibr">Laurila <italic>et al</italic>. (2014)</xref><sup>a,c</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">491</td><td valign="bottom" align="left" rowspan="1" colspan="1">513</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association/inverse*<sup>d</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib62" ref-type="bibr">Legakis <italic>et al</italic>. (2009)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">30</td><td valign="bottom" align="left" rowspan="1" colspan="1">27</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib76" ref-type="bibr">Mondello <italic>et al</italic>. (2014)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">140</td><td valign="bottom" align="left" rowspan="1" colspan="1">30</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Increased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib121" ref-type="bibr">Till <italic>et al</italic>. (2015)</xref></td><td valign="bottom" align="left" rowspan="1" colspan="1">Rats</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">Total/Acyl</td><td valign="bottom" align="left" rowspan="1" colspan="1">Increased*<sup>e</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Colorectal</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib11" ref-type="bibr">Campa <italic>et al</italic>. (2010)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">197</td><td valign="bottom" align="left" rowspan="1" colspan="1">217</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association/inverse*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib27" ref-type="bibr">D’Onghia <italic>et al</italic>. (2007)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">29</td><td valign="bottom" align="left" rowspan="1" colspan="1">50</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Inverse*</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib55" ref-type="bibr">Kemik <italic>et al</italic>. (2010)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">126</td><td valign="bottom" align="left" rowspan="1" colspan="1">36</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib67" ref-type="bibr">Mahmoudi <italic>et al</italic>. (2014)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">1249</td><td valign="bottom" align="left" rowspan="1" colspan="1">1319</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib90" ref-type="bibr">Nikolopoulos <italic>et al</italic>. (2014)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">95</td><td valign="bottom" align="left" rowspan="1" colspan="1">39</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Increased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>CP and pituitary</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib45" ref-type="bibr">Holmer <italic>et al</italic>. (2010)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">42</td><td valign="bottom" align="left" rowspan="1" colspan="1">42</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Inverse*</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib104" ref-type="bibr">Roemmler-Zehrer <italic>et al</italic>. (2014)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">40</td><td valign="bottom" align="left" rowspan="1" colspan="1">40<sup>f</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib105" ref-type="bibr">Roth <italic>et al</italic>. (2011)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">27</td><td valign="bottom" align="left" rowspan="1" colspan="1">27</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib123" ref-type="bibr">Trivin <italic>et al</italic>. (2009)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">27<sup>g</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">0</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Inverse*</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Endometrial</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib34" ref-type="bibr">Fung <italic>et al</italic>. (2013)</xref></td><td valign="bottom" align="left" rowspan="1" colspan="1">Mice</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Positive*</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Esophageal</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib25" ref-type="bibr">De Martel <italic>et al</italic>. (2007)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">52</td><td valign="bottom" align="left" rowspan="1" colspan="1">156</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Inverse<sup>h</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib28" ref-type="bibr">Doecke <italic>et al</italic>. (2008)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">774</td><td valign="bottom" align="left" rowspan="1" colspan="1">1352</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib74" ref-type="bibr">Miyazaki <italic>et al</italic>. (2012)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">25</td><td valign="bottom" align="left" rowspan="1" colspan="1">0</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib84" ref-type="bibr">Murphy <italic>et al</italic>. (2012)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">82</td><td valign="bottom" align="left" rowspan="1" colspan="1">82</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Inverse*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Gastric/gastrointestinal</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib8" ref-type="bibr">Benedix <italic>et al</italic>. (2011)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">17</td><td valign="bottom" align="left" rowspan="1" colspan="1">86</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib47" ref-type="bibr">Huang <italic>et al</italic>. (2007)</xref>a</td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">78</td><td valign="bottom" align="left" rowspan="1" colspan="1">24</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib49" ref-type="bibr">Isomoto <italic>et al</italic>. (2005)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">23</td><td valign="bottom" align="left" rowspan="1" colspan="1">249<sup>i</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Positive*</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib56" ref-type="bibr">Kemik <italic>et al</italic>. (2012)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">148</td><td valign="bottom" align="left" rowspan="1" colspan="1">40</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib83" ref-type="bibr">Murphy <italic>et al</italic>. (2011)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">359</td><td valign="bottom" align="left" rowspan="1" colspan="1">441</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Inverse*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib107" ref-type="bibr">Sadjadi <italic>et al</italic>. (2013)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">220</td><td valign="bottom" align="left" rowspan="1" colspan="1">220</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Inverse*<sup>j</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib127" ref-type="bibr">Tsolakis <italic>et al</italic>. (2008)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">20</td><td valign="bottom" align="left" rowspan="1" colspan="1">RR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib139" ref-type="bibr">Zub-Pokrowiecka <italic>et al</italic>. (2010)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">25</td><td valign="bottom" align="left" rowspan="1" colspan="1">10</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib140" ref-type="bibr">Zub-Pokrowiecka <italic>et al</italic>. (2011)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">45</td><td valign="bottom" align="left" rowspan="1" colspan="1">25</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Head and neck</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib93" ref-type="bibr">Ozsoy <italic>et al</italic>. (2015)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">40</td><td valign="bottom" align="left" rowspan="1" colspan="1">20</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Liver</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib4" ref-type="bibr">Ataseven <italic>et al</italic>. (2006)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">22</td><td valign="bottom" align="left" rowspan="1" colspan="1">25</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Increased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib65" ref-type="bibr">Lin and Yin (2007)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">40</td><td valign="bottom" align="left" rowspan="1" colspan="1">20</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Inverse*</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib79" ref-type="bibr">Motawi <italic>et al</italic>. (2013)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">79</td><td valign="bottom" align="left" rowspan="1" colspan="1">40</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Positive*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib98" ref-type="bibr">Pourtau <italic>et al</italic>. (2011)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Rats</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Decreased</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Lung</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib52" ref-type="bibr">Karapanagiotou <italic>et al</italic>. (2009)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">101</td><td valign="bottom" align="left" rowspan="1" colspan="1">60</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Increased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib57" ref-type="bibr">Kerenidi <italic>et al</italic>. (2013)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">80</td><td valign="bottom" align="left" rowspan="1" colspan="1">40</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Increased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib113" ref-type="bibr">Shimizu <italic>et al</italic>. (2003)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">43</td><td valign="bottom" align="left" rowspan="1" colspan="1">21</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib124" ref-type="bibr">Tsao <italic>et al</italic>. (2007)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">50</td><td valign="bottom" align="left" rowspan="1" colspan="1">16</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Increased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Positive*</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Ovarian</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib70" ref-type="bibr">Markowska <italic>et al</italic>. (2009)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">53</td><td valign="bottom" align="left" rowspan="1" colspan="1">32</td><td valign="bottom" align="left" rowspan="1" colspan="1">Acyl/Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association/increased*<sup>k</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Neuroendocrine</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib132" ref-type="bibr">Wang <italic>et al</italic>. (2007)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">35</td><td valign="bottom" align="left" rowspan="1" colspan="1">RR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">Increased*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">Positive*</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Non-Hodgkin lymphoma</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib114" ref-type="bibr">Skibola <italic>et al</italic>. (2005)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">458</td><td valign="bottom" align="left" rowspan="1" colspan="1">812</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association/Inverse*</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Pancreatic</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib18" ref-type="bibr">Corbetta <italic>et al</italic>. (2003)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">40<sup>l</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">35</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib30" ref-type="bibr">Ekeblad <italic>et al</italic>. (2007)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">26</td><td valign="bottom" align="left" rowspan="1" colspan="1">5</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib137" ref-type="bibr">Zhang <italic>et al</italic>. (2014)</xref></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">173</td><td valign="bottom" align="left" rowspan="1" colspan="1">476</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Prostate</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib81" ref-type="bibr">Mungan <italic>et al</italic>. (2008)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">30</td><td valign="bottom" align="left" rowspan="1" colspan="1">50<sup>m</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib68" ref-type="bibr">Malendowicz <italic>et al</italic>. (2009)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">18</td><td valign="bottom" align="left" rowspan="1" colspan="1">16<sup>m</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Acyl/Des-Acyl/Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association/Increased*<sup>k</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="bottom" align="left" colspan="8" rowspan="1"><bold>Thyroid</bold></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"> <xref rid="bib77" ref-type="bibr">Morpurgo <italic>et al</italic>. (2005)</xref><sup>a</sup></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">22</td><td valign="bottom" align="left" rowspan="1" colspan="1">15</td><td valign="bottom" align="left" rowspan="1" colspan="1">Total</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td><td valign="bottom" align="left" rowspan="1" colspan="1">NR</td><td valign="bottom" align="left" rowspan="1" colspan="1">No association</td></tr></tbody></table><table-wrap-foot><fn id="tbl-fn001"><p>The significance of increased, decreased or unchanged serum/plasma ghrelin levels in cancer with regard to incidence, progression or prognosis remains unclear. <italic>*P≤</italic>0.05. CP, craniopharyngioma; NR, not reported; RR, reference range.</p></fn><fn id="tbl-fn002"><label>a</label><p>Adjusted for body mass index/obesity/cachexia/weight loss</p></fn><fn id="tbl-fn003"><label>b</label><p>Ghrelin levels were also significantly correlated with weight loss; relationship of plasma ghrelin with cancer independent of weight loss was not reported</p></fn><fn id="tbl-fn004"><label>c</label><p>Prospective, 19-year, population-based study in 491 hypertensive and 513 nonhypertensive, healthy subjects (no cancer patients at baseline)</p></fn><fn id="tbl-fn005"><label>d</label><p>Significantly decreased risk in healthy subjects only (no association for hypertensive subjects)</p></fn><fn id="tbl-fn006"><label>e</label><p>Significant increase for human neuroblastoma, nonsignificant increase for human hepatoblastoma</p></fn><fn id="tbl-fn007"><label>f</label><p>Control patients had nonfunctioning pituitary adenoma</p></fn><fn id="tbl-fn008"><label>g</label><p>Study compared 27 patients with grade 0 (<italic>n</italic>=7), grade 1 (<italic>n</italic>=8), or grade 2 (<italic>n</italic>=12) craniopharyngioma</p></fn><fn id="tbl-fn009"><label>h</label><p>Inverse association seen in overweight subjects only</p></fn><fn id="tbl-fn010"><label>i</label><p>Controls included patients/subjects with acute gastritis, benign gastric polyp, chronic gastritis, duodenal ulcer, gastric ulcer, or normal gastric mucosa</p></fn><fn id="tbl-fn011"><label>j</label><p>Inverse relationship statistically significant for serum ghrelin and gastric noncardia cancer, gastric cardia cancer, and esophageal squamous cell carcinoma but not for gastric adenocarcinoma</p></fn><fn id="tbl-fn012"><label>k</label><p>Acyl-ghrelin concentration was significantly increased and total ghrelin level not different in cancer patients versus controls</p></fn><fn id="tbl-fn013"><label>l</label><p>Sixteen patients had gastrointestinal carcinoid and 24 had pancreatic tumor</p></fn><fn id="tbl-fn014"><label>m</label><p>Controls had benign prostate hyperplasia.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p><italic>In vivo</italic> studies of exogenous ghrelin/ghrelin-receptor agonist treatment in cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th valign="bottom" align="center" colspan="3" rowspan="1"><bold>Species</bold></th><th rowspan="1" colspan="1"></th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th valign="bottom" align="left" colspan="2" rowspan="1"><bold>Human</bold> (<italic>n</italic>)</th><th rowspan="1" colspan="1"></th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Citation</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Condition treated/outcome assessed</bold> (cancer type/model)</th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Animal model</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Treatment</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Control</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Effect on tumor incidence or growth</bold></th></tr></thead><tbody><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib14" ref-type="bibr">Chen <italic>et al.</italic> (2015)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Cancer- and cisplatin-induced muscle wasting (Lewis lung carcinoma)</td><td valign="bottom" align="left" rowspan="1" colspan="1">Mice</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib21" ref-type="bibr">DeBoer <italic>et al.</italic> (2007)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Cancer cachexia (MC sarcoma)</td><td valign="bottom" align="left" rowspan="1" colspan="1">Rats</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib38" ref-type="bibr">Garcia <italic>et al.</italic> (2015)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Cancer cachexia (various, advanced)</td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">44</td><td valign="bottom" align="left" rowspan="1" colspan="1">38</td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib42" ref-type="bibr">Hanada <italic>et al.</italic> (2003)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Cancer cachexia (human melanoma)</td><td valign="bottom" align="left" rowspan="1" colspan="1">Mice</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib44" ref-type="bibr">Hiura <italic>et al.</italic> (2012)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Chemotherapy-induced appetite/eating disorders (esophageal)</td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">21</td><td valign="bottom" align="left" rowspan="1" colspan="1">21</td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib53" ref-type="bibr">Kawaguchi <italic>et al.</italic> (2015)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Tumorigenesis (intestinal)</td><td valign="bottom" align="left" rowspan="1" colspan="1">Mice</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect/inverse*</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib66" ref-type="bibr">Lundholm <italic>et al.</italic> (2010)</xref></td><td valign="bottom" align="left" rowspan="1" colspan="1">Cancer weight loss (gastrointestinal)</td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">17<sup>b</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">14<sup>c</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib91" ref-type="bibr">Northrup <italic>et al.</italic> (2013)</xref><sup>a,d</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Tumor growth (lung)</td><td valign="bottom" align="left" rowspan="1" colspan="1">Mice</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib118" ref-type="bibr">Strasser <italic>et al.</italic> (2008)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Cancer anorexia/cachexia (various, advanced)</td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">11<sup>e</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">9<sup>f</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib128" ref-type="bibr">Tsubouchi <italic>et al.</italic> (2014)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Cancer cachexia (lung)</td><td valign="bottom" align="left" rowspan="1" colspan="1">Mice</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1"><xref rid="bib131" ref-type="bibr">Wang (2006)</xref><sup>a</sup></td><td valign="bottom" align="left" rowspan="1" colspan="1">Cancer cachexia (MC sarcoma)</td><td valign="bottom" align="left" rowspan="1" colspan="1">Mice</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="bottom" align="left" rowspan="1" colspan="1">No effect</td></tr></tbody></table><table-wrap-foot><fn id="tbl-fn015"><p>The significance of increased, decreased or unchanged serum/plasma ghrelin levels in cancer with regard to incidence, progression or prognosis remains unclear.</p></fn><fn id="tbl-fn016"><label>*</label><p><italic>P</italic><0.05 in the murine azoxymethane/dextran sodium sulfate-induced inflammation-associated colon carcinogenesis model. MC, methylcholanthrene.</p></fn><fn id="tbl-fn017"><label>a</label><p>Placebo (e.g. saline) was administered to at least one control group or used in crossover design</p></fn><fn id="tbl-fn018"><label>b</label><p>High-dose ghrelin (13±1μg/kg daily)</p></fn><fn id="tbl-fn019"><label>c</label><p>Low-dose ghrelin (0.7±0.4μg/kg daily)</p></fn><fn id="tbl-fn020"><label>d</label><p>Active treatment groups received either ghrelin 2mg/kg intraperitoneally, or anamorelin 3, 10 or 30mg/kg orally</p></fn><fn id="tbl-fn021"><label>e</label><p>High-dose ghrelin (8μg/kg daily) on days 1 and 8 and placebo on days 4 and 11 or vice versa</p></fn><fn id="tbl-fn022"><label>f</label><p>Low-dose ghrelin (2μg/kg daily) on days 1 and 8 and placebo on days 4 and 11 or vice versa.</p></fn></table-wrap-foot></table-wrap></p><p>An overall count showed that 46 (75.4%) of the studies, including all 11 involving exogenous ghrelin/ghrelin-receptor agonist treatment, reported either a null (no statistically significant difference) or inverse association of ghrelin or ghrelin genetic variants with cancer risk, presence or growth; 9 (14.8%) studies reported positive associations; and 6 (9.8%), including 4 gene studies, reported both negative or null and positive associations (<xref ref-type="table" rid="tbl1">Tables 1</xref> and <xref ref-type="table" rid="tbl2">2</xref>).</p><sec><title>Endogenous ghrelin noninterventional studies</title><p>Of the 49 noninterventional studies, 46 were clinical and 3 in animal models, including the 10 studies of genetic polymorphisms of ghrelin genes and cancer, of which 7 reported null or inverse results while 3 showed a link to increased risk (<xref ref-type="table" rid="tbl1">Table 1</xref>). However, the significance and physiologic function of differences in the serum or plasma ghrelin levels of cancer patients vs controls remained unclear, with study authors suggesting various hypotheses, most commonly based on the known metabolic actions of ghrelin. Although the studies of ghrelin levels and cancer risk generally used healthy controls, few made reference to physiologic ranges of plasma/serum ghrelin. All but three studies reporting serum/plasma ghrelin levels reported total ghrelin. Two studies reported both total ghrelin and acyl ghrelin, both having contrasting results for each measure in cancer patients vs controls (<xref rid="bib68" ref-type="bibr">Malendowicz <italic>et al</italic>. 2009</xref>, <xref rid="bib70" ref-type="bibr">Markowska <italic>et al</italic>. 2009</xref>), and one study reported results for acyl ghrelin only (<xref rid="bib36" ref-type="bibr">Garcia <italic>et al</italic>. 2006</xref>).</p><p>In the largest, gastrointestinal cancer group (including gastric, esophageal and colorectal cancers), several population-based, long-term, prospective studies showed an inverse association of baseline ghrelin level with risk of gastric, esophagogastric and esophageal cancer incidence (<xref rid="bib25" ref-type="bibr">de Martel <italic>et al.</italic> 2007</xref>, <xref rid="bib83" ref-type="bibr">Murphy <italic>et al.</italic> 2011</xref>, <xref rid="bib84" ref-type="bibr">Murphy <italic>et al.</italic> 2012</xref>). These included two nested case–control studies that used logistic regression analysis and multivariate adjustment within the Finnish Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention study, a randomized, placebo-controlled, primary prevention study in 29,133 Finnish male smokers. One study, in 261 patients with gastric noncardia adenocarcinoma (GNCA) and 98 with esophagogastric junctional adenocarcinoma (EGJA) vs 441 controls found significant inverse correlations of serum ghrelin level with incidence of both cancers (GNCA adjusted odds ratio (OR) 1.75, 95% CI: 1.49–2.04; EGJA adjusted OR: 1.56, 95% CI: 1.29–1.89; <italic>P</italic><0.001 for both) (<xref rid="bib83" ref-type="bibr">Murphy <italic>et al.</italic> 2011</xref>). The other ATBC study, in 82 patients with esophageal squamous cell carcinoma (ESCC) vs 82 controls matched for age and date of blood draw, reported a multivariate OR of 6.83 (95% CI: 1.46–31.84) for ESCC in individuals in the lowest quartile of baseline serum ghrelin vs those in the highest quartile (<italic>P</italic>=0.005 for trend). The results for both analyses remained significant for cancers occurring more than 10years after baseline ghrelin measurement (<xref rid="bib83" ref-type="bibr">Murphy <italic>et al.</italic> 2011</xref>, <xref rid="bib84" ref-type="bibr">2012</xref>).</p><p>Another nested case–control study within a population of 128,992 enrolled in a public health program between 1964 and 1969, including 52 cases of esophageal cancer identified by the year 2000, found a nonsignificant correlation of high serum ghrelin with reduced risk of esophageal cancer in overweight subjects vs controls matched for age, race, sex and date/site of blood draw (<italic>P</italic>=0.09 for trend), adjusted for BMI and <italic>Helicobacter pylori</italic> infection (<xref rid="bib25" ref-type="bibr">De Martel <italic>et al.</italic> 2007</xref>). In addition, an Australian case–control genetic study (774 esophageal cancer cases vs 1352 controls) found no correlation of the obesity-related ghrelin SNPs sampled (rs468677 (L90Q), rs696217 (M72L)) with esophageal cancer incidence (<xref rid="bib28" ref-type="bibr">Doecke <italic>et al.</italic> 2008</xref>).</p><p>Several studies in gastric, gastroesophageal, and colorectal cancers found either no difference in serum ghrelin levels in cancer patients vs controls (<xref rid="bib49" ref-type="bibr">Isomoto <italic>et al.</italic> 2005</xref>, <xref rid="bib47" ref-type="bibr">Huang <italic>et al.</italic> 2007</xref>, <xref rid="bib127" ref-type="bibr">Tsolakis <italic>et al.</italic> 2008</xref>, <xref rid="bib8" ref-type="bibr">Benedix <italic>et al.</italic> 2011</xref>, <xref rid="bib140" ref-type="bibr">Zub-Pokrowiecka <italic>et al.</italic> 2011</xref>), or lower ghrelin levels in cancer patients (<xref rid="bib56" ref-type="bibr">Kemik <italic>et al.</italic> 2012</xref>, <xref rid="bib107" ref-type="bibr">Sadjadi <italic>et al.</italic> 2013</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). However, in one of these studies, ghrelin levels were significantly higher in patients with undifferentiated adenocarcinomas (<italic>n</italic>=9) than in patients with differentiated tumors (<italic>n</italic>=14) (<italic>P</italic><0.005) (<xref rid="bib49" ref-type="bibr">Isomoto <italic>et al.</italic> 2005</xref>).</p><p>Two of three studies investigating serum ghrelin levels in colon or colorectal cancer found significantly decreased levels in the cancer patients vs controls (<xref rid="bib27" ref-type="bibr">D’Onghia <italic>et al.</italic> 2007</xref>, <xref rid="bib55" ref-type="bibr">Kemik <italic>et al.</italic> 2010</xref>), including one, in 29 patients with colorectal cancer and 50 controls, that also found ghrelin serum levels were significantly inversely associated with tumor stage (<xref rid="bib27" ref-type="bibr">D’Onghia <italic>et al.</italic> 2007</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). However, another study reported significantly higher total serum ghrelin levels in 95 patients with colon cancer vs those in 39 healthy controls matched for age, gender and BMI; serum ghrelin level was also positively correlated with tumor size and end-stage vs initial stage tumors, and inversely associated with tumor differentiation, but not correlated with patient survival, independent of Dukes stages (<xref rid="bib90" ref-type="bibr">Nikolopoulos <italic>et al.</italic> 2014</xref>). Acknowledging the many physiologic and hormonal factors regulating ghrelin serum levels, the authors concluded that it remained unclear whether ghrelin promoted or inhibited carcinogenesis (<xref rid="bib90" ref-type="bibr">Nikolopoulos <italic>et al.</italic> 2014</xref>).</p><p>Of two clinical studies in patients with liver cancer, one Turkish study reported significantly increased serum ghrelin levels in 22 patients with hepatocellular carcinoma (HCC) due to hepatitis B or D virus and similarly increased levels in 23 patients with cirrhosis vs 25 control subjects (<xref rid="bib4" ref-type="bibr">Ataseven <italic>et al.</italic> 2006</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). Since 19 of the 22 HCC patients also had cirrhosis, and had ghrelin levels similar to the cirrhosis cohort, the authors interpreted the increased ghrelin as a response to cirrhosis-related catabolic conditions (<xref rid="bib4" ref-type="bibr">Ataseven <italic>et al.</italic> 2006</xref>). In contrast, the other study reported a significantly reduced ghrelin concentration in 40 Taiwanese patients with HCC vs 20 healthy controls, and an inverse correlation of ghrelin levels with HCC stage (<xref rid="bib65" ref-type="bibr">Lin & Yin 2007</xref>).</p><p>Among four clinical studies of endogenous ghrelin in heterogeneous populations of patients with various cancers (including gastric, pancreatic, lung, breast, multiple myeloma, lymphomas, head and neck, rectal, adenocarcinoma and gynecological), one reported increased total ghrelin (<xref rid="bib76" ref-type="bibr">Mondello <italic>et al</italic>. 2014</xref>) and one increased acyl ghrelin level (<xref rid="bib36" ref-type="bibr">Garcia <italic>et al</italic>. 2006</xref>) in the cancer patients vs controls. The authors of both studies attributed these results largely to a physiologic ghrelin response to weight loss or cachexia, which was present in most patients (<xref rid="bib36" ref-type="bibr">Garcia <italic>et al.</italic> 2006</xref>, <xref rid="bib76" ref-type="bibr">Mondello <italic>et al.</italic> 2014</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). A large, 19-year, population-based prospective follow-up study in 491 hypertensive and 513 control subjects (cardiovascular disease incidence was a parallel outcome of the study) found that baseline plasma ghrelin level had no association with cancer deaths or hospital events in either cohort (<xref rid="bib61" ref-type="bibr">Laurila <italic>et al.</italic> 2014</xref>). In addition, a study in 30 patients with various advanced, inoperable cancers, primarily gastric and pancreatic, and weight loss with malnutrition, found that plasma ghrelin was significantly lower (<italic>P</italic><0.001) in the cancer patients vs 27 healthy subjects (<xref rid="bib62" ref-type="bibr">Legakis <italic>et al.</italic> 2009</xref>). The decreased ghrelin in this study was attributed to the severity and progression of cancer with possible involvement of multiorgan failure, particularly since no correlation between ghrelin level and histological type of malignancy was observed (<xref rid="bib62" ref-type="bibr">Legakis <italic>et al.</italic> 2009</xref>).</p><p>Of the four clinical studies in lung cancer, three reported significantly increased serum ghrelin levels vs controls in cancer patients (<xref rid="bib124" ref-type="bibr">Tsao <italic>et al.</italic> 2007</xref>, <xref rid="bib52" ref-type="bibr">Karapanagiotou <italic>et al.</italic> 2009</xref>, <xref rid="bib57" ref-type="bibr">Kerenidi <italic>et al.</italic> 2013</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). However, one study found that while serum ghrelin was not different overall between lung cancer patients (<italic>n</italic>=43; 21 with cachexia and 22 without cachexia) vs controls (<italic>n</italic>=21), they were significantly increased in the patients with cachexia vs those without cachexia (<xref rid="bib113" ref-type="bibr">Shimizu <italic>et al.</italic> 2003</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). The study authors suggested that the ghrelin increase was a compensatory mechanism triggered by cachectic catabolic–anabolic imbalance (<xref rid="bib113" ref-type="bibr">Shimizu <italic>et al.</italic> 2003</xref>). Of the other studies, one found that serum ghrelin levels were increased in lung cancer patients (<italic>n</italic>=80) vs healthy controls (<italic>n</italic>=40), although only 17 of the patients had weight loss, and the study groups were matched for BMI (<xref rid="bib57" ref-type="bibr">Kerenidi <italic>et al.</italic> 2013</xref>). However, serum ghrelin level had no association with survival, while leptin was independently correlated with significantly shorter survival. Noting the mutually antagonistic metabolic actions and other effects of leptin and ghrelin, the authors suggested the elevated ghrelin could be a protective mechanism to neutralize leptin and thus impede cancer progression (<xref rid="bib57" ref-type="bibr">Kerenidi <italic>et al.</italic> 2013</xref>). Another of the studies reporting increased serum ghrelin levels, in 101 patients with lung cancer vs 60 healthy controls, found this increase was independent of BMI, although patients with weight loss had significantly higher ghrelin level than those without weight loss (<xref rid="bib52" ref-type="bibr">Karapanagiotou <italic>et al.</italic> 2009</xref>). Serum ghrelin level also had no association with survival. The authors postulated that the serum ghrelin increase occurred as a compensatory response to weight loss in cachectic patients, and as an anti-inflammatory response to a lung cancer-induced ‘systemic inflammation cascade’ (<xref rid="bib52" ref-type="bibr">Karapanagiotou <italic>et al.</italic> 2009</xref>). Authors of the third study reporting increased ghrelin, in 40 Taiwanese patients with lung cancer vs 16 controls, postulated that the ghrelin increase was a compensatory mechanism to increase energy/nutrition, particularly B<sub>2</sub> and B<sub>6</sub> vitamin levels, which were greatly reduced (<xref rid="bib124" ref-type="bibr">Tsao <italic>et al.</italic> 2007</xref>).</p><p>Four studies investigated ghrelin levels in patients with craniopharyngioma (CP) – which is associated with obesity, metabolic syndrome and GH deficiency – and pituitary cancer (<xref rid="bib123" ref-type="bibr">Trivin <italic>et al.</italic> 2009</xref>, <xref rid="bib45" ref-type="bibr">Holmer <italic>et al.</italic> 2010</xref>, <xref rid="bib105" ref-type="bibr">Roth <italic>et al.</italic> 2011</xref>, <xref rid="bib104" ref-type="bibr">Roemmler-Zehrer <italic>et al.</italic> 2014</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). Three of the studies reported significantly reduced ghrelin levels in CP patients vs controls (<xref rid="bib45" ref-type="bibr">Holmer <italic>et al.</italic> 2010</xref>, <xref rid="bib105" ref-type="bibr">Roth <italic>et al.</italic> 2011</xref>, <xref rid="bib104" ref-type="bibr">Roemmler-Zehrer <italic>et al.</italic> 2014</xref>), and two reported a significant inverse association of serum ghrelin level with CP tumor growth (<xref rid="bib123" ref-type="bibr">Trivin <italic>et al.</italic> 2009</xref>, <xref rid="bib45" ref-type="bibr">Holmer <italic>et al.</italic> 2010</xref>). While two of these studies were controlled by age and gender but not BMI (<xref rid="bib45" ref-type="bibr">Holmer <italic>et al.</italic> 2010</xref>, <xref rid="bib104" ref-type="bibr">Roemmler-Zehrer <italic>et al.</italic> 2014</xref>), the one study that did match CP patients (<italic>n</italic>=27) and controls (<italic>n</italic>=27) for BMI as well as age and gender found that obese CP patients had lower ghrelin levels than obese controls (<xref rid="bib105" ref-type="bibr">Roth <italic>et al.</italic> 2011</xref>).</p><p>Among two studies of ghrelin levels in patients with pancreatic cancer, both found no difference in the plasma ghrelin levels of the cancer patients vs controls (<xref rid="bib18" ref-type="bibr">Corbetta <italic>et al.</italic> 2003</xref>, <xref rid="bib30" ref-type="bibr">Ekeblad <italic>et al.</italic> 2007</xref>), including one that also found no correlation of ghrelin level with cancer progression (<xref rid="bib18" ref-type="bibr">Corbetta <italic>et al.</italic> 2003</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). Three studies assessed associations of multiple ghrelin gene polymorphisms with breast cancer risk (<xref rid="bib130" ref-type="bibr">Wagner <italic>et al.</italic> 2006</xref>, <xref rid="bib29" ref-type="bibr">Dossus <italic>et al.</italic> 2008</xref>, <xref rid="bib32" ref-type="bibr">Feigelson <italic>et al.</italic> 2008</xref>). A European study in 1359 breast cancer cases and 2389 matched controls found that carriers of the ghrelin rs171407-G allele had a significantly increased breast cancer risk (OR: 1.2, 95% CI: 1.0–1.4; <italic>P</italic>=0.02) (<xref rid="bib29" ref-type="bibr">Dossus <italic>et al.</italic> 2008</xref>). A Polish and German study of various hormonal gene SNPs with a proven or potential functional effect, in 798 breast cancer cases and 1011 controls, found a decreased risk of cancer associated with two rare ghrelin haplotypes, GGAC (OR: 0.05, 95% CI: 0.01–0.79; <italic>P</italic>=0.001) and GGAT (OR: 0.23, 95% CI: 0.04–1.13; <italic>P</italic>=0.04) (<xref rid="bib130" ref-type="bibr">Wagner <italic>et al.</italic> 2006</xref>). The third study evaluated tagging SNPs of obesity-related genes, in 648 breast cancer cases and 659 controls from the American Cancer Society Cancer Prevention Study II Nutrition Cohort, and found no association between any ghrelin gene SNPs and breast cancer (<xref rid="bib32" ref-type="bibr">Feigelson <italic>et al.</italic> 2008</xref>).</p><p>Of two studies in prostate cancer, 1 in 30 patients vs 50 controls with benign prostate hyperplasia (BPH) found no association of ghrelin level with presence or progression of cancer (<xref rid="bib81" ref-type="bibr">Mungan <italic>et al.</italic> 2008</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). The other study found that total plasma ghrelin concentrations were similar, but acyl ghrelin levels and ratios of acyl ghrelin to total ghrelin and to obestatin were significantly higher, in 18 patients with prostate cancer vs 12 controls with BPH (<xref rid="bib68" ref-type="bibr">Malendowicz <italic>et al.</italic> 2009</xref>). A study in 53 patients with ovarian cancer reported similar findings of significantly elevated acyl ghrelin and acyl to total ghrelin ratio, but no difference in total ghrelin plasma levels, in the cancer patients vs 32 controls (<xref rid="bib70" ref-type="bibr">Markowska <italic>et al.</italic> 2009</xref>). However, the authors of this study stated that the lack of evidence of a human ovarian ghrelin receptor made it doubtful that ghrelin was directly linked to ovarian carcinogenesis (<xref rid="bib70" ref-type="bibr">Markowska <italic>et al.</italic> 2009</xref>).</p><p>Single studies also reported no association of serum ghrelin levels with head and neck cancers (<xref rid="bib93" ref-type="bibr">Ozsoy <italic>et al.</italic> 2015</xref>) and thyroid cancer (<xref rid="bib77" ref-type="bibr">Morpurgo <italic>et al.</italic> 2005</xref>), and inverse correlations of ghrelin with both presence of acute lymphoblastic leukemia and tumor burden (<xref rid="bib78" ref-type="bibr">Moschovi <italic>et al.</italic> 2008</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). A study in 35 patients with neuroendocrine tumors found that serum ghrelin level was significantly elevated as compared with a physiologic reference range in patients with hepatic metastases, which was interpreted as a co-release of ghrelin from neuroendocrine tumors generated as a physiological mechanism to maintain appetite and BMI (<xref rid="bib132" ref-type="bibr">Wang <italic>et al.</italic> 2007</xref>).</p></sec><sec><title>Exogenous ghrelin interventional studies</title><p>Of the 11 studies of exogenous ghrelin or ghrelin-receptor agonist intervention (acyl ghrelin therapies) over periods ranging from 1 to 12 weeks in patients or animals with cancer in this sample, 10 found no effect of the therapy on tumor growth or markers vs placebo or between different dose groups (<xref rid="bib42" ref-type="bibr">Hanada <italic>et al.</italic> 2003</xref>, <xref rid="bib131" ref-type="bibr">Wang <italic>et al.</italic> 2006</xref>, <xref rid="bib21" ref-type="bibr">DeBoer <italic>et al.</italic> 2007</xref>, <xref rid="bib118" ref-type="bibr">Strasser <italic>et al.</italic> 2008</xref>, <xref rid="bib66" ref-type="bibr">Lundholm <italic>et al.</italic> 2010</xref>, <xref rid="bib44" ref-type="bibr">Hiura <italic>et al.</italic> 2012</xref>, <xref rid="bib91" ref-type="bibr">Northrup <italic>et al.</italic> 2013</xref>, <xref rid="bib128" ref-type="bibr">Tsubouchi <italic>et al.</italic> 2014</xref>, <xref rid="bib14" ref-type="bibr">Chen <italic>et al.</italic> 2015</xref>); one reported both no effect and an inverse correlation of ghrelin in different animal models of cancer (<xref rid="bib53" ref-type="bibr">Kawaguchi <italic>et al.</italic> 2015</xref>) (<xref ref-type="table" rid="tbl2">Table 2</xref>).</p><p>Among the four clinical trials, one compared ghrelin therapy with placebo for treatment of chemotherapy-induced eating disorders in 21 patients with esophageal cancer vs 21 controls (<xref rid="bib44" ref-type="bibr">Hiura <italic>et al.</italic> 2012</xref>); another assessed effects of high-dose ghrelin (<italic>n</italic>=17; 13±1μg/kg daily) vs low-dose ghrelin (<italic>n</italic>=14; 0.7±0.4μg/kg daily) for weight loss in patients with gastrointestinal cancers (<xref rid="bib66" ref-type="bibr">Lundholm <italic>et al.</italic> 2010</xref>); and a third compared the effects of ghrelin at high dose (<italic>n</italic>=11; 8μg/kg daily) and low dose (<italic>n</italic>=9; 2μg/kg daily) or placebo alternately in a crossover design for treatment of anorexia/cachexia related to various cancer (<xref rid="bib118" ref-type="bibr">Strasser <italic>et al.</italic> 2008</xref>). The largest of these studies (<italic>n</italic>=82) was a pooled analysis of two similarly designed Phase II, randomized, double-blind, placebo-controlled, multicenter trials of treatment with anamorelin, a ghrelin-receptor agonist, for cancer cachexia in patients with various advanced, incurable cancers (breast, colon, lung, genitourinary and others; Eastern Cooperative Oncology Group Score of ≤2) and cachexia defined as a weight loss of ≥5 within the previous 6months (<xref rid="bib38" ref-type="bibr">Garcia <italic>et al.</italic> 2015</xref>). The incidence of neoplasms or tumor progression (benign, malignant or unspecified) was similar over this 12-week trial in both the anamorelin (<italic>n</italic>=44) and placebo (<italic>n</italic>=38) groups.</p><p>Two of the seven animal studies assessed the effect of ghrelin on tumor growth as the primary outcome (<xref rid="bib91" ref-type="bibr">Northrup <italic>et al.</italic> 2013</xref>, <xref rid="bib53" ref-type="bibr">Kawaguchi <italic>et al.</italic> 2015</xref>). In one study, ghrelin administration had a significant inverse effect on tumor growth in a murine model of inflammation-associated colon carcinogenesis (<italic>P</italic><0.0001), although it had no effect in a genetic susceptibility model (<xref rid="bib53" ref-type="bibr">Kawaguchi <italic>et al.</italic> 2015</xref>). Deletion of the ghrelin gene had no significant effect on tumorigenesis in either model. In the other study, nude mice with established, implanted A549 nonsmall cell lung cancer tumors were administered either saline, or ghrelin 2mg/kg or anamorelin dosed at 3mg/kg orally (po), 10 or 30mg/kg po (<xref rid="bib91" ref-type="bibr">Northrup <italic>et al.</italic> 2013</xref>). While tumor growth progressed steadily over the 28-day trial period, no differences in this parameter were observed between the treatment groups, despite increases in GH and IGF1 after ghrelin and anamorelin treatment (<xref rid="bib91" ref-type="bibr">Northrup <italic>et al.</italic> 2013</xref>).</p></sec></sec><sec><title>Discussion</title><sec><title>Comparison with <italic>in vitro</italic> findings</title><p>This systematic analysis of <italic>in vivo</italic> studies of associations of ghrelin with cancer provides evidence that is approximately the reverse of that suggested by published <italic>in vitro</italic> studies. Whereas the majority of <italic>in vitro</italic> studies suggest upregulation of ghrelin in cancer tissues, the majority (over 70%) of <italic>in vivo</italic> studies have shown null or inverse relations of ghrelin to cancer (<xref ref-type="table" rid="tbl1">Tables 1</xref> and <xref ref-type="table" rid="tbl2">2</xref>). Indeed, two clinical studies in this review that assessed both <italic>in vitro</italic> and <italic>in vivo</italic> levels of ghrelin in patients with cancer reported that despite findings of high ghrelin expression in tumor tissue, plasma ghrelin measures were either similar to those of healthy controls (<xref rid="bib30" ref-type="bibr">Ekeblad <italic>et al.</italic> 2007</xref>) or within the reference range for this measure (<xref rid="bib127" ref-type="bibr">Tsolakis <italic>et al.</italic> 2008</xref>). On the other hand, an animal study did report similar <italic>in vitro</italic> and <italic>in vivo</italic> findings that experimental silencing or ‘knockdown’ of the ghrelin-receptor expression in murine models of endometrial cancer led to reduced tumor growth (<xref rid="bib34" ref-type="bibr">Fung <italic>et al.</italic> 2013</xref>).</p></sec><sec><title>The ghrelin/GH/IGF1 axis</title><p>The <italic>in vivo</italic> data in this review provided little support for the hypothesis, noted above, that ghrelin could promote carcinogenesis via the GH/IGF1 pathway in an autocrine/paracrine manner (<xref rid="bib50" ref-type="bibr">Jeffery <italic>et al.</italic> 2003</xref>). The absence of carcinogenic effects demonstrated in any of the clinical or animal trials of exogenous ghrelin or ghrelin-receptor agonist therapy is also consistent with the considerable clinical data showing no association of GH therapy with increased risk of cancer in children (<xref rid="bib3" ref-type="bibr">Allen <italic>et al.</italic> 1997</xref>, <xref rid="bib108" ref-type="bibr">Sävendahl <italic>et al.</italic> 2012</xref>, <xref rid="bib95" ref-type="bibr">Patterson <italic>et al.</italic> 2014</xref>, <xref rid="bib100" ref-type="bibr">Raman <italic>et al.</italic> 2015</xref>) or in adults (<xref rid="bib92" ref-type="bibr">Olsson <italic>et al.</italic> 2012</xref>, <xref rid="bib43" ref-type="bibr">Hartman <italic>et al.</italic> 2013</xref>, <xref rid="bib9" ref-type="bibr">Brignardello <italic>et al.</italic> 2015</xref>, <xref rid="bib15" ref-type="bibr">Child <italic>et al.</italic> 2015</xref>, <xref rid="bib117" ref-type="bibr">Stochholm & Johannsson 2015</xref>). Of the four clinical trials of exogenous ghrelin/ghrelin-receptor agonist therapy, three reported no significant differences in GH/IGF1 levels vs placebo (<xref rid="bib118" ref-type="bibr">Strasser <italic>et al.</italic> 2008</xref>, <xref rid="bib66" ref-type="bibr">Lundholm <italic>et al.</italic> 2010</xref>, <xref rid="bib44" ref-type="bibr">Hiura <italic>et al.</italic> 2012</xref>). The 12-week trial of anamorelin reported significant increases in IGF1 and IGFBP3 levels vs placebo (<italic>P</italic>≤0.0002), although these concentrations remained within the normal ranges (<xref rid="bib38" ref-type="bibr">Garcia <italic>et al.</italic> 2015</xref>). A nonsignificant increase in IGF1 level was also observed with anamorelin vs placebo in the murine lung cancer study (<xref rid="bib91" ref-type="bibr">Northrup <italic>et al.</italic> 2013</xref>). General long-term clinical safety and efficacy data for anamorelin have recently become available. Data from ROMANA 3 (<italic>n</italic>=513), a 12-week safety extension study of two randomized, placebo-controlled, 12-week, Phase III trials of anamorelin, in patients with unresectable stage III or IV nonsmall cell lung cancer with cachexia given anamorelin (<italic>n</italic>=345 (67.3%)) or placebo (<italic>n</italic>=168 (32.7%)), totaling 24weeks of exposure, also showed no differences in treatment-emergent adverse events, including deaths, between the treatment and placebo groups; none of the deaths in the study were judged treatment related (<xref rid="bib20" ref-type="bibr">Currow <italic>et al.</italic> 2015</xref>). In addition, subsequent to the initial systematic search period (1 January 1982, through 31 December 2015), longer-term survival data have been published for anamorelin, which showed no difference in median survival over 1year (8.90months, 95% CI: 8.3–9.8) compared with placebo (9.17months, 95% CI: 7.9–11.0; hazard ratio 1.06, 95% CI: 0.89–1.26; <italic>P</italic>=0.47) (<xref rid="bib120" ref-type="bibr">Temel <italic>et al</italic>. 2016</xref>).</p></sec><sec><title>Variations and discrepancies in serum ghrelin levels</title><p>Although the <italic>in vivo</italic> studies included in this analysis provided little evidence of a carcinogenic role of ghrelin, many indicated changes in serum ghrelin levels in the cancer environment, which are yet to be elucidated. Increased serum ghrelin in cancer was most frequently attributed to known, noncarcinogenic, physiologic actions of ghrelin adapted to a cancer environment. These included a compensatory response to cancer weight loss and cachexia (<xref rid="bib113" ref-type="bibr">Shimizu <italic>et al.</italic> 2003</xref>, <xref rid="bib36" ref-type="bibr">Garcia <italic>et al.</italic> 2006</xref>, <xref rid="bib132" ref-type="bibr">Wang <italic>et al.</italic> 2007</xref>, <xref rid="bib52" ref-type="bibr">Karapanagiotou <italic>et al.</italic> 2009</xref>, <xref rid="bib76" ref-type="bibr">Mondello <italic>et al.</italic> 2014</xref>), which has been previously reported in the literature (<xref rid="bib134" ref-type="bibr">Wolfe <italic>et al.</italic> 2006</xref>); a mechanism to improve nutritional status (<xref rid="bib124" ref-type="bibr">Tsao <italic>et al.</italic> 2007</xref>); an anti-inflammatory response to concomitant conditions such as cirrhosis (<xref rid="bib4" ref-type="bibr">Ataseven <italic>et al.</italic> 2006</xref>); a protective response to cancer-induced inflammation (<xref rid="bib52" ref-type="bibr">Karapanagiotou <italic>et al.</italic> 2009</xref>); or a mechanism to neutralize potential carcinogenic actions of leptin (<xref rid="bib57" ref-type="bibr">Kerenidi <italic>et al.</italic> 2013</xref>). Additional cancer-related factors that may influence ghrelin levels, reported in the broader literature, include chemotherapy-induced inflammation and cancer-associated dyspepsia (<xref rid="bib69" ref-type="bibr">Malik <italic>et al.</italic> 2008</xref>), cancer-associated inflammation (<xref rid="bib41" ref-type="bibr">Guney <italic>et al.</italic> 2007</xref>, <xref rid="bib53" ref-type="bibr">Kawaguchi <italic>et al.</italic> 2015</xref>) and postoperative, acute-phase stress (<xref rid="bib71" ref-type="bibr">Maruna <italic>et al.</italic> 2008</xref>).</p><p>Other studies reported inverse correlations of serum ghrelin levels and risk of cancer (<xref rid="bib25" ref-type="bibr">De Martel <italic>et al.</italic> 2007</xref>, <xref rid="bib83" ref-type="bibr">Murphy <italic>et al.</italic> 2011</xref>, <xref rid="bib84" ref-type="bibr">2012</xref>, <xref rid="bib107" ref-type="bibr">Sadjadi <italic>et al.</italic> 2013</xref>), as well as decreased serum ghrelin levels in cancer patients vs controls (<xref rid="bib27" ref-type="bibr">D’Onghia <italic>et al.</italic> 2007</xref>, <xref rid="bib65" ref-type="bibr">Lin & Yin 2007</xref>, <xref rid="bib78" ref-type="bibr">Moschovi <italic>et al.</italic> 2008</xref>, <xref rid="bib62" ref-type="bibr">Legakis <italic>et al.</italic> 2009</xref>, <xref rid="bib55" ref-type="bibr">Kemik <italic>et al.</italic> 2010</xref>, <xref rid="bib56" ref-type="bibr">2012</xref>, <xref rid="bib105" ref-type="bibr">Roth <italic>et al.</italic> 2011</xref>, <xref rid="bib140" ref-type="bibr">Zub-Pokrowiecka <italic>et al.</italic> 2011</xref>) (<xref ref-type="table" rid="tbl1">Table 1</xref>). The reasons for decreased ghrelin levels in cancer in this analysis were also unclear, but are hypothesized to involve cancer-associated impairment of normal physiologic regulation of ghrelin production and response to other factors (<xref rid="bib113" ref-type="bibr">Shimizu <italic>et al.</italic> 2003</xref>, <xref rid="bib47" ref-type="bibr">Huang <italic>et al.</italic> 2007</xref>, <xref rid="bib62" ref-type="bibr">Legakis <italic>et al.</italic> 2009</xref>, <xref rid="bib140" ref-type="bibr">Zub-Pokrowiecka <italic>et al.</italic> 2011</xref>). Studies suggest that physiologic ghrelin responses to fasting and postprandial states are blunted or nonexistent in cancer patients (<xref rid="bib105" ref-type="bibr">Roth <italic>et al.</italic> 2011</xref>, <xref rid="bib140" ref-type="bibr">Zub-Pokrowiecka <italic>et al.</italic> 2011</xref>) and in rats with hepatoma cells (Portau <italic>et al.</italic> 2011). In addition, cancer-related surgeries such as gastrectomy and esophagectomy are associated with decreased serum ghrelin levels, relative to presurgery levels (<xref rid="bib140" ref-type="bibr">Zub-Pokrowiecka <italic>et al.</italic> 2011</xref>, <xref rid="bib74" ref-type="bibr">Miyazaki <italic>et al.</italic> 2012</xref>).</p><p>Several studies in this analysis reported inverse associations of ghrelin to tumor progression, suggesting a protective effect (<xref rid="bib27" ref-type="bibr">D’Onghia <italic>et al.</italic> 2007</xref>, <xref rid="bib65" ref-type="bibr">Lin & Yin 2007</xref>, <xref rid="bib78" ref-type="bibr">Moschovi <italic>et al.</italic> 2008</xref>, <xref rid="bib123" ref-type="bibr">Trivin <italic>et al.</italic> 2009</xref>, <xref rid="bib45" ref-type="bibr">Holmer <italic>et al.</italic> 2010</xref>), which could involve anti-inflammatory actions (<xref rid="bib6" ref-type="bibr">Bataar <italic>et al.</italic> 2011</xref>, <xref rid="bib53" ref-type="bibr">Kawaguchi <italic>et al.</italic> 2015</xref>). In preclinical models, ghrelin has demonstrated significant anti-inflammatory actions, including inhibition of the production of proinflammatory cytokines (<xref rid="bib26" ref-type="bibr">Dixit <italic>et al.</italic> 2004</xref>, <xref rid="bib64" ref-type="bibr">Li <italic>et al.</italic> 2004</xref>, <xref rid="bib40" ref-type="bibr">Gonzalez-Rey <italic>et al.</italic> 2006</xref>, <xref rid="bib14" ref-type="bibr">Chen <italic>et al.</italic> 2015</xref>).</p></sec><sec><title>Genetic findings</title><p>This analysis found no clear, net effect of ghrelin gene polymorphisms on cancer risk (<xref ref-type="table" rid="tbl1">Table 1</xref>), which is consistent with the conclusions of previous meta-analyses that evaluated the same genetic study data across ghrelin and ghrelin-receptor SNPs in patients with varied cancer types (<xref rid="bib94" ref-type="bibr">Pabalan <italic>et al.</italic> 2014</xref>, <xref rid="bib138" ref-type="bibr">Zhu <italic>et al.</italic> 2015</xref>). Follow-up analyses of results showing either positive (<xref rid="bib29" ref-type="bibr">Dossus <italic>et al.</italic> 2008</xref>, <xref rid="bib79" ref-type="bibr">Motawi <italic>et al.</italic> 2013</xref>) or inverse (<xref rid="bib114" ref-type="bibr">Skibola <italic>et al.</italic> 2005</xref>, <xref rid="bib130" ref-type="bibr">Wagner <italic>et al.</italic> 2006</xref>, <xref rid="bib61" ref-type="bibr">Laurila <italic>et al.</italic> 2014</xref>) associations of ghrelin gene SNPs with cancer risk warrant further investigation (<xref ref-type="table" rid="tbl1">Table 1</xref>).</p></sec><sec><title>Limitations of this analysis</title><p>Although 61 studies were included in this analysis, the greatest number investigated gastrointestinal system cancers and additional studies in other cancers are needed to obtain a more complete picture of the potentially complex actions of ghrelin. Since most of the clinical studies were conducted in white populations in North America or Europe, studies with greater ethnic and racial diversity, larger sample sizes, and prospective designs are also needed. The studies were also inconsistent in use of multivariable analysis and adjustment, particularly involving factors such as BMI and cachexia, to isolate the actions of ghrelin on incidence and growth of cancer, and in use of referent physiologic ghrelin levels for confirmation/clarification of findings. The questions also remain as to whether serum/plasma total or acyl ghrelin is the most relevant measure with reference to cancer (i.e. association with cancer risk, presence, or progression). Finally, long-term prospective studies of exogenous ghrelin or ghrelin-receptor agonist administration that focus on tumor progression as a primary outcome are needed.</p></sec></sec><sec><title>Conclusions</title><p>The available <italic>in vivo</italic> study evidence suggests that ghrelin has either a null or inverse association with risk or progression of most cancers, although there is not enough evidence to confirm that this holds for all cancers. These findings also suggest that the safety profile of ghrelin or ghrelin-receptor agonist therapy may be favorable for treatment of cachexia and wasting in patients with cancer. Additional large-scale prospective clinical trials are warranted to further elucidate the effects of ghrelin on tumors and general activity in various cancer states, and to evaluate the safety and benefits of ghrelin/ghrelin-receptor agonist treatment in patients with cancer.</p></sec><sec><title>Declaration of interest</title><p>The content of this manuscript and the decision to publish are solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or the National Institutes of Health. S Sever has declared no conflicts of interest.</p></sec><sec><title>Funding</title><p>D L White receives research support from the National Institute of Diabetes Digestive and Kidney Diseases (R03 DK095082, PI: White) and the Michael E DeBakey Veterans Affairs Health Services Research Center of Innovations (CIN13-413). J M Garcia has received consulting or advisory fees from Aeterna Zentaris and Helsinn Therapeutics (USA), and research grants from the Department of Veterans Affairs (MERIT grants bib1-BX000507 and bib1 CX000174, and the NIA T32AG000183 and AG040583), Aeterna Zentaris, and Helsinn Therapeutics (USA). Support for developing this manuscript was provided by Helsinn Therapeutics.</p></sec></body><back><ack><title>Acknowledgements</title><p>Copyediting, editorial assistance and production assistance was provided by The Curry Rockefeller Group, LLC, Tarrytown, NY, USA.</p></ack><ref-list><title>References</title><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akamizu</surname><given-names>T</given-names></name><name><surname>Shinomiya</surname><given-names>T</given-names></name><name><surname>Irako</surname><given-names>T</given-names></name><name><surname>Fukunaga</surname><given-names>M</given-names></name><name><surname>Nakai</surname><given-names>Y</given-names></name><name><surname>Nakai</surname><given-names>Y</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name></person-group><year>2005</year><article-title>Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>90</volume><fpage>6</fpage>–<lpage>9</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2004-1640</pub-id>)<pub-id pub-id-type="pmid">15483072</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>JA</given-names></name><name><surname>Garcia</surname><given-names>JM</given-names></name></person-group><year>2013</year><article-title>Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment</article-title>. <source>Current Opinion in Supportive and Palliative Care</source><volume>7</volume><fpage>368</fpage>–<lpage>375</lpage>. (<pub-id pub-id-type="doi">10.1097/SPC.0000000000000012</pub-id>)<pub-id pub-id-type="pmid">24145681</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>DB</given-names></name><name><surname>Rundle</surname><given-names>AC</given-names></name><name><surname>Graves</surname><given-names>DA</given-names></name><name><surname>Blethen</surname><given-names>SL</given-names></name></person-group><year>1997</year><article-title>Risk of leukemia in children treated with human growth hormone: review and reanalysis</article-title>. <source>Journal of Pediatrics</source><volume>131</volume><fpage>S32</fpage>–<lpage>S36</lpage>. (<pub-id pub-id-type="doi">10.1016/s0022-3476(97)70008-8</pub-id>)<pub-id pub-id-type="pmid">9255225</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ataseven</surname><given-names>H</given-names></name><name><surname>Bahcecioglu</surname><given-names>IH</given-names></name><name><surname>Kuzu</surname><given-names>N</given-names></name><name><surname>Yalniz</surname><given-names>M</given-names></name><name><surname>Celebi</surname><given-names>S</given-names></name><name><surname>Erensoy</surname><given-names>A</given-names></name><name><surname>Ustundag</surname><given-names>B</given-names></name></person-group><year>2006</year><article-title>The levels of ghrelin, leptin, TNF-α, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection</article-title>. <source>Mediators of Inflammation</source><volume>2006</volume><fpage>78380</fpage> (<pub-id pub-id-type="doi">10.1155/MI/2006/78380</pub-id>)<pub-id pub-id-type="pmid">17047295</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aydin</surname><given-names>S</given-names></name><name><surname>Karatas</surname><given-names>F</given-names></name><name><surname>Geckil</surname><given-names>H</given-names></name></person-group><year>2008</year><article-title>Simultaneous quantification of acylated and desacylated ghrelin in biological fluids</article-title>. <source>Biomedical Chromatography</source><volume>22</volume><fpage>1354</fpage>–<lpage>1359</lpage>. (<pub-id pub-id-type="doi">10.1002/bmc.1065</pub-id>)<pub-id pub-id-type="pmid">18651597</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bataar</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>K</given-names></name><name><surname>Taub</surname><given-names>DD</given-names></name></person-group><year>2011</year><article-title>The effects of ghrelin on inflammation and the immune system</article-title>. <source>Molecular and Cellular Endocrinology</source><volume>340</volume><fpage>44</fpage>–<lpage>58</lpage>. (<pub-id pub-id-type="doi">10.1016/j.mce.2011.04.019</pub-id>)<pub-id pub-id-type="pmid">21565248</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bednarek</surname><given-names>MA</given-names></name><name><surname>Feighner</surname><given-names>SD</given-names></name><name><surname>Pong</surname><given-names>SS</given-names></name><name><surname>McKee</surname><given-names>KK</given-names></name><name><surname>Hreniuk</surname><given-names>DL</given-names></name><name><surname>Silva</surname><given-names>MV</given-names></name><name><surname>Warren</surname><given-names>VA</given-names></name><name><surname>Howard</surname><given-names>AD</given-names></name><name><surname>Van Der Ploeg</surname><given-names>LH</given-names></name><name><surname>Heck</surname><given-names>JV</given-names></name></person-group><year>2000</year><article-title>Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a</article-title>. <source>Journal of Medicinal Chemistry</source><volume>43</volume><fpage>4370</fpage>–<lpage>4376</lpage>. (<pub-id pub-id-type="doi">10.1021/jm0001727</pub-id>)<pub-id pub-id-type="pmid">11087562</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benedix</surname><given-names>F</given-names></name><name><surname>Westphal</surname><given-names>S</given-names></name><name><surname>Patschke</surname><given-names>R</given-names></name><name><surname>Luley</surname><given-names>C</given-names></name><name><surname>Lippert</surname><given-names>H</given-names></name><name><surname>Wolff</surname><given-names>S</given-names></name></person-group><year>2011</year><article-title>Comparison of serum and salivary ghrelin in healthy adults, morbidly obese, and patients with metastatic carcinoma</article-title>. <source>Obesity Surgery</source><volume>21</volume><fpage>1265</fpage>–<lpage>1271</lpage>. (<pub-id pub-id-type="doi">10.1007/s11695-010-0161-8</pub-id>)<pub-id pub-id-type="pmid">20390373</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brignardello</surname><given-names>E</given-names></name><name><surname>Felicetti</surname><given-names>F</given-names></name><name><surname>Castiglione</surname><given-names>A</given-names></name><name><surname>Fortunati</surname><given-names>N</given-names></name><name><surname>Matarazzo</surname><given-names>P</given-names></name><name><surname>Biasin</surname><given-names>E</given-names></name><name><surname>Sacerdote</surname><given-names>C</given-names></name><name><surname>Ricardi</surname><given-names>U</given-names></name><name><surname>Fagioli</surname><given-names>F</given-names></name><name><surname>Corrias</surname><given-names>A</given-names></name><etal></etal></person-group><year>2015</year><article-title>GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution</article-title>. <source>Journal of Endocrinological Investigation</source><volume>38</volume><fpage>171</fpage>–<lpage>176</lpage>. (<pub-id pub-id-type="doi">10.1007/s40618-014-0179-1</pub-id>)<pub-id pub-id-type="pmid">25344310</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callaghan</surname><given-names>B</given-names></name><name><surname>Furness</surname><given-names>JB</given-names></name></person-group><year>2014</year><article-title>Novel and conventional receptors for ghrelin, desacyl-ghrelin, and pharmacologically related compounds</article-title>. <source>Pharmacological Reviews</source><volume>66</volume><fpage>984</fpage>–<lpage>1001</lpage>. (<pub-id pub-id-type="doi">10.1124/pr.113.008433</pub-id>)<pub-id pub-id-type="pmid">25107984</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campa</surname><given-names>D</given-names></name><name><surname>Pardini</surname><given-names>B</given-names></name><name><surname>Naccarati</surname><given-names>A</given-names></name><name><surname>Vodickova</surname><given-names>L</given-names></name><name><surname>Novotny</surname><given-names>J</given-names></name><name><surname>Steinke</surname><given-names>V</given-names></name><name><surname>Rahner</surname><given-names>N</given-names></name><name><surname>Holinski-Feder</surname><given-names>E</given-names></name><name><surname>Morak</surname><given-names>M</given-names></name><name><surname>Schackert</surname><given-names>HK</given-names></name><etal></etal></person-group><year>2010</year><article-title>Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study</article-title>. <source>BMC Gastroenterology</source><volume>10</volume><fpage>112</fpage> (<pub-id pub-id-type="doi">10.1186/1471-230X-10-112</pub-id>)<pub-id pub-id-type="pmid">20920174</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Meng</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Du</surname><given-names>J</given-names></name></person-group><year>2012</year><article-title>Association between circulating levels of IGF1 and IGFBP3 and lung cancer risk: a meta-analysis</article-title>. <source>PLoS ONE</source><volume>7</volume><fpage>e49884</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0049884</pub-id>)<pub-id pub-id-type="pmid">23185474</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Enriori</surname><given-names>PJ</given-names></name></person-group><year>2015</year><article-title>Ghrelin: a journey from GH secretagogue to regulator of metabolism</article-title>. <source>Translational Gastrointestinal Cancer</source><volume>4</volume><fpage>14</fpage>–<lpage>27</lpage>. (<pub-id pub-id-type="doi">10.3978/j.issn.2224-4778.2014.09.07</pub-id>)</mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JA</given-names></name><name><surname>Splenser</surname><given-names>A</given-names></name><name><surname>Guillory</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Mendiratta</surname><given-names>M</given-names></name><name><surname>Belinova</surname><given-names>B</given-names></name><name><surname>Halder</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>YP</given-names></name><name><surname>Garcia</surname><given-names>JM</given-names></name></person-group><year>2015</year><article-title>Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved</article-title>. <source>Journal of Cachexia, Sarcopenia and Muscle</source><volume>6</volume><fpage>132</fpage>–<lpage>143</lpage>. (<pub-id pub-id-type="doi">10.1002/jcsm.12023</pub-id>)</mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Child</surname><given-names>CJ</given-names></name><name><surname>Conroy</surname><given-names>D</given-names></name><name><surname>Zimmerman</surname><given-names>AG</given-names></name><name><surname>Woodmansee</surname><given-names>WW</given-names></name><name><surname>Erfurth</surname><given-names>EM</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name></person-group><year>2015</year><article-title>Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study</article-title>. <source>European Journal of Endocrinology</source><volume>172</volume><fpage>779</fpage>–<lpage>790</lpage>. (<pub-id pub-id-type="doi">10.1530/EJE-4-1123</pub-id>)<pub-id pub-id-type="pmid">25810462</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopin</surname><given-names>LK</given-names></name><name><surname>Seim</surname><given-names>I</given-names></name><name><surname>Walpole</surname><given-names>CM</given-names></name><name><surname>Herington</surname><given-names>AC</given-names></name></person-group><year>2012</year><article-title>The ghrelin axis – does it have an appetite for cancer progression?</article-title><source>Endocrine Reviews</source><volume>33</volume><fpage>849</fpage>–<lpage>891</lpage>. (<pub-id pub-id-type="doi">10.1210/er.2011-1007</pub-id>)<pub-id pub-id-type="pmid">22826465</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemmons</surname><given-names>DR</given-names></name></person-group><year>2004</year><article-title>The relative roles of growth hormone and IGF1 in controlling insulin sensitivity</article-title>. <source>Journal of Clinical Investigation</source><volume>113</volume><fpage>25</fpage>–<lpage>27</lpage>. (<pub-id pub-id-type="doi">10.1172/JCI200420660</pub-id>)<pub-id pub-id-type="pmid">14702105</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbetta</surname><given-names>S</given-names></name><name><surname>Peracchi</surname><given-names>M</given-names></name><name><surname>Cappiello</surname><given-names>V</given-names></name><name><surname>Lania</surname><given-names>A</given-names></name><name><surname>Lauri</surname><given-names>E</given-names></name><name><surname>Vago</surname><given-names>L</given-names></name><name><surname>Beck-Peccoz</surname><given-names>P</given-names></name><name><surname>Spada</surname><given-names>A</given-names></name></person-group><year>2003</year><article-title>Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>88</volume><fpage>3117</fpage>–<lpage>3120</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2002-021842</pub-id>)<pub-id pub-id-type="pmid">12843152</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname><given-names>DJ</given-names></name><name><surname>Holmberg</surname><given-names>L</given-names></name><name><surname>Melvin</surname><given-names>JC</given-names></name><name><surname>Loda</surname><given-names>M</given-names></name><name><surname>Chowdhury</surname><given-names>S</given-names></name><name><surname>Rudman</surname><given-names>SM</given-names></name><name><surname>Van Hemelrijck</surname><given-names>M</given-names></name></person-group><year>2014</year><article-title>Serum glucose and risk of cancer: a meta-analysis</article-title>. <source>BMC Cancer</source><volume>14</volume><fpage>985</fpage> (<pub-id pub-id-type="doi">10.1186/1471-2407-14-985</pub-id>)<pub-id pub-id-type="pmid">25526881</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currow</surname><given-names>DC</given-names></name><name><surname>Temel</surname><given-names>JS</given-names></name><name><surname>Fearon</surname><given-names>K</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Friend</surname><given-names>J</given-names></name><name><surname>Abernethy</surname><given-names>AP</given-names></name></person-group><year>2015</year><article-title>A safety extension study of anamorelin in advanced non-small cell lung cancer patients with cachexia: ROMANA 3</article-title>. <source>Journal of Clinical Oncology</source><volume>33</volume><fpage>e20715</fpage>.</mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeBoer</surname><given-names>MD</given-names></name><name><surname>Zhu</surname><given-names>XX</given-names></name><name><surname>Levasseur</surname><given-names>P</given-names></name><name><surname>Meguid</surname><given-names>MM</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Inui</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>JE</given-names></name><name><surname>Halem</surname><given-names>HA</given-names></name><name><surname>Dong</surname><given-names>JZ</given-names></name><name><surname>Datta</surname><given-names>R</given-names></name><etal></etal></person-group><year>2007</year><article-title>Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia</article-title>. <source>Endocrinology</source><volume>148</volume><fpage>3004</fpage>–<lpage>3012</lpage>. (<pub-id pub-id-type="doi">10.1210/en.2007-0016</pub-id>)<pub-id pub-id-type="pmid">17347304</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delhanty</surname><given-names>PJ</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Visser</surname><given-names>JA</given-names></name><name><surname>van Kerkwijk</surname><given-names>A</given-names></name><name><surname>Huisman</surname><given-names>M</given-names></name><name><surname>van Ijcken</surname><given-names>WF</given-names></name><name><surname>Swagemakers</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>RG</given-names></name><name><surname>Themmen</surname><given-names>AP</given-names></name><name><surname>van der Lely</surname><given-names>AJ</given-names></name></person-group><year>2010</year><article-title>Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice</article-title>. <source>PLoS ONE</source><volume>5</volume><fpage>e11749</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0011749</pub-id>)<pub-id pub-id-type="pmid">20668691</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delhanty</surname><given-names>PJ</given-names></name><name><surname>Huisman</surname><given-names>M</given-names></name><name><surname>Julien</surname><given-names>M</given-names></name><name><surname>Mouchain</surname><given-names>K</given-names></name><name><surname>Brune</surname><given-names>P</given-names></name><name><surname>Themmen</surname><given-names>AP</given-names></name><name><surname>Abribat</surname><given-names>T</given-names></name><name><surname>van der Lely</surname><given-names>AJ</given-names></name></person-group><year>2015</year><article-title>The acylated (AG) to unacylated (UAG) ghrelin ratio in esterase inhibitor-treated blood is higher than previously described</article-title>. <source>Clinical Endocrinology</source><volume>82</volume><fpage>142</fpage>–<lpage>146</lpage>. (<pub-id pub-id-type="doi">10.1111/cen.12489</pub-id>)<pub-id pub-id-type="pmid">24810977</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delporte</surname><given-names>C</given-names></name></person-group><year>2013</year><article-title>Structure and physiological actions of ghrelin</article-title>. <source>Scientifica</source><volume>2013</volume><fpage>518909</fpage> (<pub-id pub-id-type="doi">10.1155/2013/518909</pub-id>)<pub-id pub-id-type="pmid">24381790</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Martel</surname><given-names>C</given-names></name><name><surname>Haggerty</surname><given-names>TD</given-names></name><name><surname>Corley</surname><given-names>DA</given-names></name><name><surname>Vogelman</surname><given-names>JH</given-names></name><name><surname>Orentreich</surname><given-names>N</given-names></name><name><surname>Parsonnet</surname><given-names>J</given-names></name></person-group><year>2007</year><article-title>Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus</article-title>. <source>American Journal of Gastroenterology</source><volume>102</volume><fpage>1166</fpage>–<lpage>1172</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1572-0241.2007.01116.x</pub-id>)<pub-id pub-id-type="pmid">17378911</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>VD</given-names></name><name><surname>Schaffer</surname><given-names>EM</given-names></name><name><surname>Pyle</surname><given-names>RS</given-names></name><name><surname>Collins</surname><given-names>GD</given-names></name><name><surname>Sakthivel</surname><given-names>SK</given-names></name><name><surname>Palaniappan</surname><given-names>R</given-names></name><name><surname>Lillard</surname><given-names>JW</given-names><suffix>Jr</suffix></name><name><surname>Taub</surname><given-names>DD</given-names></name></person-group><year>2004</year><article-title>Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells</article-title>. <source>Journal of Clinical Investigation</source><volume>114</volume><fpage>57</fpage>–<lpage>66</lpage>. (<pub-id pub-id-type="doi">10.1172/JCI200421134</pub-id>)<pub-id pub-id-type="pmid">15232612</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Onghia</surname><given-names>V</given-names></name><name><surname>Leoncini</surname><given-names>R</given-names></name><name><surname>Carli</surname><given-names>R</given-names></name><name><surname>Santoro</surname><given-names>A</given-names></name><name><surname>Giglioni</surname><given-names>S</given-names></name><name><surname>Sorbellini</surname><given-names>F</given-names></name><name><surname>Marzocca</surname><given-names>G</given-names></name><name><surname>Bernini</surname><given-names>A</given-names></name><name><surname>Campagna</surname><given-names>S</given-names></name><name><surname>Marinello</surname><given-names>E</given-names></name><etal></etal></person-group><year>2007</year><article-title>Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI</article-title>. <source>Biomedicine and Pharmacotherapy</source><volume>61</volume><fpage>137</fpage>–<lpage>141</lpage>. (<pub-id pub-id-type="doi">10.1016/j.biopha.2006.08.007</pub-id>)<pub-id pub-id-type="pmid">17258885</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doecke</surname><given-names>JD</given-names></name><name><surname>Zhao</surname><given-names>ZZ</given-names></name><name><surname>Stark</surname><given-names>MS</given-names></name><name><surname>Green</surname><given-names>AC</given-names></name><name><surname>Hayward</surname><given-names>NK</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Webb</surname><given-names>PM</given-names></name><name><surname>Whiteman</surname><given-names>DC</given-names></name><collab>& Australian Cancer Study</collab></person-group><year>2008</year><article-title>Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers</article-title>. <source>Cancer Epidemiology, Biomarkers and Prevention</source><volume>17</volume><fpage>1007</fpage>–<lpage>1012</lpage>. (<pub-id pub-id-type="doi">10.1158/1055-9965.EPI-08-0023</pub-id>)</mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dossus</surname><given-names>L</given-names></name><name><surname>McKay</surname><given-names>JD</given-names></name><name><surname>Canzian</surname><given-names>F</given-names></name><name><surname>Wilkening</surname><given-names>S</given-names></name><name><surname>Rinaldi</surname><given-names>S</given-names></name><name><surname>Biessy</surname><given-names>C</given-names></name><name><surname>Olsen</surname><given-names>A</given-names></name><name><surname>Tjønneland</surname><given-names>A</given-names></name><name><surname>Jakobsen</surname><given-names>MU</given-names></name><name><surname>Overvad</surname><given-names>K</given-names></name><etal></etal></person-group><year>2008</year><article-title>Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)</article-title>. <source>Carcinogenesis</source><volume>29</volume><fpage>1360</fpage>–<lpage>1366</lpage>. (<pub-id pub-id-type="doi">10.1093/carcin/bgn083</pub-id>)<pub-id pub-id-type="pmid">18375957</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekeblad</surname><given-names>S</given-names></name><name><surname>Lejonklou</surname><given-names>MH</given-names></name><name><surname>Grimfjärd</surname><given-names>P</given-names></name><name><surname>Johansson</surname><given-names>T</given-names></name><name><surname>Eriksson</surname><given-names>B</given-names></name><name><surname>Grimelius</surname><given-names>L</given-names></name><name><surname>Stridsberg</surname><given-names>M</given-names></name><name><surname>Stålberg</surname><given-names>P</given-names></name><name><surname>Skogseid</surname><given-names>B</given-names></name></person-group><year>2007</year><article-title>Co-expression of ghrelin and its receptor in pancreatic endocrine tumours</article-title>. <source>Clinical Endocrinology</source><volume>66</volume><fpage>115</fpage>–<lpage>122</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1365-2265.2006.02695.x</pub-id>)<pub-id pub-id-type="pmid">17201810</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ergun-Longmire</surname><given-names>B</given-names></name><name><surname>Mertens</surname><given-names>AC</given-names></name><name><surname>Mitby</surname><given-names>P</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Heller</surname><given-names>G</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Yasui</surname><given-names>Y</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name><name><surname>Sklar</surname><given-names>CA</given-names></name></person-group><year>2006</year><article-title>Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>91</volume><fpage>3494</fpage>–<lpage>3498</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2006-0656</pub-id>)<pub-id pub-id-type="pmid">16822820</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feigelson</surname><given-names>HS</given-names></name><name><surname>Teras</surname><given-names>LR</given-names></name><name><surname>Diver</surname><given-names>WR</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Patel</surname><given-names>AV</given-names></name><name><surname>Stevens</surname><given-names>VL</given-names></name><name><surname>Calle</surname><given-names>EE</given-names></name><name><surname>Thun</surname><given-names>MJ</given-names></name><name><surname>Bouzyk</surname><given-names>M</given-names></name></person-group><year>2008</year><article-title>Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II</article-title>. <source>Breast Cancer Research</source><volume>10</volume><fpage>R57</fpage> (<pub-id pub-id-type="doi">10.1186/bcr2114</pub-id>)<pub-id pub-id-type="pmid">18611262</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feigerlová</surname><given-names>E</given-names></name><name><surname>Diene</surname><given-names>G</given-names></name><name><surname>Conte-Auriol</surname><given-names>F</given-names></name><name><surname>Molinas</surname><given-names>C</given-names></name><name><surname>Gennero</surname><given-names>I</given-names></name><name><surname>Salles</surname><given-names>JP</given-names></name><name><surname>Arnaud</surname><given-names>C</given-names></name><name><surname>Tauber</surname><given-names>M</given-names></name></person-group><year>2008</year><article-title>Hyperghrelinemia precedes obesity in Prader-Willi syndrome</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>93</volume><fpage>2800</fpage>–<lpage>2805</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2007-2138</pub-id>)<pub-id pub-id-type="pmid">18460565</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>JN</given-names></name><name><surname>Jeffrey</surname><given-names>PL</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name><name><surname>Seim</surname><given-names>I</given-names></name><name><surname>Roche</surname><given-names>D</given-names></name><name><surname>Obermair</surname><given-names>A</given-names></name><name><surname>Chopin</surname><given-names>LK</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name></person-group><year>2013</year><article-title>Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo</article-title>. <source>American Journal of Physiology: Endocrinology and Metabolism</source><volume>305</volume><fpage>E305</fpage>–<lpage>E3013</lpage>. (<pub-id pub-id-type="doi">10.1152/ajpendo.00156.2013</pub-id>)<pub-id pub-id-type="pmid">23736537</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>JM</given-names></name><name><surname>Polvino</surname><given-names>WJ</given-names></name></person-group><year>2009</year><article-title>Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers</article-title>. <source>Growth Hormone and IGF Research</source><volume>19</volume><fpage>267</fpage>–<lpage>273</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ghir.2008.12.003</pub-id>)<pub-id pub-id-type="pmid">19196529</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>JM</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Mann</surname><given-names>D</given-names></name><name><surname>Epner</surname><given-names>D</given-names></name><name><surname>Hayes</surname><given-names>TG</given-names></name><name><surname>Marcelli</surname><given-names>M</given-names></name><name><surname>Cunningham</surname><given-names>GR</given-names></name></person-group><year>2006</year><article-title>Hypogonadism in male patients with cancer</article-title>. <source>Cancer</source><volume>106</volume><fpage>2583</fpage>–<lpage>2591</lpage>. (<pub-id pub-id-type="doi">10.1002/cncr.21889</pub-id>)<pub-id pub-id-type="pmid">16688773</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>JM</given-names></name><name><surname>Swerdloff</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Kyle</surname><given-names>M</given-names></name><name><surname>Kipnes</surname><given-names>M</given-names></name><name><surname>Biller</surname><given-names>BM</given-names></name><name><surname>Cook</surname><given-names>D</given-names></name><name><surname>Yuen</surname><given-names>KC</given-names></name><name><surname>Bonert</surname><given-names>V</given-names></name><name><surname>Dobs</surname><given-names>A</given-names></name><etal></etal></person-group><year>2013</year><article-title>Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>98</volume><fpage>2422</fpage>–<lpage>2429</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2013-1157</pub-id>)<pub-id pub-id-type="pmid">23559086</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>JM</given-names></name><name><surname>Boccia</surname><given-names>RV</given-names></name><name><surname>Graham</surname><given-names>CD</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Duus</surname><given-names>EM</given-names></name><name><surname>Allen</surname><given-names>S</given-names></name><name><surname>Friend</surname><given-names>J</given-names></name></person-group><year>2015</year><article-title>Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomized, placebo-controlled, double-blind trials</article-title>. <source>Lancet Oncology</source><volume>16</volume><fpage>108</fpage>–<lpage>116</lpage>. (<pub-id pub-id-type="doi">10.1016/S1470-2045(14)71154-4</pub-id>)<pub-id pub-id-type="pmid">25524795</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauna</surname><given-names>C</given-names></name><name><surname>van de Zande</surname><given-names>B</given-names></name><name><surname>van Kerkwijk</surname><given-names>A</given-names></name><name><surname>Themmen</surname><given-names>AP</given-names></name><name><surname>van der Lely</surname><given-names>AJ</given-names></name><name><surname>Delhanty</surname><given-names>PJ</given-names></name></person-group><year>2007</year><article-title>Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R)</article-title>. <source>Molecular and Cellular Endocrinology</source><volume>274</volume><fpage>30</fpage>–<lpage>34</lpage>. (<pub-id pub-id-type="doi">10.1016/j.mce.2007.05.010</pub-id>)<pub-id pub-id-type="pmid">17601657</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Rey</surname><given-names>E</given-names></name><name><surname>Chorny</surname><given-names>A</given-names></name><name><surname>Delgado</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>Therapeutic action of ghrelin in a mouse model of colitis</article-title>. <source>Gastroenterology</source><volume>130</volume><fpage>1707</fpage>–<lpage>1720</lpage>. (<pub-id pub-id-type="doi">10.1053/j.gastro.2006.01.041</pub-id>)<pub-id pub-id-type="pmid">16697735</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guney</surname><given-names>Y</given-names></name><name><surname>Ozel Turkcu</surname><given-names>U</given-names></name><name><surname>Hicsonmez</surname><given-names>A</given-names></name><name><surname>Nalca Andrieu</surname><given-names>M</given-names></name><name><surname>Kurtman</surname><given-names>C</given-names></name></person-group><year>2007</year><article-title>Ghrelin may reduce radiation-induced mucositis and anorexia in head-neck cancer</article-title>. <source>Medical Hypotheses</source><volume>68</volume><fpage>538</fpage>–<lpage>540</lpage>. (<pub-id pub-id-type="doi">10.1016/j.mehy.2006.08.022</pub-id>)<pub-id pub-id-type="pmid">17030099</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanada</surname><given-names>T</given-names></name><name><surname>Toshinai</surname><given-names>K</given-names></name><name><surname>Kajimura</surname><given-names>N</given-names></name><name><surname>Nara-Ashizawa</surname><given-names>N</given-names></name><name><surname>Tsukada</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Osuye</surname><given-names>K</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><name><surname>Matsukura</surname><given-names>S</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name></person-group><year>2003</year><article-title>Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells</article-title>. <source>Biochemical and Biophysical Research Communications</source><volume>301</volume><fpage>275</fpage>–<lpage>279</lpage>. (<pub-id pub-id-type="doi">10.1016/S0006-291X(02)03028-0</pub-id>)<pub-id pub-id-type="pmid">12565855</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartman</surname><given-names>ML</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Crowe</surname><given-names>BJ</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name><name><surname>Erfurth</surname><given-names>EM</given-names></name><name><surname>Kleinberg</surname><given-names>DL</given-names></name><name><surname>Zimmermann</surname><given-names>AG</given-names></name><name><surname>Woodmansee</surname><given-names>WW</given-names></name><name><surname>Cutler</surname><given-names>GB</given-names><suffix>Jr</suffix></name><name><surname>Chipman</surname><given-names>JJ</given-names></name><etal></etal></person-group><year>2013</year><article-title>Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>98</volume><fpage>980</fpage>–<lpage>988</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2012-2684</pub-id>)<pub-id pub-id-type="pmid">23345098</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiura</surname><given-names>Y</given-names></name><name><surname>Takiguchi</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Kurokawa</surname><given-names>Y</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><name><surname>Miyata</surname><given-names>H</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name><etal></etal></person-group><year>2012</year><article-title>Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study</article-title>. <source>Cancer</source><volume>118</volume><fpage>4785</fpage>–<lpage>4794</lpage>. (<pub-id pub-id-type="doi">10.1002/cncr.27430</pub-id>)<pub-id pub-id-type="pmid">22282373</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmer</surname><given-names>H</given-names></name><name><surname>Pozarek</surname><given-names>G</given-names></name><name><surname>Wirfält</surname><given-names>E</given-names></name><name><surname>Popovic</surname><given-names>V</given-names></name><name><surname>Ekman</surname><given-names>B</given-names></name><name><surname>Björk</surname><given-names>J</given-names></name><name><surname>Erfurth</surname><given-names>EM</given-names></name></person-group><year>2010</year><article-title>Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>95</volume><fpage>5395</fpage>–<lpage>5402</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2010-0993</pub-id>)<pub-id pub-id-type="pmid">20826582</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotta</surname><given-names>M</given-names></name><name><surname>Ohwada</surname><given-names>R</given-names></name><name><surname>Katakami</surname><given-names>H</given-names></name><name><surname>Shibasaki</surname><given-names>T</given-names></name><name><surname>Hizuka</surname><given-names>N</given-names></name><name><surname>Takano</surname><given-names>K</given-names></name></person-group><year>2004</year><article-title>Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>89</volume><fpage>5707</fpage>–<lpage>5712</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2004-0353</pub-id>)<pub-id pub-id-type="pmid">15531532</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Fan</surname><given-names>YZ</given-names></name><name><surname>Ge</surname><given-names>BJ</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Tu</surname><given-names>ZY</given-names></name></person-group><year>2007</year><article-title>Circulating ghrelin in patients with gastric or colorectal cancer</article-title>. <source>Digestive Diseases and Sciences</source><volume>52</volume><fpage>803</fpage>–<lpage>809</lpage>. (<pub-id pub-id-type="doi">10.1007/s10620-006-9508-3</pub-id>)<pub-id pub-id-type="pmid">17245626</pub-id></mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>TJ</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Lipinska</surname><given-names>I</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Keaney</surname><given-names>JF</given-names><suffix>Jr</suffix></name><name><surname>Vasan</surname><given-names>RS</given-names></name></person-group><year>2008</year><article-title>Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>93</volume><fpage>3149</fpage>–<lpage>3157</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2008-0207</pub-id>)<pub-id pub-id-type="pmid">18492761</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isomoto</surname><given-names>J</given-names></name><name><surname>Ueno</surname><given-names>H</given-names></name><name><surname>Nishi</surname><given-names>Y</given-names></name><name><surname>Yasutake</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Kawano</surname><given-names>N</given-names></name><name><surname>Ohnita</surname><given-names>K</given-names></name><name><surname>Mizuta</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name><etal></etal></person-group><year>2005</year><article-title>Circulating ghrelin levels in patients with various upper gastrointestinal diseases</article-title>. <source>Digestive Diseases and Sciences</source><volume>50</volume><fpage>833</fpage>–<lpage>838</lpage>. (<pub-id pub-id-type="doi">10.1007/s10620-005-2648-z</pub-id>)<pub-id pub-id-type="pmid">15906753</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>PL</given-names></name><name><surname>Herington</surname><given-names>AC</given-names></name><name><surname>Chopin</surname><given-names>LK</given-names></name></person-group><year>2003</year><article-title>The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer</article-title>. <source>Cytokine and Growth Factor Reviews</source><volume>14</volume><fpage>113</fpage>–<lpage>122</lpage>. (<pub-id pub-id-type="doi">10.1016/S1359-6101(02)00089-8</pub-id>)<pub-id pub-id-type="pmid">12651223</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>TY</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>HH</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Son</surname><given-names>HC</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Sim</surname><given-names>MS</given-names></name></person-group><year>2004</year><article-title>Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>89</volume><fpage>5392</fpage>–<lpage>5396</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2004-0872</pub-id>)<pub-id pub-id-type="pmid">15531487</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karapanagiotou</surname><given-names>EM</given-names></name><name><surname>Polyzos</surname><given-names>A</given-names></name><name><surname>Dilana</surname><given-names>KD</given-names></name><name><surname>Gratsias</surname><given-names>I</given-names></name><name><surname>Boura</surname><given-names>P</given-names></name><name><surname>Gkiozos</surname><given-names>I</given-names></name><name><surname>Syrigos</surname><given-names>KN</given-names></name></person-group><year>2009</year><article-title>Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients</article-title>. <source>Lung Cancer</source><volume>66</volume><fpage>393</fpage>–<lpage>398</lpage>. (<pub-id pub-id-type="doi">10.1016/j.lungcan.2009.02.006</pub-id>)<pub-id pub-id-type="pmid">19282046</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>M</given-names></name><name><surname>Kanemaru</surname><given-names>A</given-names></name><name><surname>Fukushima</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Haruyama</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>N</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name><etal></etal></person-group><year>2015</year><article-title>Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice</article-title>. <source>Cancer Science</source><volume>106</volume><fpage>1130</fpage>–<lpage>1136</lpage>. (<pub-id pub-id-type="doi">10.1111/cas.12725</pub-id>)<pub-id pub-id-type="pmid">26094822</pub-id></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandwala</surname><given-names>HM</given-names></name><name><surname>McCutcheon</surname><given-names>IE</given-names></name><name><surname>Flyvbjerg</surname><given-names>A</given-names></name><name><surname>Friend</surname><given-names>KE</given-names></name></person-group><year>2000</year><article-title>The effects of insulin-like growth factors on tumorigenesis and neoplastic growth</article-title>. <source>Endocrine Reviews</source><volume>1</volume><fpage>215</fpage>–<lpage>244</lpage>. (<pub-id pub-id-type="doi">10.1210/er.21.3.215</pub-id>)</mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemik</surname><given-names>O</given-names></name><name><surname>Sumer</surname><given-names>A</given-names></name><name><surname>Kemik</surname><given-names>AS</given-names></name><name><surname>Hasirci</surname><given-names>I</given-names></name><name><surname>Purisa</surname><given-names>S</given-names></name><name><surname>Dulger</surname><given-names>AC</given-names></name><name><surname>Demiriz</surname><given-names>B</given-names></name><name><surname>Tuzun</surname><given-names>S</given-names></name></person-group><year>2010</year><article-title>The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer</article-title>. <source>World Journal of Surgical Oncology</source><volume>8</volume><fpage>85</fpage> (<pub-id pub-id-type="doi">10.1186/1477-7819-8-85</pub-id>)<pub-id pub-id-type="pmid">20920199</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemik</surname><given-names>O</given-names></name><name><surname>Kemik</surname><given-names>AS</given-names></name><name><surname>Begenik</surname><given-names>H</given-names></name><name><surname>Erdur</surname><given-names>FM</given-names></name><name><surname>Emre</surname><given-names>H</given-names></name><name><surname>Sumer</surname><given-names>A</given-names></name><name><surname>Purisa</surname><given-names>S</given-names></name><name><surname>Tuzun</surname><given-names>S</given-names></name><name><surname>Kotan</surname><given-names>C</given-names></name></person-group><year>2012</year><article-title>The relationship among acute-phase response proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic</article-title>. <source>Human and Experimental Toxicology</source><volume>31</volume><fpage>117</fpage>–<lpage>125</lpage>. (<pub-id pub-id-type="doi">10.1177/0960327111417271</pub-id>)<pub-id pub-id-type="pmid">21803781</pub-id></mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerenidi</surname><given-names>T</given-names></name><name><surname>Lada</surname><given-names>M</given-names></name><name><surname>Tsaroucha</surname><given-names>A</given-names></name><name><surname>Georgoulias</surname><given-names>P</given-names></name><name><surname>Mystridou</surname><given-names>P</given-names></name><name><surname>Gourgoulianis</surname><given-names>KI</given-names></name></person-group><year>2013</year><article-title>Clinical significance of serum adipokines levels in lung cancer</article-title>. <source>Medical Oncology</source><volume>30</volume><fpage>507</fpage> (<pub-id pub-id-type="doi">10.1007/s12032-013-0507-x</pub-id>)<pub-id pub-id-type="pmid">23430445</pub-id></mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Hosoda</surname><given-names>H</given-names></name><name><surname>Date</surname><given-names>Y</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name></person-group><year>1999</year><article-title>Ghrelin is a growth-hormone-releasing acylated peptide from stomach</article-title>. <source>Nature</source><volume>402</volume><fpage>656</fpage>–<lpage>660</lpage>. (<pub-id pub-id-type="doi">10.1038/45230</pub-id>)<pub-id pub-id-type="pmid">10604470</pub-id></mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korbonits</surname><given-names>M</given-names></name><name><surname>Goldstone</surname><given-names>AP</given-names></name><name><surname>Gueorguiev</surname><given-names>M</given-names></name><name><surname>Grossman</surname><given-names>AB</given-names></name></person-group><year>2004</year><article-title>Ghrelin – a hormone with multiple functions</article-title>. <source>Frontiers in Neuroendocrinology</source><volume>25</volume><fpage>27</fpage>–<lpage>68</lpage>. (<pub-id pub-id-type="doi">10.1016/j.yfrne.2004.03.002</pub-id>)<pub-id pub-id-type="pmid">15183037</pub-id></mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuppens</surname><given-names>RJ</given-names></name><name><surname>Diène</surname><given-names>G</given-names></name><name><surname>Bakker</surname><given-names>NE</given-names></name><name><surname>Molinas</surname><given-names>C</given-names></name><name><surname>Faye</surname><given-names>S</given-names></name><name><surname>Nicolino</surname><given-names>M</given-names></name><name><surname>Bernoux</surname><given-names>D</given-names></name><name><surname>Delhanty</surname><given-names>PJ</given-names></name><name><surname>van der Lely</surname><given-names>AJ</given-names></name><name><surname>Allas</surname><given-names>S</given-names></name><etal></etal></person-group><year>2015</year><article-title>Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome</article-title>. <source>Endocrine</source><volume>50</volume><fpage>633</fpage>–<lpage>642</lpage>. (<pub-id pub-id-type="doi">10.1007/s12020-015-0614-x</pub-id>)<pub-id pub-id-type="pmid">25989955</pub-id></mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurila</surname><given-names>M</given-names></name><name><surname>Santaniemi</surname><given-names>M</given-names></name><name><surname>Kesäniemi</surname><given-names>YA</given-names></name><name><surname>Ukkola</surname><given-names>O</given-names></name></person-group><year>2014</year><article-title>High plasma ghrelin protects from coronary heart disease and Leu72Leu polymorphism of ghrelin gene from cancer in healthy adults during the 19 years follow-up study</article-title>. <source>Peptides</source><volume>61</volume><fpage>122</fpage>–<lpage>129</lpage>. (<pub-id pub-id-type="doi">10.1016/j.peptides.2014.09.012</pub-id>)<pub-id pub-id-type="pmid">25257375</pub-id></mixed-citation></ref><ref id="bib62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legakis</surname><given-names>I</given-names></name><name><surname>Stathopoulos</surname><given-names>J</given-names></name><name><surname>Matzouridis</surname><given-names>T</given-names></name><name><surname>Stathopoulos</surname><given-names>GP</given-names></name></person-group><year>2009</year><article-title>Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals</article-title>. <source>Anticancer Research</source><volume>29</volume><fpage>3949</fpage>–<lpage>3952</lpage>.<pub-id pub-id-type="pmid">19846934</pub-id></mixed-citation></ref><ref id="bib63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>GH</given-names></name><name><surname>Tarnawski</surname><given-names>AS</given-names></name></person-group><year>2007</year><article-title>Ghrelin stimulates angiogenesis in human microvascular endothelial cells: implications beyond GH release</article-title>. <source>Biochemical and Biophysical Research Communications</source><volume>353</volume><fpage>238</fpage>–<lpage>243</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbrc.2006.11.144</pub-id>)<pub-id pub-id-type="pmid">17184731</pub-id></mixed-citation></ref><ref id="bib64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>WG</given-names></name><name><surname>Gavrila</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Gunnlaugsson</surname><given-names>S</given-names></name><name><surname>Stoll</surname><given-names>LL</given-names></name><name><surname>McCormick</surname><given-names>ML</given-names></name><name><surname>Sigmund</surname><given-names>CD</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Weintraub</surname><given-names>NL</given-names></name></person-group><year>2004</year><article-title>Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells</article-title>. <source>Circulation</source><volume>109</volume><fpage>2221</fpage>–<lpage>2226</lpage>. (<pub-id pub-id-type="doi">10.1161/01.CIR.0000127956.43874.F2</pub-id>)<pub-id pub-id-type="pmid">15117840</pub-id></mixed-citation></ref><ref id="bib65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Yin</surname><given-names>MC</given-names></name></person-group><year>2007</year><article-title>B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer</article-title>. <source>European Journal of Nutrition</source><volume>46</volume><fpage>293</fpage>–<lpage>299</lpage>. (<pub-id pub-id-type="doi">10.1007/s00394-007-0665-8</pub-id>)<pub-id pub-id-type="pmid">17571208</pub-id></mixed-citation></ref><ref id="bib66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundholm</surname><given-names>K</given-names></name><name><surname>Gunnebo</surname><given-names>L</given-names></name><name><surname>Körner</surname><given-names>U</given-names></name><name><surname>Iresjö</surname><given-names>BM</given-names></name><name><surname>Engström</surname><given-names>C</given-names></name><name><surname>Hyltander</surname><given-names>A</given-names></name><name><surname>Smedh</surname><given-names>U</given-names></name><name><surname>Bosaeus</surname><given-names>I</given-names></name></person-group><year>2010</year><article-title>Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study</article-title>. <source>Cancer</source><volume>116</volume><fpage>2044</fpage>–<lpage>2052</lpage>. (<pub-id pub-id-type="doi">10.1002/cncr.24917</pub-id>)<pub-id pub-id-type="pmid">20186829</pub-id></mixed-citation></ref><ref id="bib67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>T</given-names></name><name><surname>Karimi</surname><given-names>K</given-names></name><name><surname>Arkani</surname><given-names>M</given-names></name><name><surname>Farahani</surname><given-names>H</given-names></name><name><surname>Vahedi</surname><given-names>M</given-names></name><name><surname>Dabiri</surname><given-names>R</given-names></name><name><surname>Nobakht</surname><given-names>H</given-names></name><name><surname>Asadi</surname><given-names>A</given-names></name><name><surname>Mirakhorli</surname><given-names>M</given-names></name><name><surname>Arshi</surname><given-names>B</given-names></name><etal></etal></person-group><year>2014</year><article-title>Resistin -420C>G promoter variant and colorectal cancer risk</article-title>. <source>International Journal of Biological Markers</source><volume>29</volume><fpage>e233</fpage>–<lpage>e238</lpage>. (<pub-id pub-id-type="doi">10.5301/jbm.5000079</pub-id>)<pub-id pub-id-type="pmid">24585435</pub-id></mixed-citation></ref><ref id="bib68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malendowicz</surname><given-names>W</given-names></name><name><surname>Ziolkowska</surname><given-names>A</given-names></name><name><surname>Szyszka</surname><given-names>M</given-names></name><name><surname>Kwias</surname><given-names>Z</given-names></name></person-group><year>2009</year><article-title>Elevated blood active ghrelin and unaltered total ghrelin and obestatin concentrations in prostate carcinoma</article-title>. <source>Urologia Internationalis</source><volume>83</volume><fpage>471</fpage>–<lpage>475</lpage>. (<pub-id pub-id-type="doi">10.1159/000251190</pub-id>)<pub-id pub-id-type="pmid">19996657</pub-id></mixed-citation></ref><ref id="bib69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>NM</given-names></name><name><surname>Moore</surname><given-names>GB</given-names></name><name><surname>Kaur</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>YL</given-names></name><name><surname>Wood</surname><given-names>SL</given-names></name><name><surname>Morrow</surname><given-names>RW</given-names></name><name><surname>Sanger</surname><given-names>GJ</given-names></name><name><surname>Andrews</surname><given-names>PL</given-names></name></person-group><year>2008</year><article-title>Adaptive upregulation of gastric and hypothalamic ghrelin receptors and increased plasma ghrelin in a model of cancer chemotherapy-induced dyspepsia</article-title>. <source>Regulatory Peptides</source><volume>148</volume><fpage>33</fpage>–<lpage>38</lpage>. (<pub-id pub-id-type="doi">10.1016/j.regpep.2008.03.005</pub-id>)<pub-id pub-id-type="pmid">18455814</pub-id></mixed-citation></ref><ref id="bib70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markowska</surname><given-names>A</given-names></name><name><surname>Ziółkowska</surname><given-names>A</given-names></name><name><surname>Jaszczyńska-Nowinka</surname><given-names>K</given-names></name><name><surname>Madry</surname><given-names>R</given-names></name><name><surname>Malendowicz</surname><given-names>LK</given-names></name></person-group><year>2009</year><article-title>Elevated blood plasma concentrations of active ghrelin and obestatin in benign ovarian neoplasms and ovarian cancers</article-title>. <source>European Journal of Gynaecological Oncology</source><volume>30</volume><fpage>518</fpage>–<lpage>522</lpage>.<pub-id pub-id-type="pmid">19899406</pub-id></mixed-citation></ref><ref id="bib71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruna</surname><given-names>P</given-names></name><name><surname>Gürlich</surname><given-names>R</given-names></name><name><surname>Rosická</surname><given-names>M</given-names></name></person-group><year>2008</year><article-title>Ghrelin as an acute-phase reactant during postoperative stress response</article-title>. <source>Hormone and Metabolic Research</source><volume>40</volume><fpage>404</fpage>–<lpage>409</lpage>. (<pub-id pub-id-type="doi">10.1055/s-2008-1065329</pub-id>)<pub-id pub-id-type="pmid">18404598</pub-id></mixed-citation></ref><ref id="bib72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Hosoda</surname><given-names>H</given-names></name><name><surname>Kitajima</surname><given-names>Y</given-names></name><name><surname>Morozumi</surname><given-names>N</given-names></name><name><surname>Minamitake</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name></person-group><year>2001</year><article-title>Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides</article-title>. <source>Biochemical and Biophysical Research Communications</source><volume>287</volume><fpage>142</fpage>–<lpage>146</lpage>. (<pub-id pub-id-type="doi">10.1006/bbrc.2001.5553</pub-id>)<pub-id pub-id-type="pmid">11549267</pub-id></mixed-citation></ref><ref id="bib73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikami</surname><given-names>K</given-names></name><name><surname>Ozasa</surname><given-names>K</given-names></name><name><surname>Nakao</surname><given-names>M</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Sakauchi</surname><given-names>F</given-names></name><name><surname>Washio</surname><given-names>M</given-names></name><name><surname>Kubo</surname><given-names>T</given-names></name><etal></etal></person-group><year>2009</year><article-title>Prostate cancer risk in relation to insulin-like growth factor (IGF)-1 and IGF-binding protein-3: a nested case-control study in large scale cohort study in Japan</article-title>. <source>Asian Pacific Journal of Cancer Prevention</source><volume>10</volume><fpage>57</fpage>–<lpage>61</lpage>.</mixed-citation></ref><ref id="bib74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>N</given-names></name><name><surname>Hirai</surname><given-names>H</given-names></name><name><surname>Yokobori</surname><given-names>T</given-names></name><name><surname>Sano</surname><given-names>A</given-names></name><name><surname>Sakai</surname><given-names>M</given-names></name><name><surname>Inose</surname><given-names>T</given-names></name><name><surname>Sohda</surname><given-names>M</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Fukuchi</surname><given-names>M</given-names></name><etal></etal></person-group><year>2012</year><article-title>Ghrelin level and body weight loss after esophagectomy for esophageal cancer</article-title>. <source>Journal of Surgical Research</source><volume>176</volume><fpage>74</fpage>–<lpage>78</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jss.2011.09.016</pub-id>)<pub-id pub-id-type="pmid">22137988</pub-id></mixed-citation></ref><ref id="bib75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Shamseer</surname><given-names>L</given-names></name><name><surname>Clarke</surname><given-names>M</given-names></name><name><surname>Ghersi</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Petticrew</surname><given-names>M</given-names></name><name><surname>Shekelle</surname><given-names>P</given-names></name><name><surname>Stewart</surname><given-names>LA</given-names></name><collab>& PRISMA-P Group</collab></person-group><year>2015</year><article-title>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement</article-title>. <source>Systematic Reviews</source><volume>4</volume><fpage>1</fpage> (<pub-id pub-id-type="doi">10.1186/2046-4053-4-1</pub-id>)<pub-id pub-id-type="pmid">25554246</pub-id></mixed-citation></ref><ref id="bib76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondello</surname><given-names>P</given-names></name><name><surname>Lacquaniti</surname><given-names>A</given-names></name><name><surname>Mondello</surname><given-names>S</given-names></name><name><surname>Bolignano</surname><given-names>D</given-names></name><name><surname>Pitini</surname><given-names>V</given-names></name><name><surname>Aloisi</surname><given-names>C</given-names></name><name><surname>Buemi</surname><given-names>M</given-names></name></person-group><year>2014</year><article-title>Emerging markers of cachexia predict survival in cancer patients</article-title>. <source>BMC Cancer</source><volume>14</volume><fpage>828</fpage> (<pub-id pub-id-type="doi">10.1186/1471-2407-14-828</pub-id>)<pub-id pub-id-type="pmid">25400234</pub-id></mixed-citation></ref><ref id="bib77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morpurgo</surname><given-names>PS</given-names></name><name><surname>Cappiello</surname><given-names>V</given-names></name><name><surname>Verga</surname><given-names>U</given-names></name><name><surname>Vicentini</surname><given-names>L</given-names></name><name><surname>Vaghi</surname><given-names>I</given-names></name><name><surname>Lauri</surname><given-names>E</given-names></name><name><surname>Nebuloni</surname><given-names>M</given-names></name><name><surname>Beck-Peccoz</surname><given-names>P</given-names></name><name><surname>Spada</surname><given-names>A</given-names></name></person-group><year>2005</year><article-title>Ghrelin in human medullary thyroid carcinomas</article-title>. <source>Clinical Endocrinology</source><volume>63</volume><fpage>437</fpage>–<lpage>441</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1365-2265.2005.02360.x</pub-id>)<pub-id pub-id-type="pmid">16181236</pub-id></mixed-citation></ref><ref id="bib78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moschovi</surname><given-names>M</given-names></name><name><surname>Trimis</surname><given-names>G</given-names></name><name><surname>Vounatsou</surname><given-names>M</given-names></name><name><surname>Katsibardi</surname><given-names>K</given-names></name><name><surname>Margeli</surname><given-names>A</given-names></name><name><surname>Dimitriadi</surname><given-names>F</given-names></name><name><surname>Papassotiriou</surname><given-names>I</given-names></name><name><surname>Chrousos</surname><given-names>G</given-names></name><name><surname>Tzortzatou-Stathopoulou</surname><given-names>F</given-names></name></person-group><year>2008</year><article-title>Serial plasma concentrations of PYY and ghrelin during chemotherapy in children with acute lymphoblastic leukemia</article-title>. <source>Journal of Pediatric Hematology/Oncology</source><volume>30</volume><fpage>733</fpage>–<lpage>737</lpage>. (<pub-id pub-id-type="doi">10.1097/MPH.0b013e318179a1d8</pub-id>)<pub-id pub-id-type="pmid">19011469</pub-id></mixed-citation></ref><ref id="bib79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motawi</surname><given-names>TK</given-names></name><name><surname>Shaker</surname><given-names>OG</given-names></name><name><surname>Ismail</surname><given-names>MF</given-names></name><name><surname>Sayed</surname><given-names>NH</given-names></name></person-group><year>2013</year><article-title>Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients</article-title>. <source>Gene</source><volume>527</volume><fpage>516</fpage>–<lpage>520</lpage>. (<pub-id pub-id-type="doi">10.1016/j.gene.2013.06.053</pub-id>)<pub-id pub-id-type="pmid">23845776</pub-id></mixed-citation></ref><ref id="bib80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>TD</given-names></name><name><surname>Perez-Tilve</surname><given-names>D</given-names></name><name><surname>Tong</surname><given-names>J</given-names></name><name><surname>Pfluger</surname><given-names>PT</given-names></name><name><surname>Tschöp</surname><given-names>MH</given-names></name></person-group><year>2010</year><article-title>Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia</article-title>. <source>Journal of Cachexia, Sarcopenia and Muscle</source><volume>1</volume><fpage>159</fpage>–<lpage>167</lpage>. (<pub-id pub-id-type="doi">10.1007/s13539-010-0012-4</pub-id>)</mixed-citation></ref><ref id="bib81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mungan</surname><given-names>NA</given-names></name><name><surname>Eminferzane</surname><given-names>S</given-names></name><name><surname>Mungan</surname><given-names>AG</given-names></name><name><surname>Yesilli</surname><given-names>C</given-names></name><name><surname>Seckiner</surname><given-names>I</given-names></name><name><surname>Can</surname><given-names>M</given-names></name><name><surname>Ayoglu</surname><given-names>F</given-names></name><name><surname>Akduman</surname><given-names>B</given-names></name></person-group><year>2008</year><article-title>Diagnostic value of serum ghrelin levels in prostate cancer</article-title>. <source>Urologia Internationalis</source><volume>80</volume><fpage>245</fpage>–<lpage>248</lpage>. (<pub-id pub-id-type="doi">10.1159/000127334</pub-id>)<pub-id pub-id-type="pmid">18480624</pub-id></mixed-citation></ref><ref id="bib82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murdolo</surname><given-names>G</given-names></name><name><surname>Lucidi</surname><given-names>P</given-names></name><name><surname>Di Loreto</surname><given-names>C</given-names></name><name><surname>Parlanti</surname><given-names>N</given-names></name><name><surname>De Cicco</surname><given-names>A</given-names></name><name><surname>Fatone</surname><given-names>C</given-names></name><name><surname>Fanelli</surname><given-names>CG</given-names></name><name><surname>Bolli</surname><given-names>GB</given-names></name><name><surname>Santeusanio</surname><given-names>F</given-names></name><name><surname>De Feo</surname><given-names>P</given-names></name></person-group><year>2003</year><article-title>Insulin is required for prandial ghrelin suppression in humans</article-title>. <source>Diabetes</source><volume>52</volume><fpage>2923</fpage>–<lpage>2927</lpage>. (<pub-id pub-id-type="doi">10.2337/diabetes.52.12.2923</pub-id>)<pub-id pub-id-type="pmid">14633852</pub-id></mixed-citation></ref><ref id="bib83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>G</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Stanczyk</surname><given-names>FZ</given-names></name><name><surname>Weinstein</surname><given-names>SJ</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Virtamo</surname><given-names>J</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Albanes</surname><given-names>D</given-names></name><name><surname>Freedman</surname><given-names>ND</given-names></name></person-group><year>2011</year><article-title>The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas</article-title>. <source>Journal of the National Cancer Institute</source><volume>103</volume><fpage>1123</fpage>–<lpage>1129</lpage>. (<pub-id pub-id-type="doi">10.1093/jnci/djr194</pub-id>)<pub-id pub-id-type="pmid">21693726</pub-id></mixed-citation></ref><ref id="bib84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>G</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Albanes</surname><given-names>D</given-names></name><name><surname>Stanczyk</surname><given-names>FZ</given-names></name><name><surname>Weinstein</surname><given-names>SJ</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Virtamo</surname><given-names>J</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Freedman</surname><given-names>ND</given-names></name></person-group><year>2012</year><article-title>Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma</article-title>. <source>Gut</source><volume>61</volume><fpage>1533</fpage>–<lpage>1537</lpage>. (<pub-id pub-id-type="doi">10.1136/gutjnl-2011-300653</pub-id>)<pub-id pub-id-type="pmid">22180062</pub-id></mixed-citation></ref><ref id="bib85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagaya</surname><given-names>N</given-names></name><name><surname>Moriya</surname><given-names>J</given-names></name><name><surname>Yasumura</surname><given-names>Y</given-names></name><name><surname>Uematsu</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>F</given-names></name><name><surname>Shimizu</surname><given-names>W</given-names></name><name><surname>Ueno</surname><given-names>K</given-names></name><name><surname>Kitakaze</surname><given-names>M</given-names></name><name><surname>Miyatake</surname><given-names>K</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name></person-group><year>2004</year><article-title>Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure</article-title>. <source>Circulation</source><volume>110</volume><fpage>3674</fpage>–<lpage>3679</lpage>. (<pub-id pub-id-type="doi">10.1161/01.CIR.0000149746.62908.BB</pub-id>)<pub-id pub-id-type="pmid">15569841</pub-id></mixed-citation></ref><ref id="bib86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagaya</surname><given-names>N</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name><name><surname>Murakami</surname><given-names>S</given-names></name><name><surname>Oya</surname><given-names>H</given-names></name><name><surname>Uematsu</surname><given-names>M</given-names></name><name><surname>Miyatake</surname><given-names>K</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name></person-group><year>2005</year><article-title>Treatment of cachexia with ghrelin in patients with COPD</article-title>. <source>Chest</source><volume>128</volume><fpage>1187</fpage>–<lpage>1193</lpage>. (<pub-id pub-id-type="doi">10.1378/chest.128.3.1187</pub-id>)<pub-id pub-id-type="pmid">16162705</pub-id></mixed-citation></ref><ref id="bib87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakazato</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>N</given-names></name><name><surname>Date</surname><given-names>Y</given-names></name><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><name><surname>Matsukura</surname><given-names>S</given-names></name></person-group><year>2001</year><article-title>A role for ghrelin in the central regulation of feeding</article-title>. <source>Nature</source><volume>409</volume><fpage>194</fpage>–<lpage>198</lpage>. (<pub-id pub-id-type="doi">10.1038/35051587</pub-id>)<pub-id pub-id-type="pmid">11196643</pub-id></mixed-citation></ref><ref id="bib88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nass</surname><given-names>RM</given-names></name><name><surname>Gaylinn</surname><given-names>BD</given-names></name><name><surname>Rogol</surname><given-names>AD</given-names></name><name><surname>Thorner</surname><given-names>MO</given-names></name></person-group><year>2010</year><article-title>Ghrelin and growth hormone: story in reverse</article-title>. <source>PNAS</source><volume>107</volume><fpage>8501</fpage>–<lpage>8502</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1002941107</pub-id>)<pub-id pub-id-type="pmid">20435917</pub-id></mixed-citation></ref><ref id="bib89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolopoulos</surname><given-names>D</given-names></name><name><surname>Theocharis</surname><given-names>S</given-names></name><name><surname>Kouraklis</surname><given-names>G</given-names></name></person-group><year>2010</year><article-title>Ghrelin: a potential therapeutic target for cancer</article-title>. <source>Regulatory Peptides</source><volume>163</volume><fpage>7</fpage>–<lpage>17</lpage>. (<pub-id pub-id-type="doi">10.1016/j.regpep.2010.03.011</pub-id>)<pub-id pub-id-type="pmid">20382189</pub-id></mixed-citation></ref><ref id="bib90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolopoulos</surname><given-names>D</given-names></name><name><surname>Theocharis</surname><given-names>S</given-names></name><name><surname>Moutsios-Rentzos</surname><given-names>A</given-names></name><name><surname>Kouraklis</surname><given-names>G</given-names></name><name><surname>Kostakis</surname><given-names>A</given-names></name></person-group><year>2014</year><article-title>The role of serum total ghrelin level elevation in colon cancer patients</article-title>. <source>Journal of Balkan Union of Oncology</source><volume>19</volume><fpage>388</fpage>–<lpage>393</lpage>.<pub-id pub-id-type="pmid">24965396</pub-id></mixed-citation></ref><ref id="bib91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Northrup</surname><given-names>R</given-names></name><name><surname>Kuroda</surname><given-names>K</given-names></name><name><surname>Duus</surname><given-names>EM</given-names></name><name><surname>Barnes</surname><given-names>SR</given-names></name><name><surname>Cheatham</surname><given-names>L</given-names></name><name><surname>Wiley</surname><given-names>T</given-names></name><name><surname>Pietra</surname><given-names>C</given-names></name></person-group><year>2013</year><article-title>Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model</article-title>. <source>Supportive Care in Cancer</source><volume>21</volume><fpage>2409</fpage>–<lpage>2415</lpage>. (<pub-id pub-id-type="doi">10.1007/s00520-013-1800-0</pub-id>)<pub-id pub-id-type="pmid">23579947</pub-id></mixed-citation></ref><ref id="bib92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname><given-names>DS</given-names></name><name><surname>Buchfelder</surname><given-names>M</given-names></name><name><surname>Wiendieck</surname><given-names>K</given-names></name><name><surname>Kremenevskaja</surname><given-names>N</given-names></name><name><surname>Bengtsson</surname><given-names>BÅ</given-names></name><name><surname>Jakobsson</surname><given-names>KE</given-names></name><name><surname>Jarfelt</surname><given-names>M</given-names></name><name><surname>Johannsson</surname><given-names>G</given-names></name><name><surname>Nilsson</surname><given-names>AG</given-names></name></person-group><year>2012</year><article-title>Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up</article-title>. <source>European Journal of Endocrinology</source><volume>166</volume><fpage>1061</fpage>–<lpage>1068</lpage>. (<pub-id pub-id-type="doi">10.1530/EJE-12-0077</pub-id>)<pub-id pub-id-type="pmid">22457235</pub-id></mixed-citation></ref><ref id="bib93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozsoy</surname><given-names>S</given-names></name><name><surname>Besirli</surname><given-names>A</given-names></name><name><surname>Unal</surname><given-names>D</given-names></name><name><surname>Abdulrezzak</surname><given-names>U</given-names></name><name><surname>Orhan</surname><given-names>O</given-names></name></person-group><year>2015</year><article-title>The association between depression, weight loss and leptin/ghrelin levels in male patients with head and neck cancer undergoing radiotherapy</article-title>. <source>General Hospital Psychiatry</source><volume>37</volume><fpage>31</fpage>–<lpage>35</lpage>. (<pub-id pub-id-type="doi">10.1016/j.genhosppsych.2014.09.002</pub-id>)<pub-id pub-id-type="pmid">25440723</pub-id></mixed-citation></ref><ref id="bib94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pabalan</surname><given-names>NA</given-names></name><name><surname>Seim</surname><given-names>I</given-names></name><name><surname>Jarjanazi</surname><given-names>H</given-names></name><name><surname>Chopin</surname><given-names>LK</given-names></name></person-group><year>2014</year><article-title>Associations between ghrelin and ghrelin receptor polymorphisms and cancer in Caucasian populations: a meta-analysis</article-title>. <source>BMC Genetics</source><volume>15</volume><fpage>118</fpage> (<pub-id pub-id-type="doi">10.1186/s12863-014-0118-3</pub-id>)<pub-id pub-id-type="pmid">25376984</pub-id></mixed-citation></ref><ref id="bib95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>BC</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Sklar</surname><given-names>CA</given-names></name><name><surname>Neglia</surname><given-names>J</given-names></name><name><surname>Yasui</surname><given-names>Y</given-names></name><name><surname>Mertens</surname><given-names>A</given-names></name><name><surname>Armstrong</surname><given-names>GT</given-names></name><name><surname>Meadows</surname><given-names>A</given-names></name><name><surname>Stovall</surname><given-names>M</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name><etal></etal></person-group><year>2014</year><article-title>Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>99</volume><fpage>2030</fpage>–<lpage>2037</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2013-4159</pub-id>)<pub-id pub-id-type="pmid">24606096</pub-id></mixed-citation></ref><ref id="bib96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekic</surname><given-names>S</given-names></name><name><surname>Popovic</surname><given-names>V</given-names></name></person-group><year>2013</year><article-title>GH therapy and cancer risk in hypopituitarism: what we know from human studies</article-title>. <source>European Journal of Endocrinology</source><volume>169</volume><fpage>R89</fpage>–<lpage>R97</lpage>. (<pub-id pub-id-type="doi">10.1530/EJE-13-0389</pub-id>)<pub-id pub-id-type="pmid">23935131</pub-id></mixed-citation></ref><ref id="bib97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porporato</surname><given-names>PE</given-names></name><name><surname>Filigheddu</surname><given-names>N</given-names></name><name><surname>Reano</surname><given-names>S</given-names></name><name><surname>Ferrara</surname><given-names>M</given-names></name><name><surname>Angelino</surname><given-names>E</given-names></name><name><surname>Gnocchi</surname><given-names>VF</given-names></name><name><surname>Prodam</surname><given-names>F</given-names></name><name><surname>Ronchi</surname><given-names>G</given-names></name><name><surname>Fagoonee</surname><given-names>S</given-names></name><name><surname>Fornaro</surname><given-names>M</given-names></name><etal></etal></person-group><year>2013</year><article-title>Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice</article-title>. <source>Journal of Clinical Investigation</source><volume>123</volume><fpage>611</fpage>–<lpage>622</lpage>. (<pub-id pub-id-type="doi">10.1172/JCI39920</pub-id>)<pub-id pub-id-type="pmid">23281394</pub-id></mixed-citation></ref><ref id="bib98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pourtau</surname><given-names>L</given-names></name><name><surname>Leemburg</surname><given-names>S</given-names></name><name><surname>Roux</surname><given-names>P</given-names></name><name><surname>Leste-Lasserre</surname><given-names>T</given-names></name><name><surname>Costaglioli</surname><given-names>P</given-names></name><name><surname>Garbay</surname><given-names>B</given-names></name><name><surname>Drutel</surname><given-names>G</given-names></name><name><surname>Konsman</surname><given-names>JP</given-names></name></person-group><year>2011</year><article-title>Hormonal, hypothalamic and striatal responses to reduced body weight gain are attenuated in anorectic rats bearing small tumors</article-title>. <source>Brain, Behavior, and Immunity</source><volume>25</volume><fpage>777</fpage>–<lpage>786</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbi.2011.02.004</pub-id>)</mixed-citation></ref><ref id="bib99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prudom</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Patrie</surname><given-names>J</given-names></name><name><surname>Gaylinn</surname><given-names>BD</given-names></name><name><surname>Foster-Schubert</surname><given-names>KE</given-names></name><name><surname>Cummings</surname><given-names>DE</given-names></name><name><surname>Thorner</surname><given-names>MO</given-names></name><name><surname>Geysen</surname><given-names>HM</given-names></name></person-group><year>2010</year><article-title>Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>95</volume><fpage>2351</fpage>–<lpage>2358</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2009-2407</pub-id>)<pub-id pub-id-type="pmid">20194708</pub-id></mixed-citation></ref><ref id="bib100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raman</surname><given-names>S</given-names></name><name><surname>Grimberg</surname><given-names>A</given-names></name><name><surname>Waquespack</surname><given-names>SG</given-names></name><name><surname>Miller</surname><given-names>BS</given-names></name><name><surname>Sklar</surname><given-names>CA</given-names></name><name><surname>Meacham</surname><given-names>LR</given-names></name><name><surname>Patterson</surname><given-names>BC</given-names></name></person-group><year>2015</year><article-title>Risk of neoplasia in pediatric patients receiving growth hormone therapy – a report from the Pediatric Endocrine Society drug and therapeutics committee</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>100</volume><fpage>2192</fpage>–<lpage>2203</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2015-1002</pub-id>)<pub-id pub-id-type="pmid">25839904</pub-id></mixed-citation></ref><ref id="bib101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rau</surname><given-names>TT</given-names></name><name><surname>Sonst</surname><given-names>A</given-names></name><name><surname>Rogler</surname><given-names>A</given-names></name><name><surname>Burnat</surname><given-names>G</given-names></name><name><surname>Neumann</surname><given-names>H</given-names></name><name><surname>Oeckl</surname><given-names>K</given-names></name><name><surname>Neuhuber</surname><given-names>W</given-names></name><name><surname>Dimmler</surname><given-names>A</given-names></name><name><surname>Faller</surname><given-names>G</given-names></name><name><surname>Brzozowski</surname><given-names>T</given-names></name><etal></etal></person-group><year>2013</year><article-title>Gastrin mediated down regulation of ghrelin and its pathophysiological role in atrophic gastritis</article-title>. <source>Journal of Physiology and Pharmacology</source><volume>64</volume><fpage>719</fpage>–<lpage>725</lpage>.<pub-id pub-id-type="pmid">24388886</pub-id></mixed-citation></ref><ref id="bib102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renehan</surname><given-names>AG</given-names></name><name><surname>Zwahlen</surname><given-names>M</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name><name><surname>O’Dwyer</surname><given-names>ST</given-names></name><name><surname>Shalet</surname><given-names>SM</given-names></name><name><surname>Egger</surname><given-names>M</given-names></name></person-group><year>2004</year><article-title>Insulin-like growth factor (IGF1), IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis</article-title>. <source>Lancet</source><volume>363</volume><fpage>1346</fpage>–<lpage>1353</lpage>. (<pub-id pub-id-type="doi">10.1016/S0140-6736(04)16044-3</pub-id>)<pub-id pub-id-type="pmid">15110491</pub-id></mixed-citation></ref><ref id="bib103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renehan</surname><given-names>AG</given-names></name><name><surname>Harvie</surname><given-names>M</given-names></name><name><surname>Howell</surname><given-names>IA</given-names></name></person-group><year>2006</year><article-title>Insulin-like growth factor (IGF)-1, IGF binding protein-3, and breast cancer risk: eight years on</article-title>. <source>Endocrine-Related Cancer</source><volume>13</volume><fpage>273</fpage>–<lpage>278</lpage>. (<pub-id pub-id-type="doi">10.1677/erc.1.01219</pub-id>)<pub-id pub-id-type="pmid">16728563</pub-id></mixed-citation></ref><ref id="bib104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roemmler-Zehrer</surname><given-names>J</given-names></name><name><surname>Geigenberger</surname><given-names>V</given-names></name><name><surname>Störmann</surname><given-names>S</given-names></name><name><surname>Losa</surname><given-names>M</given-names></name><name><surname>Crippa</surname><given-names>V</given-names></name><name><surname>Otto</surname><given-names>B</given-names></name><name><surname>Bidlingmaier</surname><given-names>M</given-names></name><name><surname>Dimopoulou</surname><given-names>C</given-names></name><name><surname>Stalla</surname><given-names>GK</given-names></name><name><surname>Schopohl</surname><given-names>J</given-names></name></person-group><year>2014</year><article-title>Food intake regulating hormones in adult craniopharyngioma patients</article-title>. <source>European Journal of Endocrinology</source><volume>170</volume><fpage>627</fpage>–<lpage>635</lpage>. (<pub-id pub-id-type="doi">10.1530/EJE-13-0832</pub-id>)<pub-id pub-id-type="pmid">24474740</pub-id></mixed-citation></ref><ref id="bib105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>CL</given-names></name><name><surname>Gebhardt</surname><given-names>U</given-names></name><name><surname>Müller</surname><given-names>HL</given-names></name></person-group><year>2011</year><article-title>Appetite-regulating hormone changes in patients with craniopharyngioma</article-title>. <source>Obesity</source><volume>19</volume><fpage>36</fpage>–<lpage>42</lpage>. (<pub-id pub-id-type="doi">10.1038/oby.2010.80</pub-id>)<pub-id pub-id-type="pmid">20379145</pub-id></mixed-citation></ref><ref id="bib106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowlands</surname><given-names>MA</given-names></name><name><surname>Holly</surname><given-names>JM</given-names></name><name><surname>Gunnell</surname><given-names>D</given-names></name><name><surname>Donovan</surname><given-names>J</given-names></name><name><surname>Lane</surname><given-names>JA</given-names></name><name><surname>Hamdy</surname><given-names>F</given-names></name><name><surname>Neal</surname><given-names>DE</given-names></name><name><surname>Oliver</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>Martin</surname><given-names>RM</given-names></name></person-group><year>2012</year><article-title>Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT</article-title>. <source>Cancer Research</source><volume>72</volume><fpage>503</fpage>–<lpage>515</lpage>. (<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-1601</pub-id>)<pub-id pub-id-type="pmid">22106399</pub-id></mixed-citation></ref><ref id="bib107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadjadi</surname><given-names>A</given-names></name><name><surname>Yazdanbod</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>YY</given-names></name><name><surname>Boreiri</surname><given-names>M</given-names></name><name><surname>Samadi</surname><given-names>F</given-names></name><name><surname>Alizadeh</surname><given-names>BZ</given-names></name><name><surname>Islami</surname><given-names>F</given-names></name><name><surname>Fyfe</surname><given-names>V</given-names></name><name><surname>Babaei</surname><given-names>M</given-names></name><name><surname>Namazi</surname><given-names>MJ</given-names></name><etal></etal></person-group><year>2013</year><article-title>Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis</article-title>. <source>PLoS ONE</source><volume>8</volume><fpage>e74440</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0074440</pub-id>)<pub-id pub-id-type="pmid">24098650</pub-id></mixed-citation></ref><ref id="bib108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sävendahl</surname><given-names>L</given-names></name><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Albertsson-Wikland</surname><given-names>K</given-names></name><name><surname>Borgström</surname><given-names>B</given-names></name><name><surname>Carel</surname><given-names>JC</given-names></name><name><surname>Henrard</surname><given-names>S</given-names></name><name><surname>Speybroeck</surname><given-names>N</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Zandwijken</surname><given-names>G</given-names></name><name><surname>Hokken-Koelega</surname><given-names>A</given-names></name></person-group><year>2012</year><article-title>Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>97</volume><fpage>E213</fpage>–<lpage>E217</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2011-2882</pub-id>)<pub-id pub-id-type="pmid">22238393</pub-id></mixed-citation></ref><ref id="bib109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schernhammer</surname><given-names>ES</given-names></name><name><surname>Holly</surname><given-names>JM</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Pollak</surname><given-names>MN</given-names></name><name><surname>Hankinson</surname><given-names>SE</given-names></name></person-group><year>2006</year><article-title>Insulin-like growth factor-1, its binding proteins (IGFBP-1 and IGFBP3) and growth hormone and breast cancer risk in The Nurses Health Study II</article-title>. <source>Endocrine-Related Cancer</source><volume>13</volume><fpage>583</fpage>–<lpage>592</lpage>. (<pub-id pub-id-type="doi">10.1677/erc.1.01149</pub-id>)<pub-id pub-id-type="pmid">16728584</pub-id></mixed-citation></ref><ref id="bib110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schock</surname><given-names>H</given-names></name><name><surname>Fortner</surname><given-names>RT</given-names></name><name><surname>Surcel</surname><given-names>HM</given-names></name><name><surname>Grankvist</surname><given-names>K</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name><name><surname>Lehtinen</surname><given-names>M</given-names></name><name><surname>Lundin</surname><given-names>E</given-names></name></person-group><year>2015</year><article-title>Early pregnancy IGF1 and placental GH and risk of epithelial ovarian cancer: a nested case-control study</article-title>. <source>International Journal of Cancer</source><volume>137</volume><fpage>439</fpage>–<lpage>447</lpage>. (<pub-id pub-id-type="doi">10.1002/ijc.29387</pub-id>)<pub-id pub-id-type="pmid">25516257</pub-id></mixed-citation></ref><ref id="bib111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Severi</surname><given-names>G</given-names></name><name><surname>Morris</surname><given-names>HA</given-names></name><name><surname>MacInnis</surname><given-names>RJ</given-names></name><name><surname>English</surname><given-names>DR</given-names></name><name><surname>Tilley</surname><given-names>WD</given-names></name><name><surname>Hopper</surname><given-names>JL</given-names></name><name><surname>Boyle</surname><given-names>P</given-names></name><name><surname>Giles</surname><given-names>GG</given-names></name></person-group><year>2006</year><article-title>Circulating insulin-like growth factor-1 and binding protein-3 and risk of prostate cancer</article-title>. <source>Cancer Epidemiology, Biomarkers and Prevention</source><volume>15</volume><fpage>1137</fpage>–<lpage>1141</lpage>. (<pub-id pub-id-type="doi">10.1158/1055-9965.EPI-05-0823</pub-id>)</mixed-citation></ref><ref id="bib112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiiya</surname><given-names>T</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name><name><surname>Mizuta</surname><given-names>M</given-names></name><name><surname>Date</surname><given-names>Y</given-names></name><name><surname>Mondal</surname><given-names>MS</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Nozoe</surname><given-names>S</given-names></name><name><surname>Hosoda</surname><given-names>H</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><name><surname>Matsukura</surname><given-names>S</given-names></name></person-group><year>2002</year><article-title>Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>87</volume><fpage>240</fpage>–<lpage>244</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.87.1.240</pub-id>)<pub-id pub-id-type="pmid">11788653</pub-id></mixed-citation></ref><ref id="bib113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Nagaya</surname><given-names>N</given-names></name><name><surname>Isobe</surname><given-names>T</given-names></name><name><surname>Imazu</surname><given-names>M</given-names></name><name><surname>Okumura</surname><given-names>H</given-names></name><name><surname>Hosoda</surname><given-names>H</given-names></name><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><name><surname>Kohno</surname><given-names>N</given-names></name></person-group><year>2003</year><article-title>Increased plasma ghrelin level in lung cancer cachexia</article-title>. <source>Clinical Cancer Research</source><volume>9</volume><fpage>774</fpage>–<lpage>778</lpage>.<pub-id pub-id-type="pmid">12576449</pub-id></mixed-citation></ref><ref id="bib114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skibola</surname><given-names>DR</given-names></name><name><surname>Smith</surname><given-names>MT</given-names></name><name><surname>Bracci</surname><given-names>PM</given-names></name><name><surname>Hubbard</surname><given-names>AE</given-names></name><name><surname>Agana</surname><given-names>L</given-names></name><name><surname>Chi</surname><given-names>S</given-names></name><name><surname>Holly</surname><given-names>EA</given-names></name></person-group><year>2005</year><article-title>Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma</article-title>. <source>Cancer Epidemiology, Biomarkers and Prevention</source><volume>14</volume><fpage>1251</fpage>–<lpage>1256</lpage>. (<pub-id pub-id-type="doi">10.1158/1055-9965.EPI-04-0895</pub-id>)</mixed-citation></ref><ref id="bib115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sklar</surname><given-names>CA</given-names></name><name><surname>Mertens</surname><given-names>AC</given-names></name><name><surname>Mitby</surname><given-names>P</given-names></name><name><surname>Occhiogrosso</surname><given-names>G</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Heller</surname><given-names>G</given-names></name><name><surname>Yasui</surname><given-names>Y</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name></person-group><year>2002</year><article-title>Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>87</volume><fpage>3136</fpage>–<lpage>3141</lpage>. (<pub-id pub-id-type="doi">10.1210/jcem.87.7.8606</pub-id>)<pub-id pub-id-type="pmid">12107213</pub-id></mixed-citation></ref><ref id="bib116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soriano-Guillén</surname><given-names>L</given-names></name><name><surname>Barrios</surname><given-names>V</given-names></name><name><surname>Campos-Barros</surname><given-names>A</given-names></name><name><surname>Argente</surname><given-names>J</given-names></name></person-group><year>2004</year><article-title>Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation</article-title>. <source>Journal of Pediatrics</source><volume>144</volume><fpage>36</fpage>–<lpage>42</lpage>. (<pub-id pub-id-type="doi">10.1016/j.jpeds.2003.10.036</pub-id>)<pub-id pub-id-type="pmid">14722516</pub-id></mixed-citation></ref><ref id="bib117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stochholm</surname><given-names>K</given-names></name><name><surname>Johannsson</surname><given-names>G</given-names></name></person-group><year>2015</year><article-title>Reviewing the safety of GH replacement therapy in adults</article-title>. <source>Growth Hormone and IGF Research</source><volume>25</volume><fpage>149</fpage>–<lpage>157</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ghir.2015.06.006</pub-id>)<pub-id pub-id-type="pmid">26117668</pub-id></mixed-citation></ref><ref id="bib118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strasser</surname><given-names>F</given-names></name><name><surname>Lutz</surname><given-names>TA</given-names></name><name><surname>Maeder</surname><given-names>MT</given-names></name><name><surname>Thuerlimann</surname><given-names>B</given-names></name><name><surname>Bueche</surname><given-names>D</given-names></name><name><surname>Tschöp</surname><given-names>M</given-names></name><name><surname>Kaufmann</surname><given-names>K</given-names></name><name><surname>Holst</surname><given-names>B</given-names></name><name><surname>Brändle</surname><given-names>M</given-names></name><name><surname>von Moos</surname><given-names>R</given-names></name><etal></etal></person-group><year>2008</year><article-title>Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study</article-title>. <source>British Journal of Cancer</source><volume>98</volume><fpage>300</fpage>–<lpage>308</lpage>. (<pub-id pub-id-type="doi">10.1038/sj.bjc.6604148</pub-id>)<pub-id pub-id-type="pmid">18182992</pub-id></mixed-citation></ref><ref id="bib119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaya</surname><given-names>K</given-names></name><name><surname>Ariyasu</surname><given-names>H</given-names></name><name><surname>Kanamoto</surname><given-names>N</given-names></name><name><surname>Iwakura</surname><given-names>H</given-names></name><name><surname>Yoshimoto</surname><given-names>A</given-names></name><name><surname>Harada</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Komatsu</surname><given-names>Y</given-names></name><name><surname>Usui</surname><given-names>T</given-names></name><name><surname>Shimatsu</surname><given-names>A</given-names></name><etal></etal></person-group><year>2000</year><article-title>Ghrelin strongly stimulates growth hormone release in humans</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>85</volume><fpage>4908</fpage>–<lpage>4911</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.85.12.4908</pub-id>)<pub-id pub-id-type="pmid">11134161</pub-id></mixed-citation></ref><ref id="bib120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temel</surname><given-names>JS</given-names></name><name><surname>Abernethy</surname><given-names>AP</given-names></name><name><surname>Currow</surname><given-names>DC</given-names></name><name><surname>Friend</surname><given-names>J</given-names></name><name><surname>Duus</surname><given-names>EM</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Fearon</surname><given-names>KC</given-names></name></person-group><year>2016</year><article-title>Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials</article-title>. <source>Lancet Oncology</source><volume>17</volume><fpage>519</fpage>–<lpage>531</lpage>. (<pub-id pub-id-type="doi">10.1016/S1470-2045(15)00558-6</pub-id>)<pub-id pub-id-type="pmid">26906526</pub-id></mixed-citation></ref><ref id="bib121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Till</surname><given-names>H</given-names></name><name><surname>Schlichting</surname><given-names>N</given-names></name><name><surname>Oberbach</surname><given-names>A</given-names></name></person-group><year>2015</year><article-title>Tumor-associated energy homeostasis: hepatoblastoma and neuroblastoma affect glucose and lipid metabolism as well as ghrelin, GLP-1, and PYY in nude rats</article-title>. <source>European Journal of Pediatric Surgery</source><volume>25</volume><fpage>128</fpage>–<lpage>131</lpage>. (<pub-id pub-id-type="doi">10.1055/s-0034-1386640</pub-id>)<pub-id pub-id-type="pmid">25111274</pub-id></mixed-citation></ref><ref id="bib122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>J</given-names></name><name><surname>Prigeon</surname><given-names>RL</given-names></name><name><surname>Davis</surname><given-names>HW</given-names></name><name><surname>Bidlingmaier</surname><given-names>M</given-names></name><name><surname>Tschöp</surname><given-names>MH</given-names></name><name><surname>D’Alessio</surname><given-names>D</given-names></name></person-group><year>2013</year><article-title>Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source><volume>98</volume><fpage>2536</fpage>–<lpage>2543</lpage>. (<pub-id pub-id-type="doi">10.1210/jc.2012-4162</pub-id>)<pub-id pub-id-type="pmid">23589527</pub-id></mixed-citation></ref><ref id="bib123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trivin</surname><given-names>C</given-names></name><name><surname>Busiah</surname><given-names>K</given-names></name><name><surname>Mahlaoui</surname><given-names>N</given-names></name><name><surname>Recasens</surname><given-names>C</given-names></name><name><surname>Souberbielle</surname><given-names>JC</given-names></name><name><surname>Zerah</surname><given-names>M</given-names></name><name><surname>Sainte-Rose</surname><given-names>C</given-names></name><name><surname>Brauner</surname><given-names>R</given-names></name></person-group><year>2009</year><article-title>Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index</article-title>. <source>BMC Pediatrics</source><volume>9</volume><fpage>24.</fpage> (<pub-id pub-id-type="doi">10.1186/1471-2431-9-24</pub-id>)<pub-id pub-id-type="pmid">19341477</pub-id></mixed-citation></ref><ref id="bib124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsao</surname><given-names>SM</given-names></name><name><surname>Yin</surname><given-names>MC</given-names></name><name><surname>Liu</surname><given-names>WH</given-names></name></person-group><year>2007</year><article-title>Oxidant stress and B vitamins status in patients with non-small cell lung cancer</article-title>. <source>Nutrition and Cancer</source><volume>59</volume><fpage>8</fpage>–<lpage>13</lpage>. (<pub-id pub-id-type="doi">10.1080/01635580701365043</pub-id>)<pub-id pub-id-type="pmid">17927496</pub-id></mixed-citation></ref><ref id="bib125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschöp</surname><given-names>M</given-names></name><name><surname>Smiley</surname><given-names>DL</given-names></name><name><surname>Heiman</surname><given-names>ML</given-names></name></person-group><year>2000</year><article-title>Ghrelin induces adiposity in rodents</article-title>. <source>Nature</source><volume>407</volume><fpage>908</fpage>–<lpage>913.</lpage> (<pub-id pub-id-type="doi">10.1038/35038090</pub-id>)<pub-id pub-id-type="pmid">11057670</pub-id></mixed-citation></ref><ref id="bib126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschöp</surname><given-names>M</given-names></name><name><surname>Weyer</surname><given-names>C</given-names></name><name><surname>Tataranni</surname><given-names>PA</given-names></name><name><surname>Devanaravan</surname><given-names>V</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name><name><surname>Heiman</surname><given-names>ML</given-names></name></person-group><year>2001</year><article-title>Circulating ghrelin levels are decreased in human obesity</article-title>. <source>Diabetes</source><volume>50</volume><fpage>707</fpage>–<lpage>709</lpage>. (<pub-id pub-id-type="doi">10.2337/diabetes.50.4.707</pub-id>)<pub-id pub-id-type="pmid">11289032</pub-id></mixed-citation></ref><ref id="bib127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsolakis</surname><given-names>AV</given-names></name><name><surname>Stridsberg</surname><given-names>M</given-names></name><name><surname>Grimelius</surname><given-names>L</given-names></name><name><surname>Portela-Gomes</surname><given-names>GM</given-names></name><name><surname>Falkmer</surname><given-names>SE</given-names></name><name><surname>Waldum</surname><given-names>HL</given-names></name><name><surname>Janson</surname><given-names>ET</given-names></name></person-group><year>2008</year><article-title>Ghrelin immunoreactive cells in gastric endocrine tumors and their relation to plasma ghrelin concentration</article-title>. <source>Journal of Clinical Gastroenterology</source><volume>42</volume><fpage>381</fpage>–<lpage>388</lpage>. (<pub-id pub-id-type="doi">10.1097/MCG.0b013e318032338c</pub-id>)<pub-id pub-id-type="pmid">18277901</pub-id></mixed-citation></ref><ref id="bib128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsubouchi</surname><given-names>H</given-names></name><name><surname>Yanagi</surname><given-names>S</given-names></name><name><surname>Miura</surname><given-names>A</given-names></name><name><surname>Matsumoto</surname><given-names>N</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name></person-group><year>2014</year><article-title>Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice</article-title>. <source>European Journal of Pharmacology</source><volume>743</volume><fpage>1</fpage>–<lpage>10</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ejphar.2014.09.025</pub-id>)<pub-id pub-id-type="pmid">25257464</pub-id></mixed-citation></ref><ref id="bib129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varela</surname><given-names>L</given-names></name><name><surname>Vázquez</surname><given-names>MJ</given-names></name><name><surname>Cordido</surname><given-names>F</given-names></name><name><surname>Nogueiras</surname><given-names>R</given-names></name><name><surname>Vidal-Puig</surname><given-names>A</given-names></name><name><surname>Diéguez</surname><given-names>C</given-names></name><name><surname>López</surname><given-names>M</given-names></name></person-group><year>2011</year><article-title>Ghrelin and lipid metabolism: key partners in energy balance</article-title>. <source>Journal of Molecular Endocrinology</source><volume>46</volume><fpage>R43</fpage>–<lpage>R63.</lpage> (<pub-id pub-id-type="doi">10.1677/JME-10-0068</pub-id>)<pub-id pub-id-type="pmid">21169422</pub-id></mixed-citation></ref><ref id="bib130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>K</given-names></name><name><surname>Hemminki</surname><given-names>K</given-names></name><name><surname>Grzybowska</surname><given-names>E</given-names></name><name><surname>Klaes</surname><given-names>R</given-names></name><name><surname>Burwinkel</surname><given-names>B</given-names></name><name><surname>Bugert</surname><given-names>P</given-names></name><name><surname>Schmutzler</surname><given-names>RK</given-names></name><name><surname>Wappenschmidt</surname><given-names>B</given-names></name><name><surname>Butkiewicz</surname><given-names>D</given-names></name><name><surname>Pamula</surname><given-names>J</given-names></name><etal></etal></person-group><year>2006</year><article-title>Polymorphisms in genes involved in GH1 release and their association with breast cancer risk</article-title>. <source>Carcinogenesis</source><volume>27</volume><fpage>1867</fpage>–<lpage>1875</lpage>. (<pub-id pub-id-type="doi">10.1093/carcin/bgl036</pub-id>)<pub-id pub-id-type="pmid">16606630</pub-id></mixed-citation></ref><ref id="bib131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Andersson</surname><given-names>M</given-names></name><name><surname>Iresjö</surname><given-names>BM</given-names></name><name><surname>Lönnroth</surname><given-names>C</given-names></name><name><surname>Lundholm</surname><given-names>K</given-names></name></person-group><year>2006</year><article-title>Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia</article-title>. <source>International Journal of Oncology</source><volume>28</volume><fpage>1393</fpage>–<lpage>1400.</lpage> (<pub-id pub-id-type="doi">10.3892/ijo.28.6.1393</pub-id>)<pub-id pub-id-type="pmid">16685441</pub-id></mixed-citation></ref><ref id="bib132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HS</given-names></name><name><surname>Oh</surname><given-names>DS</given-names></name><name><surname>Ohning</surname><given-names>GV</given-names></name><name><surname>Pisegna</surname><given-names>JR</given-names></name></person-group><year>2007</year><article-title>Elevated serum ghrelin exerts an orexigenic effect that may maintain body mass index in patients with metastatic neuroendocrine tumors</article-title>. <source>Journal of Molecular Neuroscience</source><volume>33</volume><fpage>225</fpage>–<lpage>231</lpage>. (<pub-id pub-id-type="doi">10.1007/s12031-007-0004-9</pub-id>)<pub-id pub-id-type="pmid">17952631</pub-id></mixed-citation></ref><ref id="bib133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>DL</given-names></name><name><surname>Cummings</surname><given-names>DE</given-names></name></person-group><year>2005</year><article-title>Regulation of ghrelin in physiologic and pathophysiologic states</article-title>. <source>Journal of Nutrition</source><volume>135</volume><fpage>1320</fpage>–<lpage>1325</lpage>.<pub-id pub-id-type="pmid">15867333</pub-id></mixed-citation></ref><ref id="bib134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>I</given-names></name><name><surname>Sadetzki</surname><given-names>S</given-names></name><name><surname>Kanety</surname><given-names>H</given-names></name><name><surname>Kundel</surname><given-names>Y</given-names></name><name><surname>Pariente</surname><given-names>C</given-names></name><name><surname>Epstein</surname><given-names>N</given-names></name><name><surname>Oberman</surname><given-names>B</given-names></name><name><surname>Catane</surname><given-names>R</given-names></name><name><surname>Kaufman</surname><given-names>B</given-names></name><name><surname>Shimon</surname><given-names>I</given-names></name></person-group><year>2006</year><article-title>Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients</article-title>. <source>Cancer</source><volume>106</volume><fpage>966</fpage>–<lpage>973.</lpage> (<pub-id pub-id-type="doi">10.1002/cncr.21690</pub-id>)<pub-id pub-id-type="pmid">16411208</pub-id></mixed-citation></ref><ref id="bib135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>YS</given-names></name><name><surname>Keum</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Cho</surname><given-names>E</given-names></name><name><surname>Giovannucci</surname><given-names>EL</given-names></name></person-group><year>2015</year><article-title>Hyperinsulinemia, insulin resistance and colorectal adenomas: a meta-analysis</article-title>. <source>Metabolism</source><volume>64</volume><fpage>1324</fpage>–<lpage>1333</lpage>. (<pub-id pub-id-type="doi">10.1016/j.metabol.2015.06.013</pub-id>)<pub-id pub-id-type="pmid">26169471</pub-id></mixed-citation></ref><ref id="bib136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimoto</surname><given-names>A</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Sugawara</surname><given-names>A</given-names></name><name><surname>Mukoyama</surname><given-names>M</given-names></name><name><surname>Yahata</surname><given-names>K</given-names></name><name><surname>Suganami</surname><given-names>T</given-names></name><name><surname>Takaya</surname><given-names>K</given-names></name><name><surname>Hosoda</surname><given-names>H</given-names></name><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><etal></etal></person-group><year>2002</year><article-title>Plasma ghrelin and desacyl ghrelin concentrations in renal failure</article-title>. <source>Journal of the American Society of Nephrology</source><volume>13</volume><fpage>2748</fpage>–<lpage>2752</lpage>. (<pub-id pub-id-type="doi">10.1097/01.ASN.0000032420.12455.74</pub-id>)<pub-id pub-id-type="pmid">12397045</pub-id></mixed-citation></ref><ref id="bib137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Dhakal</surname><given-names>IB</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Prizment</surname><given-names>AE</given-names></name><name><surname>Anderson</surname><given-names>KE</given-names></name></person-group><year>2014</year><article-title>Genetic variability in energy balance and pancreatic cancer risk in a population-based case-control study in Minnesota</article-title>. <source>Pancreas</source><volume>43</volume><fpage>281</fpage>–<lpage>286</lpage>. (<pub-id pub-id-type="doi">10.1097/MPA.0b013e3182a7c829</pub-id>)<pub-id pub-id-type="pmid">24201779</pub-id></mixed-citation></ref><ref id="bib138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Shao</surname><given-names>B</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name></person-group><year>2015</year><article-title>No association of single nucleotide polymorphisms involved in GHRL and GHSR with cancer risk: a meta-analysis</article-title>. <source>Cancer Biomarkers</source><volume>15</volume><fpage>89</fpage>–<lpage>97.</lpage> (<pub-id pub-id-type="doi">10.3233/CBM-140441</pub-id>)<pub-id pub-id-type="pmid">25524946</pub-id></mixed-citation></ref><ref id="bib139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zub-Pokrowiecka</surname><given-names>A</given-names></name><name><surname>Rembiasz</surname><given-names>K</given-names></name><name><surname>Konturek</surname><given-names>SJ</given-names></name><name><surname>Budzynski</surname><given-names>A</given-names></name><name><surname>Konturek</surname><given-names>PC</given-names></name><name><surname>Budzynski</surname><given-names>P</given-names></name></person-group><year>2010</year><article-title>Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection</article-title>. <source>Medical Science Monitor</source><volume>16</volume><fpage>CR493</fpage>–<lpage>CR500</lpage>.<pub-id pub-id-type="pmid">20885354</pub-id></mixed-citation></ref><ref id="bib140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zub-Pokrowiecka</surname><given-names>A</given-names></name><name><surname>Rembiasz</surname><given-names>K</given-names></name><name><surname>Konturek</surname><given-names>PC</given-names></name><name><surname>Budzyński</surname><given-names>A</given-names></name><name><surname>Konturek</surname><given-names>SJ</given-names></name><name><surname>Winiarski</surname><given-names>M</given-names></name><name><surname>Bielański</surname><given-names>W</given-names></name></person-group><year>2011</year><article-title>Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy</article-title>. <source>World Journal of Gastroenterology</source><volume>17</volume><fpage>449</fpage>–<lpage>458</lpage>. (<pub-id pub-id-type="doi">10.3748/wjg.v17.i4.449</pub-id>)<pub-id pub-id-type="pmid">21274374</pub-id></mixed-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Belgique/explor/OpenAccessBelV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000460 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000460 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Belgique
|area= OpenAccessBelV2
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.25. |  |